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Abstract 
Bacterial transposons typically exist in a mutually beneficial relationship with the host cell. 
Limited transposition can benefit the host while also ensuring the survival of the element. An 
important component of this relationship is that transposition must be tightly regulated. In 
this thesis I explore ways that the host and transposon each control transposition in E. coli 
and provide evidence that a transposon can also control host gene expression in S. enterica 
Typhimurium. Post-transcriptional regulation with small non-coding RNAs (sRNA) has 
emerged as a key way that bacteria respond to stress and regulate many cellular processes. 
The RNA-binding protein Hfq is the nexus of sRNA regulatory networks and acts by 
promoting base-pairing interactions between sRNAs and their target mRNAs. Previous work 
found that Hfq is a potent negative regulator of IS10 transposition in E. coli and suggested 
that Hfq inhibited transposase translation using an IS10-encoded sRNA (RNA-OUT) as well 
as an undefined mechanism that was independent of RNA-OUT. I show that Hfq promotes 
base-pairing between RNA-OUT and IS10 transposase mRNA (RNA-IN) by melting the 
secondary structure of both RNAs to expose residues involved in intermolecular base-
pairing. I also investigated how Hfq can repress translation of RNA-IN in the absence of 
RNA-OUT and demonstrate that Hfq-binding to an mRNA can directly repress translation in 
the absence of any sRNA. The data suggested Hfq may regulate other transposons and I show 
that the unrelated IS200 element is also subject to Hfq regulation. In contrast to the IS10 
system, Hfq represses IS200 transposase (tnpA) translation completely independent of the 
IS200-encoded sRNA (art200). Translation initiation on tnpA is inhibited >350-fold by the 
cooperation of Hfq, art200, and an RNA structural element in the tnpA 5’UTR illustrating 
how host- and transposon-encoded factors can coordinate to repress transposition. Lastly, I 
demonstrate that tnpA is processed to produce an sRNA that alters transcript abundance >2-
fold for 73 S. enterica Typhimurium genes, which provides a new twist on our understanding 
of host-transposon interactions. Taken together, this work suggests that RNA transactions 
play an important role in governing host-transposon relationships in bacteria. 
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Chapter 1  
1 General Introduction 
Transposable elements are ubiquitous in nature and have had a profound impact on 
reshaping genomes throughout evolution. The radical idea that genes could ‘jump’ 
throughout a genome and change chromosome structure and gene expression was first 
proposed almost 70 years ago by Barbara McClintock (McClintock, 1948). McClintock 
was studying the genetic determinants of kernel colour on the short arm of chromosome 9 
in Zea mays (maize) when she observed an increase in unstable mutations (‘mutable 
loci’) that led to phenotypic mosaicism (i.e. variegation) on individual kernels. By 
studying the chromosomes of different parts of a single kernel (which arose from a single 
zygote), McClintock found that the changes in phenotype were due to physical changes in 
the chromosome and this provided the first evidence of a dynamic genome. These 
mutable loci were proposed to be caused by the action of two unlinked genetic elements, 
Ac (Activator) and Ds (Dissociator). The Ac element caused double-strand breaks in 
chromosome 9 that led to movement, or transposition, of Ac or Ds DNA to new locations 
in the genome. Ac/Ds transposition led to fully reversible changes in gene expression at 
the loci they moved to, as well as chromosomal abnormalities that resulted from breakage 
(McClintock, 1948; McClintock, 1949; McClintock, 1950). It took the wider scientific 
community almost 30 years to accept McClintock’s concept of a dynamic genome, where 
pieces of DNA could physically move throughout a genome and alter gene expression of 
the ‘host’ organism. 
 Transposons have now been identified in all domains of life (Biémont, 2010; 
Filee et al, 2007; Siguier et al, 2014). Despite being initially viewed as ‘junk’ or ‘selfish’ 
DNA, transposons are now recognized as a driving force of evolution and genome 
plasticity in both eukaryotes and prokaryotes (Feschotte, 2008; Feschotte & Pritham, 
2007; Lapp & Hunter, 2016; Patel, 2016; Siguier et al, 2014; Volff, 2006). The focus of 
this thesis is to explore the relationship between bacterial transposons and the host cell. 
Specifically, I have investigated the ways in which the host organism and transposon 
together regulate transposition to minimize the burden of these potentially mutagenic 
genetic elements. Beginning with the model transposon, Tn10/IS10, I show in Chapters 2 
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and 3 that the Escherichia coli RNA-binding protein Hfq regulates expression of the 
transposase protein by two distinct mechanisms. In Chapter 4 I extend these studies to a 
poorly understood transposon, IS200, and characterize a combination of transposon- and 
host-encoded factors that work synergistically to silence transposition. Lastly, I present 
work in Chapter 5 that shows how a bacterial transposon can affect virulence in 
Salmonella enterica subsp. enterica serovar Typhimurium (Salmonella Typhimurium) by 
a previously unknown mechanism. 
 
1.1 Introduction to bacterial transposons 
It took 15 years from McClintock’s discovery of Ac/Ds elements in maize before the first 
transposable element was discovered in bacteria. Infection of E. coli with a temperate 
bacteriophage led to a mutator phenotype where the bacteriophage could move 
throughout the genome and affect expression of the genes at or near the integration site. 
This bacteriophage was named Mu and provided the first example of replicative 
transposition (Taylor, 1963). Soon after, small fragments of foreign DNA causing polar 
mutations in the gal operon and bacteriophage l were discovered and termed Insertion 
Sequences (IS) (Fiandt et al, 1972; Hirsch et al, 1972a; Hirsch et al, 1972b; Shapiro, 
1969). Surprisingly, these IS elements were found to be a normal component of the E. 
coli genome and often present in multiple copies (Saedler & Heiss, 1973). Similar to 
Ac/Ds and Mu, transposition of IS elements could alter expression of genes located at the 
insertion site (Saedler et al, 1974). The discovery of IS elements was soon followed by 
the observation that antibiotic resistance genes could move between plasmids and the 
chromosome (Barth et al, 1976; Hedges & Jacob, 1974), and these elements were first 
named transposons (Tn). The relationship between Tn and IS elements was finally 
recognized when two inverted copies of IS1 were found flanking a transposable toxin in 
Enterotoxigenic E. coli (ETEC) (So et al, 1979). 
 Throughout this thesis I will use the generic term transposon to refer to all 
transposable elements. However, there is tremendous variety in the genetic organization, 
size, and mechanism of bacterial transposons. The simplest transposons are IS elements, 
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which encode only the transposase enzyme (Tnp) required for transposition reactions. 
The transposase gene (tnp) is typically flanked by inverted repeats which are recognized 
by Tnp as the boundaries of the transposon. Composite transposons (Tn) consist of two 
IS elements flanking extra genes (passenger genes) that are not involved in transposition; 
these passenger genes often provide a selective advantage to the host organism (e.g. 
determinants for antibiotic resistance or virulence). Only one copy of the IS is required to 
produce a functional Tnp, which can catalyze transposition of the entire Tn or only the IS 
(Figure 1.1). The classic distinction between IS and Tn is complicated by the discovery of 
IS that carry passenger genes, conjugative Tn that also encode determinants for 
intercellular transfer, and non-autonomous transposons that require a Tnp expressed from 
an unlinked transposon (Siguier et al, 2015).  
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Figure 1.1. Overview of bacterial transposons. 
(A) Comparison of Tn and IS elements. Composite transposons (Tn) consist of two 
insertion sequences (IS; orange) flanking extra genes (passenger genes, blue) which are 
not involved in transposition reactions and typically provide a selective advantage to the 
host (e.g. antibiotic resistance genes). IS elements consist of a transposase gene (light 
orange) flanked by transposon ends (dark orange) which almost always contain inverted 
repeat sequences. Flanking ‘host’ DNA is shown in green. Note that the two IS elements 
in a Tn do not necessarily have to be identical, and only one copy needs to encode a 
functional transposase protein; IS elements in a Tn can also transpose independent of the 
rest of the Tn. (B) General transposition reaction for a non-replicative transposon (e.g. 
IS10). The transposase protein (blue) is expressed from an IS element; the transposase 
promoter is often located within or near the inverted repeats (i). Two monomers of 
transposase bind the transposon ends (dark orange, ii) to form a transpososome. A 
transposase heterodimer catalyzes the excision of transposon DNA (iii) from the donor 
site (light green), and then catalyzes the insertion of the transposon DNA into a new 
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DNA sequence (dark green, iv). The transpososome is disassembled following insertion 
and the transposon is now stably integrated into a new locus in the chromosome (v). Note 
that no genetic material is lost at the insertion site but many transposons cause a target 
site duplication. 
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1.2 Impact of transposons on genome evolution and 
adaptation 
Transposons were initially dismissed as selfish elements that propagate at the expense of 
the host organism. Transposition events can cause double-strand breaks, insertions, 
deletions, and other chromosomal rearrangements that all contribute to genomic 
instability. Accordingly, they were viewed as molecular parasites. However, transposons 
contribute to the rapid evolution of bacterial genomes and can provide a selective 
advantage to the host (Lee et al, 2016; Nevers & Saedler, 1977; Siguier et al, 2014; 
Sundaram et al, 2014). In this way, transposons exist in a mutually beneficial relationship 
with the host bacterium, where limited transposition can benefit the host as well as 
ensuring survival of the element. 
 One broad way in which transposons affect the host is by facilitating large 
chromosomal rearrangements. Transposon expansion through repeated transposition 
generates homologous sequences dispersed throughout a genome. Multi-copy 
transposons are then sites of intrachromosomal recombination that results in large-scale 
inversions, deletions, and rearrangements (Alokam et al, 2002; Daveran-Mingot et al, 
1998; Haack & Roth, 1995; He et al, 2015; Lee et al, 2016; Mahillon & Chandler, 1998). 
As bacteria are asexual, transposon-mediated genome rearrangements are major drivers 
of evolution. Transposon expansion is also thought to be the first step in genome 
streamlining that many host-adapted pathogens undergo (Plague et al, 2008; Schmitz-
Esser et al, 2011; Siguier et al, 2014; Touchon & Rocha, 2007). In addition to generating 
chromosomal rearrangements and deletions, increased transposition promotes the 
formation of pseudogenes that are subsequently lost due to purifying selection (Mira et al, 
2001; Moran & Plague, 2004). Transposition typically generates more severe mutations 
than point mutations and therefore accelerates the process of pseudogene formation that 
precedes genome reduction. 
 Transposons can also affect gene expression by shuffling regulatory elements or 
inserting into the genome such that genes are turned on or off. In Burkholderia cepacia, 
insertion of IS1490 creates a fusion promoter for the tftAB gene cluster and accordingly 
increases expression of catabolic genes for the toxin 2,4,5-trichlorophenoxyacetic acid, 
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allowing cells to use this herbicide as a sole carbon source (Hubner & Hendrickson, 
1997). Similarly, an IS2-encoded promoter leads to constitutive expression from the gal 
operon in E. coli. However, activation only occurs when IS2 inserts in one orientation; in 
the opposing orientation IS2 represses gal expression 100-fold (Saedler et al, 1974). In E. 
coli, the cryptic bgl operon is activated by insertion of IS1 and IS5 elements, but here 
activation is a result of changes to cis-regulatory elements in the bgl promoter, rather than 
a transposon-encoded promoter (Reynolds et al, 1981; Schnetz & Rak, 1992). Gene 
inactivation by transposons can also be selected for rapidly in response to a strong 
selective pressure. Infections by Yersinia pestis generate a strong immune response 
against the capsular antigen which provides an adaptive immunity against future 
infections. However, mutants of Y. pestis readily escape this adaptive immune response 
as a result of IS1541 insertion into the cafA1 gene, thereby preventing assembly of the 
antigen without compromising virulence (Cornelius et al, 2009). Interestingly, an IS1541 
insertion into the inv gene in Y. pestis is believed to have been a key speciation event and 
the loss of Inv expression from IS1541 insertion contributes to the systemic disease that 
makes plague so deadly (Simonet et al, 1996). IS1541 represents a case where a single 
transposon can contribute to evolution of a species as well as adaptation to a specific 
selective pressure. 
 In addition to causing genetic changes to the host genome, transposons 
themselves can directly contribute genes that provide a selective advantage to the host. 
By definition, these passenger genes do not contribute transposition functions but instead 
ensure survival and dissemination of the transposon. Passenger genes can encode 
determinates for virulence (Fetherston & Perry, 1994; Fetherston et al, 1992; So et al, 
1979), but are best known for conferring antibiotic resistance. In this way, transposons 
are intimately associated with the spread of antimicrobial resistance. Penicillin and 
sulfonamide were the first antibiotics used clinically and resistance to both of these drugs 
emerged within 10 years of first use (Barber & Rozwadowska-Dowzenko, 1948; Levy & 
Marshall, 2004). Likewise, streptomycin-resistant Mycobacterium tuberculosis was 
identified the same year that streptomycin was introduced (Crofton & Mitchison, 1948). 
The number and distribution of resistant bacteria has increased dramatically, in large part 
because of transposon-mediated dissemination of these genes (Caniça et al, 2015). 
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Several transposons were first isolated from antibiotic-resistant bacteria and more 
transposons are discovered alongside antibiotic resistance determinates to this day (Carias 
et al, 1998; Ferreira et al, 2016; Petrovski et al, 2011; Rice & Carias, 1998; Warburton et 
al, 2007). Vancomycin and colistin are last-line antibiotics for multi-drug resistant Gram-
positive and Gram-negative bacteria respectively. Genes encoding resistance to both of 
these antibiotics (vancomycin, vanA; colistin, mcr-1) have been recently found as part of 
composite transposons Tn1546 and ISApl1, respectively (Qureshi et al, 2014; Snesrud et 
al, 2016). Transposons help the spread of antibiotic resistance genes indirectly by 
facilitating the evolution of other mobile genetic elements (MGE) such as bacteriophage 
and plasmids. Transposons accomplish this by shuffling genes between MGE and 
chromosomes. It is also tempting to speculate that the strong selective pressure applied by 
antibiotic use rapidly causes the evolution of composite transposons. Here, resident IS 
elements can form a composite transposon with antibiotic resistance determinants and 
generate a new transposon which can rapidly spread antibiotic resistance genes 
throughout a bacterial population. 
 
1.3 Regulation of bacterial transposons 
A key component of the host-transposon relationship is that transposition must be tightly 
regulated. Although transposons contribute to genetic variability and often carry 
beneficial genes, high levels of transposition leads to genomic instability of the host 
(Curcio & Derbyshire, 2003). Accordingly, bacteria employ a number of mechanisms to 
limit the amount of transposition to protect genomic integrity. Additionally, transposons 
themselves exhibit self-restraint which ensures survival of the element by avoiding 
killing of the host.  
1.3.1 Intrinsic control of transposition 
The frequency of transposition in a given cell is typically determined by the amount of 
transposase protein present. Transposase expression is accordingly a key point of 
regulation for controlling transposition in bacteria. 
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 Many endogenous promoters for transposase genes are inherently weak thus 
limiting transcription. For example, the promoters for IS30, IS1911, and IS10 transposase 
are all <10% as active as pLacUV5, while promoter activity for IS21 is undetectable in 
vivo (Dalrymple & Arber, 1985; Duval-Valentin et al, 2001; Reimmann et al, 1989; 
Simons et al, 1983). Additionally, many promoters overlap with the transposase binding 
site in the terminal inverted repeat of the element (Figure 1.1B, i). This allows a form of 
feedback inhibition where transposase expression (or in some cases a C-terminally 
truncated protein) inhibits its own transcription (Duval-Valentin et al, 2001; Hu et al, 
1994; Zerbib et al, 1990). The production of truncated transposase proteins is also a 
feature common to many elements. The catalytic domain for most transposases is located 
in the C-terminal domain, so premature transcription termination generates an inactive 
transposase (Nagy & Chandler, 2004). For IS50, an internal promoter generates an N-
terminally truncated transposase that forms non-productive transposase heterodimers and 
inhibits transposase activity (Johnson & Reznikoff, 1984). 
 Transposase expression is also repressed by intrinsic post-transcriptional control. 
Transposition into an actively transcribed gene might be expected to increase transposase 
expression by read-through transcription from adjacent genes. However, IS10 and IS50 
encode symmetrical repeats that form an mRNA secondary structure that sequesters the 
translation initiation region (TIR) and blocks translation. One of these repeats is upstream 
of the native promoter, so only read-through transcripts form this structure (Kleckner, 
1990a; Krebs & Reznikoff, 1986; Ma et al, 1994). Intrinsically weak Shine-Dalgarno 
sequences, programmed translational frameshifting, and leaderless mRNAs also 
contribute to weak translation of transposase mRNAs (Kleckner, 1990b; Nagy & 
Chandler, 2004). Transposons can also encode regulatory RNAs that inhibit transposase 
expression. IS10 encodes an antisense RNA (asRNA, RNA-OUT) that is complementary 
to the first 35nt of transposase mRNA (RNA-IN). Base-pairing between RNA-OUT and 
RNA-IN prevents ribosome binding and leads to degradation of RNA-IN (Kittle et al, 
1989; Ma & Simons, 1990; Simons & Kleckner, 1983). For IS30, the asRNA (RNA-C) is 
complementary to the transposase coding sequence and is proposed to block translation 
elongation (Arini et al, 1997). The advent of transcriptomics in a range of bacteria has 
identified at least 17 novel asRNAs to transposases indicating that this mode of 
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regulation is widespread: however, only two asRNAs have been functionally 
characterized (reviewed in (Ellis & Haniford, 2016)). 
 In addition to poor expression, transposase proteins themselves are typically 
unstable including IS1 and IS911 transposase (Haren et al, 1997; Reif & Saedler, 1975). 
Lastly, formation of the transpososome (a higher order complex of transposon DNA and 
transposase) and the transposition reaction catalyzed by transposase are inefficient due to 
suboptimal protein-DNA interactions and inefficient catalysis by transposase (Gueguen et 
al, 2005).  
1.3.2 Host factors affecting transposition 
Bacterial cells control transposition by regulating almost every step in transposition 
including transcription initiation, translation, transposase-DNA interactions, 
transpososome dynamics, and post-translational control of transposase levels.  
 Transposition is repressed in two ways by DNA Adenine Methyltransferase 
(Dam). First, many transposase promoters are repressed by Dam-methylation including 
IS10, IS50, IS3, and IS903. Transposase promoters are almost always located at the ends 
of transposons and accordingly overlap with transposase binding sites. Methylation 
interferes with transposase-DNA interactions for IS10 and IS50 (and likely most 
transposases), and therefore Dam can represses expression and function of transposase 
proteins (Roberts et al, 1985; Spielmann-Ryser et al, 1991; Yin et al, 1988). Epigenetic 
control of transposons accomplishes two things: (i) transposition is linked to cell-cycle, 
and (ii) transposase proteins will act preferentially in cis. DNA is hemi-methylated 
following replication and transposase transcription will therefore be highest in the short 
amount of time between replication and re-establishment of methylation by Dam. 
Additionally, transposase will preferentially bind to hemi-methylated DNA which leads 
to a cis-bias where transposase proteins act preferentially on the DNA they were 
expressed from. There are few examples of other host factors affecting transposase 
expression. The global transcription factors LexA and Crp are proposed to directly 
control transcription of IS50 transposase (Kuan & Tessman, 1991; Ross et al, 2014). Less 
is known about post-transcriptional regulation of transposase expression: RNase E 
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degrades IS10 transposase mRNA as a consequence of translational inhibition, and the 
RNA-binding protein Hfq represses IS10 transposase translation (Jain & Kleckner, 1993; 
Ross et al, 2010). 
 Transposition is also controlled by the host at the post-translational level. Proteins 
involved in nucleoid architecture commonly control formation and stability of the 
transpososome (Mahillon & Chandler, 1998; Nagy & Chandler, 2004). IHF, HU, and H-
NS all interact with transposon sequence in vitro and in vivo stimulate transpososome 
assembly or transposition (Lavoie & Chaconas, 1993; Signon & Kleckner, 1995; Surette 
et al, 1989; Wardle et al, 2005; Whitfield et al, 2009). The stability of transposase 
proteins may also be an important way that the host ensures transposase proteins act in 
cis. Lon protease rapidly degrades the IS903 transposase (half-life < 3 min) by 
recognizing the C-terminal portion of the protein. In cis, the transposase N-terminal 
domain can interact with transposon DNA co-translationally, resulting in the initial 
formation of the transpososome before the labile C-terminus is produced (Derbyshire et 
al, 1990). Additional host factors for transposition include Gyrase and Topisomerase I 
(Pato & Banerjee, 1996), DnaA (Yin & Reznikoff, 1987), and ClpX (Levchenko et al, 
1995). 
 
1.4 Transposons and stress response 
In her Nobel Prize acceptance speech, McClintock proposed that the host organism could 
‘activate’ transposition in response to stress (McClintock, 1984). A transient increase in 
transposition could lead to mutations that allow the host to adapt to extreme stress as well 
as ensuring the survival of the transposon. There is some evidence that transposon 
activity increases in response to bacterial stress. UV radiation induces IS10 transposition 
in E. coli (Eichenbaum & Livneh, 1998) and ISDra2 transposition in Deinococcus 
radiodurans (Pasternak et al, 2010), tetracycline exposure stimulates the CTnDOT 
conjugative transposon in Bacteroides (Shoemaker & Salyers, 1988), and IS1 insA 
transcription increases in E. coli in response to elevated concentrations of divalent metals 
(Brocklehurst & Morby, 2000). The molecular mechanisms underlying transposon 
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activation are not clear, although activation by host factors rather than changes in 
intrinsic regulation appears to be more likely. In Pseudomonas putida nutrient limitation 
during stationary phase growth induces the stress-responsive sigma factor, sS, and 
increases transcription of Tn4652 transposase (Ilves et al, 2001). The involvement of Hfq 
in repressing Tn10 and Tn5 transposition (Ross et al, 2014; Ross et al, 2010) might be 
another way that transposons respond to stress. Hfq is a global regulator of stress 
responses in bacteria and acts by promoting the action of small non-coding RNAs. 
 
1.5 Regulatory RNA in bacteria 
The central dogma of molecular biology was proposed in 1958 by Francis Crick and 
reinforced almost 20 years of belief that RNA acted as an intermediate between DNA and 
protein (Crick, 1958). This view began to change in the 1970s with the discovery of long 
noncoding RNAs and self-splicing catalytic RNAs in eukaryotes (Morris & Mattick, 
2014). It was not until 1981 that the first regulatory RNA in bacteria was discovered. The 
~108 nt RNA I inhibited replication of the ColE1 plasmid by base-pairing with the RNA 
that is processed to produce the replication primer (Tomizawa & Itoh, 1981). While 
eukaryotic regulatory RNAs continued to be discovered at an accelerating rate, bacterial 
regulatory RNAs were thought to be peculiar to extrachromosomal DNA such as 
plasmids and transposons. This view changed 15 years ago with the discovery that 
regulatory RNAs are widespread in bacteria and play an essential role in regulating many 
biological processes (Waters & Storz, 2009). 
1.5.1 Base-pairing small RNAs (sRNA) 
The largest class of regulatory RNA in bacteria are small non-coding RNAs (sRNA). The 
first sRNAs discovered in E. coli were expressed from intergenic regions of the 
chromosome, were 50-250 nts long, and contained a Rho-independent transcriptional 
terminator (Gottesman, 2004). These observations guided the first computational 
searches for sRNAs which together identified almost 150 novel sRNAs in E. coli, over 30 
of which were experimentally validated (Argaman et al, 2001; Chen et al, 2002; Rivas et 
al, 2001; Wassarman et al, 2001). In recent years it has become clear that untranslated 
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regions of mRNAs are also a rich source of sRNAs (Chao et al, 2012; Chao & Vogel, 
2016; Guo et al, 2014; Miyakoshi et al, 2015a; Miyakoshi et al, 2015b). sRNAs regulate 
gene expression at the post-transcriptional level by base-pairing mechanisms. Because 
sRNAs are expressed from loci distinct from their target, they are also referred to as 
trans-acting sRNA (Figure 1.2A). sRNAs share limited and often discontinuous 
complementarity with target mRNAs, typically consisting of 6-8 nt seed regions (perfect, 
continuous complementarity) with up to 20 nt of additional discontinuous 
complementarity.  
Base-pairing between an sRNA and mRNA can increase protein synthesis but the 
vast majority of sRNAs repress target protein expression (common mechanisms for target 
repression and activation are summarized in Figure 1.2B). The translation initiation 
region (TIR) is a ~50-60 nt region at the 5’end of protein coding genes that includes the 
Shine-Dalgarno (SD) sequence and translation initiation codon (typically AUG); the TIR 
begins up to 40 nts upstream of AUG and ends at the fifth translated codon (nts -40 to 
+15 relative to AUG) (Huttenhofer & Noller, 1994; Shine & Dalgarno, 1975). Base-
pairing between an sRNA and any part of the TIR is able to inhibit translation by 
sterically occluding 30S ribosome binding (Bouvier et al, 2008). However, sRNAs such 
as GcvB and RyhB inhibit translation by base-pairing far upstream of the TIR and 
masking a translational enhancer and inhibiting an upstream ORF respectively (Sharma et 
al, 2007; Vecerek et al, 2007). Active translation typically stabilizes mRNAs by 
protecting from cellular ribonucleases (usually RNase E) and other components of the 
degradosome (Jain & Kleckner, 1993; Mohanty & Kushner, 2016). mRNA turnover is 
therefore a secondary effect of translational repression and ensures repression is 
irreversible (Morita et al, 2006). sRNAs can also directly recruit RNase E and other 
components of the degradosome to induce mRNA degradation and this is the main 
pathway for sRNAs that base-pair outside the TIR (Bandyra et al, 2012; Caron et al, 
2010; Masse et al, 2003). 
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Figure 1.2. Common mechanisms for sRNA-mediated gene regulation. 
(A) Gene schematics for bacterial sRNAs and target mRNAs. Canonical sRNAs (blue) 
are located in intergenic regions, are 50-250 nt long, contain a Rho-independent 
terminator (3’ stem-loop structure followed by a poly-U stretch), and have a promoter 
that is strongly induced in response to stress or external stimuli. Many sRNAs contain 
additional structural elements that can be important for stability and/or function. Target 
mRNAs (red) are encoded in a different region of the genome. The translation initiation 
region (TIR) is a 50-60 nt region at the 5’end of a protein coding gene and contains the 
ribosome binding site (encompassing the Shine-Dalgarno sequence), translation initiation 
codon (typically AUG), and the sequence immediately surrounding these elements. (B) 
Common modes of sRNA-mediated gene regulation. sRNAs (blue) base-pair with target 
mRNAs (red) by limited and discontinuous sequence complementarity. The consequence 
of base-pairing is repression (red box) or activation (green box) of protein synthesis. 
Most sRNAs base-pair with the TIR which blocks ribosome (grey circles) binding (i); as 
ribosomes typically protect mRNAs from RNase cleavage, a secondary consequence of 
blocking translation is degradation of the mRNA by cellular RNases (scissors). sRNA 
base-pairing outside of the TIR can recruit cellular RNases and induce transcript 
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degradation independent of inhibition of translation initiation (ii). Translation of some 
mRNAs is inhibited by secondary structure, and sRNAs can base-pair with an mRNA and 
induce structural changes that allows ribosome access (iii). Lastly, sRNAs can bind and 
mask RNase recognition sequences on mRNAs and prevent degradation of the mRNA 
(iv). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
16 
 
sRNAs can also increase protein expression although this mode of action is less 
common. In the best studied example, the 5’UTR of rpoS (the stress-responsive sigma 
factor, sS) forms a secondary structure that sequesters the TIR. DsrA binding to the rpoS 
5’UTR remodels this secondary structure and activates translation (Lease et al, 1998; 
Majdalani et al, 1998). sRNAs can also stabilize mRNAs and therefore increase protein 
expression independent of controlling translation (Fröhlich et al, 2013; Papenfort et al, 
2013). 
 Transcription of most sRNAs is induced (up to 100-fold) in response to specific 
stimuli such as outer membrane stress (MicA, RybB), sugar-phosphate stress (SgrS), low 
iron (RyhB), or oxidative stress (OxyS) (Waters & Storz, 2009). Transcriptional 
activation of sRNAs can occur through repressors and activators. The ferric iron uptake 
repressor (Fur) inhibits RyhB transcription in the presence of iron. In iron-limiting 
conditions, RyhB expression is de-repressed and RyhB then inhibits expression of iron-
storage and -binding proteins (e.g. sdhCDAB) to increase iron availability in the cell 
(Masse et al, 2003; Massé & Gottesman, 2002). In contrast, sugar-phosphate stress (e.g. 
accumulation of glucose-6-phosphate) leads to activation of SgrR which is a 
transcriptional activator of SgrS (Vanderpool & Gottesman, 2004). SgrS combats sugar-
phosphate stress by repressing glucose transporters and stabilizing the mRNA for a sugar 
phosphatase (Kawamoto et al, 2006; Papenfort et al, 2013; Rice et al, 2012). However, 
some sRNAs are expressed and repress their targets constitutively. ChiX is transcribed 
constitutively in the absence of chitin and represses the chitin transporter chiP. The 
presence of chitin induces degradation of ChiX, thereby increasing ChiP expression 
(Figueroa-Bossi et al, 2009; Rasmussen et al, 2009). sRNAs can be synthesized faster 
than protein regulators and can therefore provide a rapid response, in many cases acting 
within minutes of induction to regulate target mRNAs. sRNAs also have an advantage 
over protein regulators because the regulatory molecule does not need to be translated, 
which conserves time and resources within the cell. This ensures bacteria are able rapidly 
and efficiently adapt to stress conditions. Finally, sRNAs can target multiple mRNAs 
which allows the coordinate expression of a network of functionally related proteins 
(Wagner & Romby, 2015). 
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1.5.2 Antisense RNAs (asRNA) 
Antisense RNAs (asRNAs) are often considered a subclass of sRNAs, with the key 
difference being that they are encoded on the opposite strand of DNA to the mRNA they 
regulate (also called cis-acting sRNA). Accordingly, asRNAs share extensive and perfect 
complementarity (30 to >300 nt) with their mRNA (Wagner et al, 2002). Most asRNAs 
have been identified in MGE (plasmids, transposon, and bacteriophage) although 
transcriptomics experiments have identified asRNAs as a natural component of many 
bacterial genomes; over 300 putative asRNAs were discovered in E. coli, 21 of which 
have been experimentally validated (Lybecker et al, 2014; Sesto et al, 2013). Like 
sRNAs, asRNAs act by base-pairing with mRNAs although the consequences of pairing 
are diverse (Figure 1.3). asRNAs can regulate transcription attenuators, stabilize or 
induce degradation of mRNAs, and repress translation (Brantl, 2007). Unlike sRNAs, 
most asRNAs are constitutively expressed. Because of extensive complementarity 
between asRNAs and mRNAs, pairing results in an extended duplex that is frequently 
targeted for degradation by RNase III. A single asRNA can also regulate divergently 
encoded genes. Here, an asRNA for one gene/operon can increase transcription of the 
neighboring gene/operon. The result is that a single asRNA represses one group of genes 
while activating a neighboring set of genes, and this arrangement is accordingly referred 
to as an excludon (Sesto et al, 2013). In most cases the asRNA ensures discordant 
expression of genes with opposing functions. 
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Figure 1.3. Common mechanisms employed by antisense RNAs. 
Antisense RNAs (asRNA) regulate (A) transcription, (B) translation, (C,D) plasmid 
replication, and (E,F) can affect mRNA stability. Antisense RNAs are shown in red, 
mRNAs in blue, and black rectangles indicate promoters. Black and green arrows 
indicate the action of RNases. Reprinted from Current Opinion in Microbiology, Volume 
10, S. Brantl, Regulatory mechanisms employed by cis-encoded antisense RNAs, Pages 
102-109, 2007, with permission from Elsevier. 
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1.5.3 RNAs that regulate protein activity and riboswitches 
Regulatory RNAs can also act by antagonizing the action of RNA-binding proteins. CsrA 
(carbon storage regulator) regulates gene expression at the post-transcriptional level by 
binding GGA motifs typically located in the 5’UTR of target mRNAs (Babitzke & 
Romeo, 2007). CsrA binding to mRNAs usually inhibits translation by blocking 
ribosome access and translation inhibition leads to transcript turnover. CsrA binding can 
also stabilize mRNAs by an unclear mechanism. Two regulatory RNAs, CsrB and CsrC, 
antagonize CsrA by mimicking substrates and titrating CsrA away from target mRNAs 
Similarly, the 6S RNA mimics an open promoter and sequesters s70 containing RNA 
polymerase ultimately repressing transcription of s70-dependent promoters (Wassarman, 
2007). 
 Riboswitches are structural elements in mRNAs that undergo conformation 
changes to regulate transcription or translation. These cis-regulatory elements differ from 
the above examples of regulatory RNA because they are not expressed as an independent 
RNA, instead they regulate the same molecule of RNA they are encoded on. 
Riboswitches can sense stalled ribosomes, changes in temperature (also referred to as 
RNA thermometers), tRNA availability, or even small molecule ligands (Grundy & 
Henkin, 2006; Waters & Storz, 2009). 
 
1.6 Hfq 
Hfq was first identified in 1968 as a host factor for Qb phage replication (Franze de 
Fernandez et al, 1968). Early studies of Hfq revealed that it is an abundant, heat-stable 
protein that binds single-stranded AU-rich sequences on RNA (de Haseth & Uhlenbeck, 
1980a; de Haseth & Uhlenbeck, 1980b; Franze de Fernandez et al, 1972; Hori & 
Yanazaki, 1974; Senear & Steitz, 1976). The first hint of the importance of Hfq was the 
finding that a hfq mutant was extremely pleiotropic, exhibiting decreased growth rate and 
altered cell morphology, increased sensitivity to osmotic and UV stress, and decreased 
plasmid supercoiling (Tsui et al, 1994). Hfq is now recognized as a central component of 
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many bacterial stress and virulence responses, acting as a chaperone for sRNAs 
(Papenfort & Vogel, 2010; Vogel & Luisi, 2011). 
1.6.1 Structure and RNA-binding properties 
Hfq is a member of the Sm/LSm family of RNA-binding proteins and is present in over 
half of all sequenced bacteria (Sobrero & Valverde, 2012; Sun et al, 2002). The E. coli 
Hfq monomer is 102 amino acids (11.2 kDa) and consists of a compact LSm domain 
(consisting of an Sm1 and Sm2 motif) with a ~40 residue intrinsically disordered C-
domain (CTD). Hfq monomers assemble into a toroidal homohexamer that contains three 
RNA-binding surfaces (Figure 1.4; reviewed in (Brennan & Link, 2007; Sauer, 2013; 
Updegrove et al, 2016)). 
 The N-terminus of each monomer forms the proximal binding surface (located on 
the ‘top’ of the hexamer). A nucleotide binding pocket located in the monomer-monomer 
interface interacts primarily with uracil (U; to a lesser extent adenine, A) residues and 
accordingly the proximal surface can interact with a U6 motif. A group of glutamine (Q8) 
and lysine residues (K41, K56, K57) together provide specificity for U and A and a 
phenylalanine (F42) is involved in base-stacking interactions. The proximal surface is 
thought of as the sRNA-binding surface and preferentially interacts with the poly-U tail 
following the Rho-Independent terminator found on almost all sRNAs. Additional 
specificity for Rho-Independent terminators comes from preferential binding to 
structured regions and 3’OH (Ishikawa et al, 2012; Sauer & Weichenrieder, 2011). 
 The opposing distal surface of Hfq (located on the ‘bottom’ of the hexamer) is 
viewed as the mRNA-binding surface. Each monomer of Hfq binds an ARN triplet, 
where R refers to either purine and N is any nucleotide. Discrimination for the A site is 
largely due to hydrogen bonding between glutamine (Q33) and N6/7 on adenine, and a 
conserved tyrosine (Y25) forms base-stacking interactions with the purine in the R site 
(Link et al, 2009). The preferred binding motif for the distal surface on the hexamer is 
accordingly (ARN)6. 
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Figure 1.4. Structure of Hfq. 
(A) Secondary structural elements highlighting the conserved Sm1 and Sm2 motifs in 
Hfq. (B,C) Each protomer is a a-b1-5 structural unit (i.e. one a-helix and five b-strands) 
in which the b-strands form antiparallel sheets. The b2-strand is twisted and curved to 
such an extent that it contributes to both sheets to form a self-closing, squat barrel. The 
N-terminal helix and squat barrel are structural signatures of Hfq-Sm-LSm proteins. The 
b4 and b5 strands on the periphery of each Hfq subunit expose hydrogen-bonding edges 
that interact with the strands of the neighboring protomers, so that sheets effectively 
continue over the entire ring. (D) Two faces for interaction with RNAs (orange) are 
presented on opposite sides of the Hfq ring. The proximal face (the surface on which the 
N-terminal a-helix is exposed) includes residues in the Sm2 sequence motif. Disordered 
tails are likely to emanate from the equator of the Hfq ring and may form distributive 
electrostatic interactions with nucleic acids. This figure and legend is adapted by 
permission from Macmillan Publishers Ltd: NATURE REVIEWS MICROBIOLOGY 
(Vogel & Luisi, 2011), copyright 2011. 
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The lateral (or rim) surface of Hfq connects the proximal and distal surfaces. In Gram-
negative bacteria, this surface is extremely basic and is mostly thought to interact non-
specifically with RNA. A cluster of arginine residues (R17/18/19) are required for Hfq’s 
chaperone activity in many systems, and this surface is proposed to be the active site for 
sRNA-mRNA pairing (see below) (Panja et al, 2013).  Intriguingly, the lateral surface is 
acidic in gram-positive bacteria where Hfq is mostly uninvolved in post-transcriptional 
regulation (Sobrero & Valverde, 2012; Vogel & Luisi, 2011; Zheng et al, 2016). 
 The role of the Hfq CTD has remained controversial (Sobrero & Valverde, 2012; 
Updegrove et al, 2016) but recent work indicates that the CTD plays an important role in 
promoting the release of sRNA-mRNA paired species (see below) and regenerating Hfq 
for further catalysis (Santiago-Frangos et al, 2016). The CTD is proposed to ‘sweep’ the 
proximal surface and promote release of sRNAs thereby preventing the sequestration of 
Hfq in nonproductive Hfq-sRNA complexes. 
1.6.2 Role of Hfq in post-transcriptional regulation 
The canonical role of Hfq in post-transcriptional regulation is to facilitate sRNA-
mediated regulation of mRNAs (Hopkins et al, 2011; Moller et al, 2002; Soper & 
Woodson, 2008; Zhang et al, 2002). Hfq is believed to accomplish this with dedicated 
RNA-binding surfaces: the proximal surface binds sRNAs, the distal surface binds 
mRNAs, and the rim contributes to non-specific RNA interactions (Figure 1.5A). First 
and foremost, Hfq stabilizes almost all sRNAs by protecting from RNases and the 
degradosome (Figure 1.5B). For example, the half-life of RyhB decreases from >30 min 
in a WT strain to <1 min in an hfq-null strain (Masse et al, 2003). Second, Hfq is required 
for the function of almost all sRNAs in vivo and accelerates the rate of sRNA-mRNA 
pairing in vitro. The mechanism for Hfq-catalyzed pairing appears to vary based on the 
specific sRNA-mRNA pair (Schu et al, 2015; Zhang et al, 2013). In the simplest model, 
Hfq binds both an sRNA and mRNA pair and increases the local concentration of each 
RNA as well as correctly orienting the pairing sequences on each RNA (Figure 1.5C, i) 
(Panja & Woodson, 2012). The positively charged lateral surface may also provide an 
electrostatically favorable environment for nucleating pairing (ii) (Panja et al, 2013; 
Zheng et al, 2016). 
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Figure 1.5. Main functions of Hfq in post-transcriptional regulation. 
(A) Cartoon of Hfq hexamers highlighting the three RNA-binding surface. The proximal 
surface (blue) interacts with sRNAs and is located on the ‘top’ of the toroidal 
homohexamer. The distal surface (red) is on the opposing surface and interacts with 
mRNAs. The lateral surface or rim (purple) is on the side of the hexamer and connects 
the distal and proximal surfaces. The unstructured CTD of each monomer is shown with 
black lines and is omitted for clarity in the rest of the figure. (B) Hfq binds the Rho-
independent terminator at the 3’end of sRNAs (blue) to protect from degradation by 
cellular RNases (scissors). (C) The proximal surface of Hfq binds an sRNA (blue) and 
the cognate mRNA (red) interacts with the distal surface (on the same hexamer). Pairing 
between complementary sequences (yellow) can be accelerated by Hfq increasing the 
local concentration and/or orienting the RNAs correctly (i). Alternatively, pairing is 
25 
 
catalyzed on the lateral surface (ii). (D) Pairing sequences on sRNAs (blue) or mRNAs 
(not shown) can be sequestered in secondary structure. Hfq binding can remodel the RNA 
to expose this sequence. 
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Lastly, Hfq can actively remodel an sRNA and/or mRNA to expose pairing 
sequences (Figure 1.5D) (Geissmann & Touati, 2004; Soper et al, 2011; Updegrove et al, 
2016). The requirement of Hfq in sRNA-mRNA pairing partially stems from the 
instability of an sRNA-mRNA duplex. For this reason Hfq was not believed to be 
important for asRNAs, which share extensive complementarity with their partner mRNAs 
(Gottesman & Storz, 2011; Thomason & Storz, 2010). In vitro experiments have 
demonstrated that sRNA-mRNA complexes formed in the presence of Hfq are more 
stable than those formed without (Soper et al, 2010; Soper & Woodson, 2008), and it’s 
believed that Hfq promotes more extensive pairing than could occur in the absence of 
Hfq . 
 With regards to facilitating pairing, Hfq is an accessory protein for post-
transcriptional control while sRNAs are the effector molecule. There is some evidence 
that Hfq can act autonomously to repress translation (Salvail et al, 2013; Vecerek et al, 
2005; Vytvytska et al, 2000) as well as one example where the role of Hfq and an sRNA 
are switched. The sRNA Spot42 recruits Hfq to the TIR of sdhC mRNA and the 
association of Hfq with sdhC represses translation (Desnoyers & Masse, 2012). In this 
case Hfq is the effector protein and Spot42 is an accessory factor for translational control. 
 
1.7 Mobile genetic elements and pathogenesis of 
Salmonella Typhimurium 
Many bacterial pathogens contain foreign DNA that has been acquired over evolutionary 
time and contributes to virulence (Frost et al, 2005). For the closely related organisms, E. 
coli and Salmonella enterica subsp. enterica serovar Typhimurium, all phenotypic 
differences are due to horizontally acquired genes (Ochman et al, 2000). In S. 
Typhimurium, pathogenesis is almost exclusively due to genes encoded in prophage 
(bacteriophage lysogen) and large segments (10-200 kb) of horizontally acquired DNA 
referred to as Salmonella pathogenicity islands (SPI) (Figueroa-Bossi et al, 2001; Gyles 
& Boerlin, 2014; Juhas et al, 2009; Moreno Switt et al, 2012). 
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 S. Typhimurium is a foodborne pathogen that causes a generally self-limiting 
gastrointestinal illness and is the main cause of hospitalizations and deaths due to 
foodborne disease in the United States (Elaine et al, 2011). S. Typhimurium and related 
serovars of S. enterica cause approximately 155,000 deaths worldwide, with over 93 
million cases each year (Feasey et al). S. Typhimurium employs two main type-III 
secretion systems (T3SS) encoded by SPIs (SPI-1 and SPI-2) to infect mammalian hosts. 
T3SS have two components: (i) structural proteins that assemble to form the needle 
complex in the bacterial membrane, and (ii) effector proteins that are injected into the 
cytosol of host-cells (de Jong et al, 2012). The two main T3SS used by S. Typhimurium 
are encoded by SPI-1 and SPI-2.  
 SPI-1 is a ~40kb genomic island that encodes the T3SS required for invasion of 
non-phagocytic cells. SPI-1 is crucial for S. Typhimurium crossing the intestinal 
epithelium in infected hosts (Lostroh & Lee, 2001; Que et al, 2013). SPI-1 encoded 
effector proteins are injected into the host cell and perturb host signal transduction 
pathways to induce cytoskeleton rearrangements and membrane ruffling, leading to the 
engulfment of the bacteria in a phagosome (Salmonella containing vacuole, SCV). SPI-2 
genes become activated inside the SCV and are important for intracellular survival 
(Ibarra & Steele-Mortimer, 2009). 
 
1.8 Scope of this thesis 
There is a wealth of information about transcriptional and post-translational regulation of 
bacterial transposons, but much less is known about post-transcriptional regulation of 
transposase expression. In Chapters 2 and 3 I investigate post-transcriptional regulation 
of the model transposon, Tn10/IS10, and show that the host bacterium regulates 
transposition at the post-transcriptional level. I provide evidence in Chapter 2 that the E. 
coli RNA-binding protein Hfq catalyzes antisense pairing between IS10 transposase 
mRNA (RNA-IN), and a cis-encoded asRNA (RNA-OUT). Hfq was previously 
implicated in translational control of IS10 transposase expression (Ross et al, 2010), but 
exactly how Hfq accomplishes this was unclear. My work shows that Hfq alters the 
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secondary structure of both RNA-IN and RNA-OUT to expose sequence otherwise 
sequestered in secondary structure. I present work in Chapter 3 that shows that Hfq 
regulates IS10 transposase expression in an antisense-independent manner. In the absence 
of RNA-OUT, Hfq represses transposase translation by directly binding to the TIR and 
blocking ribosome binding. This is one of only a few examples where Hfq regulates 
protein synthesis in the absence of a regulatory RNA. Additionally, I show that induction 
of an sRNA can perturb transposon regulation by Hfq and this provides evidence that Hfq 
links bacterial stress responses to transposition at the post-transcriptional level.  
 In Chapter 4, I expand my studies to a unrelated transposon, IS200. The 
identification of an asRNA encoded by IS200 led us to ask if Hfq regulates a second 
antisense system in a similar way to IS10. Unlike IS10, Hfq does not participate in 
antisense regulation but does directly repress translation. I show Hfq works 
synergistically with an asRNA and mRNA secondary structure in the transposase mRNA 
to repress transposition. Importantly, we demonstrated for the first time that IS200 
transposition could be measured under standard laboratory conditions, but only when we 
disrupted post-transcriptional control. My work provides an explanation for the long-
standing observation that IS200 elements are essentially dormant transposons. This work 
also shows that the host bacteria and transposon encode negative regulators of 
transposition that work together to inhibit a single step in transposition (transposase 
translation initiation). 
 Lastly, I present evidence in Chapter 5 that a transposon-encoded RNA regulates 
gene expression in S. Typhimurium. The finding that IS200 is silenced by three 
seemingly redundant post-transcriptional mechanisms prompted me to ask if IS200-
encoded RNAs serve a transposition-independent role in S. Typhimurium. IS200 
elements are highly conserved and are present in multiple copies in many Salmonella 
enterica genomes, despite being inactive transposons. I speculated that there might be a 
selective advantage to the host bacteria by maintaining IS200 elements in high copy-
number. Since the transposase protein is almost never synthesized, I profiled gene 
expression in S. Typhimurium under conditions where expression of IS200-encoded 
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RNAs was altered. My work shows that the IS200 transposase mRNA is processed to 
produce a trans-acting sRNA that regulates SPI-1 gene expression in S. Typhimurium.  
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Chapter 2  
2 Hfq restructures RNA-IN and RNA-OUT and facilitates 
antisense pairing in the Tn10/IS10 system1 
2.1 Introduction 
Small RNAs (sRNAs) have emerged as important components of gene expression 
regulatory networks in bacteria. sRNAs generally function by base-pairing to mRNAs 
with which they share at least partial sequence complementarity. Base-pairing between 
sRNAs and mRNAs typically influences translation and/or stability of the mRNA (for 
reviews, see (Gottesman & Storz, 2011; Vogel & Luisi, 2011)). sRNAs are categorized as 
either trans- or cis-encoded. Trans-encoded sRNAs are expressed from distinct loci 
relative to the transcripts they regulate, whereas cis-encoded sRNAs are expressed from 
the strand opposite their target mRNA and, consequently, are perfectly complementary to 
at least a portion of their target RNA (Figure 2.1A). Cis-encoded sRNAs are also referred 
to as antisense RNAs (or asRNA). The regulation imposed by many trans-encoded 
sRNAs is dependent on the protein Hfq, an Sm-family protein that is present in many 
bacterial species. With regard to sRNA-based regulation, Hfq functions by promoting the 
pairing of sRNAs to their target mRNAs (Moller et al, 2002; Vogel & Luisi, 2011; Zhang 
et al, 2002). The expression of many trans-encoded sRNAs is up-regulated by 
environmental stress, and typically this imposes a biological response to stress through 
Hfq-mediated pairing of sRNAs and their target mRNAs (Altuvia et al, 1997; Vogel & 
Papenfort, 2006) 
 asRNAs were originally found on extrachromosomal DNAs, such as plasmids and 
transposons. Chromosomally encoded asRNAs have since been identified, although a 
subset of these is imbedded within mobile DNA elements that have recently been 
acquired (e.g., pathogenicity islands). The general perception is that, due to the perfect  
                                                
1
 The work in this chapter is reproduced (with permission, Appendix A) from: Ross JA, Ellis MJ, Hossain 
S, Haniford DB (2013) Hfq restructures RNA-IN and RNA-OUT and facilitates antisense pairing in the 
Tn10/IS10 system. RNA 19: 670-684.  
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Figure 2.1. Small regulatory RNAs (sRNAs) and the Tn10/IS10 antisense system. 
(A) Cis- vs. trans-encoded sRNAs. Transcribed strands of three different genes and their 
corresponding RNAs (colour coded) are shown. Pairing of a trans-sRNA (gold) and an 
mRNA (green) and of a cis-sRNA (pink) and an mRNA (cyan) is shown. Hfq (blue 
hexamer) catalyzes pairing in the former case where there is partial sequence 
complementarity between partners, but it is unclear if it also catalyzes pairing in the latter 
case when there is perfect sequence complementarity between partners. Asterisks (*) 
define the translation initiation region (TIR) of the mRNAs. (B) Structure of Tn10 and 
IS10-Kan. Tn10 is a 9147 bp composite transposon that confers tetracycline resistance 
(TetR). Tn10 is comprised of IS10-left and IS10-Right, the latter of which encodes a 
functional transposase protein that catalyzes DNA cleavage and joining events involving 
the “outside” (OE) and “inside” (IE) ends. The transposase mRNA (RNA-IN) is encoded 
from the promoter pIN (blue squares). A second promoter (pOUT – black squares) within 
IS10-Right encodes a cis-sRNA (also referred to as an antisense RNA), RNA-OUT. To 
follow transposition of IS10-Right in E. coli, a KanR gene cassette was cloned into IS10-
Right, creating IS10-Kan. RNA-OUT is depicted as a stable stem-loop structure (black) 
and RNA-IN is depicted as a blue line with asterisks defining the TIR. RNA-OUT is 
known to pair with RNA-IN, and this inhibits translation of RNA-IN, thereby down-
regulating transposition. Hfq can enhance the rate of RNA-IN:OUT pairing in vitro, but it 
is not known if Hfq plays a role in this antisense system in vivo. 
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complementarity between asRNAs and their targets, the regulatory function of asRNAs 
will not be dependent on Hfq (Waters & Storz, 2009). 
 Tn10/IS10 (Figure 2.1B) encodes a 69 nt asRNA (RNA-OUT) that regulates 
transposase expression by pairing with the transposase mRNA (RNA-IN). This pairing 
down-regulates transposase translation by sequestering the 5’ translational initiation 
region (TIR) from the ribosome, thereby limiting transposase translation (Ma & Simons, 
1990; Simons & Kleckner, 1983). We recently demonstrated that the frequency of 
Tn10/IS10 transposition from a multi-copy plasmid is greatly increased in an hfq- strain 
of Escherichia coli, thereby implicating Hfq as a potent negative regulator of Tn10/IS10 
transposition (Ross et al, 2010). The Hfq-effect was much less robust in a system with 
reduced RNA-OUT levels, suggesting that Hfq functions, in part, through antisense 
regulation. Transposase expression from a translational fusion was also found to increase 
in the hfq- background, consistent with a post-transcriptional role for Hfq in transposase 
regulation. Furthermore, studies in vitro demonstrated that Hfq bound both RNA-IN and 
RNA-OUT and increased the rate at which these molecules pair. Taken together, these 
results are consistent with Hfq playing an important role in translational regulation 
mediated by an asRNA (Ross et al, 2010). 
 The finding that Hfq participates in a regulatory system involving an asRNA 
raises questions regarding the mechanism through which Hfq acts in this system and 
invites comparisons to its mechanism of action in trans-sRNA regulated systems. Hfq 
readily forms a hexamer, and the hexameric unit possesses at least two RNA binding 
sites. These sites, referred to as the proximal and distal binding sites, are located on 
opposing surfaces of the toroidal structure of the hexamer. Structure-based design of 
mutations in the proximal and distal binding sits has been important in defining the RNA 
binding specificities of these sites. The proximal site mutation K56A blocks Hfq binding 
to U-rich trans-sRNAs, thereby implicating the proximal site as the trans-sRNA binding 
site. In contrast, the Y25A mutation impairs Hfq binding to A-rich RNAs as well as 
mRNAs, thereby implicating the distal site in mRNA binding (Brennan & Link, 2007; 
Mikulecky et al, 2004; Olejniczak, 2011). 
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 In the current work, we have further evaluated the interactions between E. coli 
Hfq and Tn10/IS10-encoded RNA-IN and RNA-OUT and have begun to evaluate the 
importance of these interactions with respect to the function of the asRNA system of this 
transposon. 
 
2.2 Results 
2.2.1 Hfq binds RNA-IN approximately 80-fold more tightly than RNA-
OUT 
In previous work, we demonstrated using Electrophoretic Mobility Shift Assay (EMSA) 
that E. coli Hfq binds RNA-IN and RNA-OUT (Ross et al, 2010). Our initial objective in 
the current work was to quantify the binding strength of these interactions to facilitate 
comparison with previously defined trans-sRNA/mRNA partners whose pairing is 
catalyzed by Hfq. Towards this end, we prepared 32P-labeled RNA-OUT (69 nt + 2 extra 
nucleotides encoded by the expression construct) and a truncated form of RNA-IN (the 
first 160 nt) by in vitro transcription and individually mixed each of these RNAs (~0.1 
nM) with purified Hfq over a broad range of Hfq concentrations. Binding reactions were 
then analyzed on a 6% polyacrylamide gel. 
 We show in Figure 2.2A that two distinct Hfq-bound RNA-OUT complexes were 
generated in our ‘Hfq titration’. Just under 50% of the input RNA was shifted to a 
reduced mobility (Hfq:OUT-1) at an Hfq concentration of 14 nM (lane 3). At 38 nM Hfq 
(lane 9) a second complex (Hfq:OUT-2) was detected and at 48 nM Hfq:OUT-2 and 
Hfq:OUT-1 were present at close to a 1:1 ratio. Apparent dissociation constants KD1 and 
KD2, for Hfq:OUT-1 and Hfq:OUT-2 respectively, are 19.6 and 44.8 nM, calculated per 
Hfq hexamer (Figure 2.2B and Table 2.1). 
We show in Figure 2.2C that Hfq also formed multiple complexes (4 distinct 
species) with RNA-IN-160. Hfq:IN-1 formed at the lowest Hfq concentration in the 
titration. The apparent KD for this complex is ~ 0.24 nM per hexamer (Figure 2.2D and 
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Table 2.1). This represents an 81-fold higher affinity relative to Hfq binding to RNA-
OUT. At higher Hfq concentrations, additional Hfq:IN complexes were formed (Hfq:IN-  
 
Figure 2.2. Hfq binds with high and moderate affinities to RNA-IN and RNA-OUT 
in vitro. 
32P-labeled RNA-OUT (A) or RNA-IN (C) was mixed with varying concentrations 
(reported per hexamer) of purified Hfq protein, and the reactions were subject to EMSA 
as described in Materials and Methods. Band intensities were quantified (ImageQuant), 
and the percent of each shifted species (relative to total labeled RNA) was plotted vs Hfq6 
concentration (B,D). RNA-OUT formed two complexes with Hfq, Hfq:OUT*1, and 
Hfq:OUT*2. RNA-IN formed four complexes with Hfq, Hfq:IN*1, Hfq:IN*2, Hfq:IN*3, 
and Hfq:IN*4. Apparent dissociation constants (KD) are indicated. See Table 2.1 for 
summary of KD values and Hill coefficients determined in this study. RNA-OUT and 
RNA-IN were present at a final concentration of ~0.1 nM. Error bars represent standard 
error from two experiments. KD is reported ± standard error. 
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Table 2.1. In vitro binding of RNA-OUT or RNA-IN to WT, distal-, or proximal-
impaired Hfq mutants.  
RNA Species Hfq Variant KD1 (nM) KD2 (nM) h 
RNA-OUT HfqWT 19.6 ± 0.94 44.8 ± 2.57 3.45 ±0.49 
 his6-HfqWT 75.6 ± 6.98 179 ± 18.5 2.20 ± 0.36 
 his6-HfqY25A 94.3 ±6.50 202 ± 2.50 2.42 ± 0.32 
 his6-HfqK56A - 389 ± 14.1 - 
RNA-IN HfqWT 0.24 ± 0.01 1.18 ± 0.12 2.44 ± 0.27 
 his6-HfqWT 0.99 ± 0.13 2.29 ± 0.31 2.09 ± 0.55 
 his6-HfqY25A 1.69 ± 0.23 11.1 ± 2.92 1.32 ± 0.20 
 his6-HfqK56A 3.10 ± 0.40 15.1 ± 1.01 1.00 ± 0.10 
Binding observed by EMSA. The percentages of RNA bound by Hfq were plotted vs 
Hfq6 concentration (in nM), and the data were fit to a binding curve to determine apparent 
KD values and Hill slopes (h), expressed ± standard error. Binding assays were performed 
twice. 
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2; Hfq:IN-3 and Hfq:IN-4). It appears as though Hfq:IN-2 was generated from Hfq:IN-1, 
Hfq:IN-3 was generated from Hfq:IN-2 and Hfq:IN-4 was generated from Hfq:IN-3, as 
the appearance of each of these species coincided with the reduction in the amount of the 
species with the next highest gel mobility. The apparent KD and Hill Coefficient for each 
Hfq:RNA complex is summarized in Table 2.1. 
 Super-shifting in the above experiments can most easily be explained by each of 
the RNAs having multiple Hfq binding sites with different affinities. Detection of super-
shifting over a narrower Hfq concentration range for RNA-OUT versus RNA-IN 
(reflected in the higher Hill Coefficient) is consistent with a higher degree of 
cooperativity in the former. 
2.2.2 RNase and hydroxyl radical footprinting of RNA-IN, RNA-OUT, 
and Hfq:RNA complexes. 
To further characterize Hfq:RNA-IN and Hfq:RNA-OUT interactions in vitro we used a 
combination of hydroxyl radical and ribonuclease (RNase) footprinting. Hydroxyl radical 
and RNase footprinting have both been used to identify Hfq binding sites within target 
mRNA and sRNAs (Brescia et al, 2003; Lease & Woodson, 2004; Rolle et al, 2006; 
Vecerek et al, 2005). RNase footprinting also provides insight into the structure of the 
RNA as well as structural changes in the RNA upon protein binding. Structure-probing 
techniques have not previously been applied to RNA-IN and RNA-OUT, although a 
model for RNA-OUT (Model I) was proposed based on predictions from in silico RNA 
folding programs and genetic data (see Figure 2.3B) (Case et al, 1989; Kittle et al, 1989).  
 For RNase structure probing/footprinting, 5’ end-labeled RNA-OUT was treated 
with either RNase A, T1 or V1 in the presence or absence of purified Hfq protein. RNase 
A and T1 cleave RNA following single stranded C/U and G, respectively, while RNase 
V1 cleaves 3’ of paired nucleotides.  
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Figure 2.3. Structure-probe analysis of RNA-OUT and Hfq:RNA-OUT complex. 
(A) 32P-labeled RNA-OUT (65 nM) was incubated with or without Hfq as indicated 
before hydroxyl radical (lanes 4-7) or ribonuclease (A, T1, or V1; lanes 8-19) treatments. 
Reactions, including untreated RNA (lanes 2,3) and a G-ladder (lane 1), were analyzed 
on a 10% denaturing polyacrylamide gel. Nucleotide labeling is relative to the RNA-
OUT in vitro transcriptional start site, which includes two extra nucleotides introduced by 
T7 RNA polymerase at the 5’end of the RNA. Where Hfq was included, it was present at 
1460, 2190, and 4380 nM. (B) A previous model of RNA-OUT (Model I) is compared to 
the model derived from the current work (Model II). Colored letters represent RNase-
sensitive positions in RNA-OUT observed in the absence of Hfq. Red indicates cleavage 
by either RNase A or T1, while blue indicates cleavage by RNase V1. Symbols (triangles 
and asterisks) are defined in the text. 
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RNase probing of RNA-OUT yielded a predicted structure similar to what has 
been previously proposed (Figure 2.3B). However, our data support some modifications 
to this model (see Figure 2.3A and B; note that ribonuclease-sensitive residues in Model 
II are colored red for A or T1 and blue for V1). U33, which was previously predicted to 
be in the unpaired loop, exhibited moderate sensitivity to V1 and relatively low 
sensitivity to A, suggesting that this residue is base-paired, presumably to A39. C42 and 
C43 were both strongly sensitive to A and this is consistent with a two-nucleotide bulge 
(bulge 1) in the 3’ side of the stem, immediately adjacent to the loop. Also, in Model II 
bulge 2 is larger than in Model I, consisting of 6 as opposed to 3 unpaired residues. This 
is supported by sensitivity of U24, A25, U26 and U27 to A and low sensitivity of G48 to 
T1. Additionally, for 14 of the 23 base-pairs in the predicted stem, at least one nucleotide 
in the pair showed sensitivity to V1 and only 2 base-pairs had one nucleotide that was 
sensitive to A. The V1-sensitive residues appeared in all 4 segments of the stem that are 
separated by bulges. In contrast, no residues in the loop or bulges exhibited V1 
sensitivity. 
 Addition of Hfq to RNA-OUT caused some significant changes in the RNase 
cleavage profile (indicated by upward and downward pointing triangles in Figure 2.3A 
and B).  In this experiment Hfq was added to RNA-OUT at concentrations sufficient 
(based on EMSA data; Figure S2.1A) to give greater than 90% Hfq:OUT-1 (1460 nM) 
and greater than 90% Hfq:OUT-2 (2190 and 4380 nM). Based on similarities of sample 
loading and total reactivity relative to the ‘no Hfq’ control, results for the ‘intermediate’ 
Hfq concentration (2190 nM – lanes 10, 14 and 18) were the easiest to analyze and are 
discussed in detail below.  
 Hfq binding appears to destabilize the base-paired stem of RNA-OUT. All four of 
the stem regions contained residues that increased in sensitivity to single strand-specific 
ribonuclease (upward facing red triangles) and the lower stem also contained residues 
that exhibited reduced sensitivity to double strand-specific ribonuclease (downward 
facing blue triangles). Destabilization of the stem by Hfq could be functionally 
significant because the 5’ portion of the stem, including residues 6-33, is expected to pair 
with RNA-IN in the antisense response. 
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 Interestingly, of the predicted 15 unpaired residues in RNA-OUT, 8 exhibited 
increased reactivity to single strand-specific ribonucleases. While it is not obvious how to 
interpret this result, perhaps the simplest explanation is that Hfq binding to RNA-OUT 
prevents conversion of loops and/or bulges to structures that include base-paired regions.  
 Finally, a stretch of 5 consecutive residues in bulge 2 (nucleotides 23-27) 
exhibited a decrease in sensitivity to all 3 RNases (green asterisks). This suppression 
could result from Hfq binding to this segment. Notably, this is a very U-rich sequence (5’ 
UUAUUG 3’) that is predicted to be in single stranded form. E. coli Hfq has been shown 
to preferentially bind U-rich single stranded sequences in sRNAs through its proximal 
binding site (Ishikawa et al, 2012) and we provide evidence below that Hfq engages 
RNA-OUT exclusively through its proximal binding site (Figure 2.6). Using data from 
our RNase probing of RNA-OUT in the presence of Hfq, we determined a single 
structure of an RNA-OUT:Hfq complex (Figure S2.3A). This predicted structure is 
largely single stranded, with the exception of five base-pairs forming between nucleotides 
29-33 and 59-63. Of the 35 nucleotides that are predicted to base-pair with RNA-IN, 30 
are in single stranded regions after Hfq addition. 
 We also performed hydroxyl radical footprinting on Hfq:RNA-OUT complexes to 
further investigate the position(s) of Hfq binding (Figure 2.3A, lanes 4-7) but were 
unable to see clear and reproducible patterns of protection. The hydroxyl radical cleavage 
pattern was, however, useful in assigning cleavage products produced in the RNase 
structure-probe experiments.  
 We next probed the structure of the first 160 nucleotides of RNA-IN with RNases 
as described for RNA-OUT. In the absence of Hfq there was a significant amount of 
reactivity to V1 nuclease (compare lanes 2 and 11 in Figure 2.4A), which is indicative of 
this RNA forming base-paired segments. Two regions in which V1-reactive residues 
clustered (residues 17-35 and 45-60; indicated by a solid blue line in Figure 2.4A) also 
showed minimal reactivity to single strand-specific ribonucleases. Hard constraints from 
the nuclease data (circled letters in Figure 2.4B) were input into the Mfold program to 
generate a model of RNA-IN-160 structure. Notably, addition of these hard constraints 
53 
 
resulted in the output of a single structure. The model predicts one substantial stem that 
includes 11 base-pairs and 2 bulges. The stem includes residues 25-36 on one strand and 
residues 45-60 on the other strand. At least one nucleotide in each of the 11 predicted 
base-pairs showed reactivity to V1. We note that our model for RNA-IN-160 includes 
some secondary structure involving the first 20 nucleotides. However the single base-pair 
between position 6 and 149 is unlikely to maintain the most 5’ and 3’ portions of the 
RNA in a stable secondary structure. The absence of stable secondary structure within the 
first 8 nucleotides of RNA-IN suggests that there is no structural impediment to initiating 
pairing with RNA-OUT. Of the first 35 nucleotides of RNA-IN-160 that are 
complementary to RNA-OUT, residues 25-35 are sequestered in a stem that may interfere 
with the antisense response.  
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Figure 2.4. RNase footprinting of RNA-IN. 
(A) 32P-labeled RNA-IN-160 (45 nM) was incubated with or without Hfq as indicated 
before treatment with ribonuclease A, T1, or V1 (lanes 5-13). Reactions, including RNA 
not treated with RNase (lanes 2-4) and a G-ladder (lane 1), were analyzed on a 10% 
denaturing polyacrylamide gel. Nucleotide labeling is relative to the RNA-IN in vitro 
transcriptional start site, which is nucleotide 1. Blue bars highlight clusters of V1 
sensitivity observed in the absence of Hfq. (B) A model is shown for the secondary 
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structure of RNA-IN-160. The model was produced using Mfold with hard constrains 
(circled positions) obtained from two independent structure-probe experiments (part A 
and Figure S2.2). RNase A/T1 cleavage is indicated with red letters, while V1 cleavage is 
indicated with blue letters. Symbols (triangles and asterisks) are defined in the text. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
56 
 
Addition of Hfq to RNA-IN-160 had substantial effects on RNA structure. Much 
of the V1 sensitivity in the predicted stem was lost (indicated by downward pointing blue 
triangles in both Figures 2.4A and B). Strikingly, starting at position 104 and continuing 
to position 149 there was a large increase in V1 sensitivity with the addition of Hfq. As 
there were few residues within the 104-149 segment that showed substantial increases in 
either A or T1 sensitivity upon Hfq addition, it appears likely that some intramolecular 
base-pairing is occurring in this region. There were also a few regions that showed a 
decrease in reactivity to both single and double strand-specific ribonucleases. This 
includes segments 3-13, 17-25, 38-40 and 71-92 (denoted by green asterisks). These 
regions could define Hfq binding sites. Notably, at the highest concentration of Hfq used 
in this experiment, we anticipate, based on EMSA data (Figure S2.1B), that there could 
be as many as three distinct Hfq binding sites in RNA-IN-160. A predicted structure of 
RNA-IN-160 in the presence of Hfq is presented in Figure S2.3B.  Consistent with the 
RNase footprinting data, the first 98 nucleotides of RNA-IN are mostly single stranded, 
with two small hairpins formed at nucleotides 34-56 and 66-79. An extensive stem-loop 
structure is predicted to form from nucleotides 99-160. We note that 33 out of 35 
nucleotides of RNA-IN that are expected to base-pair with RNA-OUT are single-stranded 
in the presence of Hfq.  
 Note that RNase data for RNA-IN-160 footprinting comes from two independent 
experiments (Figure 2.4A and Figure S2.2). All reactivities were reproducible except at 
positions C72-C75 where we saw Hfq-dependent protection of these residues only in the 
experiment shown in Figure S2.2. 
 To further probe the location of Hfq binding sites in RNA-IN-160 we performed 
hydroxyl radical footprinting on 5’ end-labeled RNA-IN-160 using multiple Hfq 
concentrations (Figure 2.5). Quantitation of portions of the gel image showing the 
greatest differences in band intensity for ‘no Hfq’ (lane 2) and selected ‘plus Hfq’ 
samples (lanes 3, 6 and 10) is also presented. A region spanning residues 29 to 46 showed 
protection against hydroxyl radical cleavage at both 149 nM and 347 nM Hfq. At the 
higher Hfq concentration additional zones of protection were observed as indicated 
beside the gel image (green asterisks). Due to discontinuities in the patterns of protection 
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it is difficult to infer the boundaries of individual binding sites and therefore the total 
number of sites. However, based on the density of protected residues in the 29-46 
segment and the fact that there was uniform protection in this cluster at an intermediate 
Hfq concentration, we suggest that this cluster defines a single Hfq binding site. The 
region spanning residues 84 to 94 includes the second highest density of protected 
residues and could represent a second Hfq binding site. This second site would be a lower 
affinity site relative to the site within the nucleotide 29-46 segment, as protections in this 
site were only observed at the highest Hfq concentrations. Unfortunately we were not 
able to obtain high quality hydroxyl radical footprinting data for the most 5’ portion of 
RNA-IN-160 to further test the possibility raised by RNase footprinting that this segment 
also contains an Hfq binding site. We do note that 5 residues (38, 39, 40, 45 and 46) 
within segment 29-46 showed a general suppression of cleavage by RNases (Figure 
2.4A), as did residues 80, 82 and 86, which are close to or within segment 84-94, 
supporting the possibility that these segments include Hfq binding sites. 
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Figure 2.5. Hydroxyl radical footprinting of RNA-IN. 
(A) 32P-labeled RNA-IN-160 (45 nM) was incubated with increasing concentrations of 
Hfq (lanes 3-10) and then subject to hydroxyl radical treatment (lanes 2-10). Lane 1 
contains RNA not treated with hydroxyl radicals. Samples were analyzed as in Figure 
2.4. Nucleotides are numbered as in Figure 2.4. Green asterisks identify positions 
protected from hydroxyl radical cleavage in the presence of Hfq, while purple asterisks 
identify positons where Hfq induced hypersensitivity to hydroxyl radical cleavage. (B) 
Quantification of band intensities from selected lanes of the gel image in part A is shown. 
Reactivity is presented in arbitrary units. 
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2.2.3 RNA-binding sites in Hfq that interact with RNA-IN and RNA-
OUT 
Hfq has at least two distinct RNA-binding surfaces, enabling it to simultaneously bind 
multiple RNAs and catalyze trans-sRNA/mRNA pairing reactions. To gain insight into 
how Hfq interacts with RNA-IN and RNA-OUT, we performed experiments designed to 
define the surfaces in Hfq that interact with these RNAs. It should be recognized that Hfq 
binding determinants for an asRNA have not previously been reported. Two 
complementary approaches were used. In one approach we performed binding assays 
with RNA-IN-160 or RNA-OUT and Hfq mutants that are defective in either proximal 
site (HfqK56A) or distal site (HfqY25A) RNA binding. In the second approach we performed 
binding assays with HfqWT and RNA-IN-160 or RNA-OUT in the presence of competitor 
RNAs that exhibit high affinities for either the proximal (DsrA) or distal (A18) RNA-
binding surfaces of Hfq.  
 For binding experiments with Y25A and K56A mutant forms of Hfq, it was 
necessary to use Hfq bearing a C-terminal his6 epitope tag (hereafter referred to as ‘his6-
Hfq’). This is because, unlike HfqWT, the two mutant forms of Hfq are not heat stable and 
therefore cannot be purified in the same way as untagged HfqWT (Mikulecky et al, 2004). 
However, all three forms of the his6-tagged Hfq can be purified using nickel affinity 
chromatography. We show in Figure 2.6A and Table 2.1 that WT and Y25A forms of 
his6-Hfq bound RNA-OUT with similar affinities (KD1 ~ 76 nM and 94 nM, 
respectively). In contrast, his6-HfqK56A bound very poorly to RNA-OUT at Hfq 
concentrations up to 309 nM. At the high end of the HfqK56A titration (upwards of 464 
nM Hfq6) essentially all of RNA-OUT was bound by HfqK56A, forming Hfq:OUT-2 with 
an apparent KD ~ 389 nM. This represents a 5-fold reduction in the affinity of his6-
HfqK56A versus his6-HfqWT for RNA-OUT.  
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Figure 2.6. RNA-OUT interacts specifically with the proximal RNA-binding surface 
of Hfq. 
(A) EMSAs with 32P-labeled RNA-OUT (~0.4 nM) and either WT or mutant forms of 
Hfq. HfqY25A is defective in RNA-binding at the distal site, and HfqK56A is defective in 
RNA-binding at the proximal site. The corresponding curves are presented below each 
gel image. Error bars represent standard error from two experiments. Note that all forms 
of Hfq used in this experiment possess a his6 epitope tag at their C termini. Species are 
labeled as in Figure 2.2. (B) EMSAs performed in the presence of competitor RNAs. 
HfqWT (untagged) was first mixed with various concentrations of DsrA or A18 RNA for 5 
min, and 32P-labeled RNA-OUT (0.4 nM) was added. After an additional 15 min, 
reactions were subjected to polyacrylamide gel electrophoresis. A species expected to 
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represent a ternary complex is labeled A18:Hfq:OUT*. IC50 values were calculated from 
curves shown in Figure S2.4 and are reported in Table 2.2. 
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The above results are consistent with Hfq binding RNA-OUT through its 
proximal site, which is typical of how Hfq binds trans-sRNAs. If this is correct, then it is 
expected that an sRNA, but not a distal-specific RNA, would act as a competitor for 
RNA-OUT binding to untagged HfqWT. We show in Figure 2.6B that this is the case. 
When we pre-incubated Hfq with DsrA (an sRNA) or A18 (a distal-specific RNA) and 
then added 32P-labeled RNA-OUT, only DsrA inhibited Hfq:OUT-1 complex formation; 
IC50 values (Table 2.2 and Figure S2.4) are ~ 7 nM and > 4000 nM for DsrA and A18, 
respectively. In fact, there was evidence of ternary complex formation at A18 
concentrations above 31 nM (see lanes 18-24 in Figure 2.6B). Overall, we conclude that 
RNA-OUT behaves like a trans-sRNA in its interaction with Hfq.  
In titrations with RNA-IN-160 and his6-tagged Hfq proteins (WT, K56A and 
Y25A) there was a moderate reduction in binding affinity. This is reflected by changes in 
KD1 of 1.7 and 3-fold, respectively for HfqY25A and HfqK56A versus HfqWT (see Figure 
2.7A and Table 2.1). These results are consistent with RNA-IN-160 binding to both the 
proximal and distal sites. Competition experiments support this inference as both DsrA 
and A18 gave some inhibition of Hfq:IN-1 formation when each of these RNAs was pre-
incubated with Hfq prior to addition of RNA-IN-160. More specifically, we observed 
strong inhibition of Hfq:IN-1 formation at concentrations above the KD for A18:Hfq 
complex formation, which is ~ 10 nM (Sun & Wartell, 2006) (Figure 2.7B, lanes 11-15; 
IC50 ~ 11 nM, Table 2.2;  Figure S2.4). In contrast, we observed weak inhibition of 
Hfq:IN-1 formation at DsrA concentrations above the KD for DsrA:Hfq complex 
formation, which is ~ 21 nM (Mikulecky et al, 2004) (Figure 2.7B, lanes 6-8; IC50 ~ 53 
nM – Table 2.2 and Figure S2.4). At A18 concentrations above its KD for Hfq (lanes 11-
15) primarily the proximal site is expected to be available for RNA-IN-160 binding and 
at DsrA concentrations above its KD for Hfq (lanes 5-7) primarily the distal site is 
expected to be available for RNA-IN-160 binding. Accordingly, the stronger inhibition 
observed for A18 is consistent with the distal site of Hfq being the higher affinity site for 
RNA-IN-160 binding. This is typical of Hfq binding to mRNAs (Mikulecky et al, 2004; 
Soper & Woodson, 2008). 
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We also performed a competition experiment where both competitors were mixed 
with Hfq simultaneously and then RNA-IN-160 was added (Figure 2.7B, lanes 16-26). 
Very strong inhibition of Hfq:IN-1 formation was only observed when the concentrations 
of both A18 and DsrA were close to or above their respective KD values for Hfq complex 
formation (lanes 23-26). These results suggest that an additional RNA binding site in Hfq 
does not contribute significantly to the formation of a stable Hfq:RNA-IN-160 complex.   
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Table 2.2. In vitro competition by DsrA or A18 for binding of HfqWT to RNA-IN or 
RNA-OUT 
RNA Species DsrA IC50 (nM) A18 IC50 (nM) DsrA+A18 IC50 (nM)a 
RNA-OUT 6.77 ± 0.317 >4000b N.D. 
RNA-IN 52.7 ± 14.1 10.6 ± 1.18 8.93 ± 2.12 
IC50 values (± standard error) were measured by EMSA. Percentage of competition was 
plotted vs competitor concentration, and IC50 values were obtained from the resulting 
curves (shown in Figure S2.4). Competition assays were performed.  
N.D., not determined. 
aReported for each competitor in the mix. 
bInstead of competition, a ternary complex was formed. 
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Figure 2.7. RNA-IN interacts with the distal and proximal RNA-binding surfaces of 
Hfq. 
(A) EMSAs with 32P-labeled RNA-IN (0.17 nM) and either WT or mutant forms of his6-
tagged Hfq. Species are labeled as in Figure 2.2. Binding curves are shown below the 
corresponding EMSA, and the apparent KD values are reported in Table 2.1. Error bars 
represent standard error from two experiments. (B) EMSAs performed in the presence of 
competitor RNAs. Competitor experiments were performed as described in Figure 2.6B 
except RNA-IN was present at a concentration of 0.17 nM. For lanes 18-26, a 1:1 mix of 
DsrA and A18 was serially diluted to the indicated concentrations before competition. 
IC50 values were calculated from curves shown in Figure S2.4 and are reported in Table 
2.2. 
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2.2.4 HfqK56A exhibits a reduced rate of RNA-IN:RNA-OUT pairing in 
vitro 
The results in the previous section show that RNA-IN can contact both the distal and 
proximal sites on Hfq and that RNA-OUT binds only to the proximal site. One or more of 
these interactions is likely important for the acceleration in the rate of RNA-IN:OUT 
pairing directed by Hfq that we previously documented (Ross et al, 2010). The proximal 
site is likely of particular importance, as both RNA species could conceivably bind here 
and begin to pair. Accordingly, we asked if an intact proximal RNA-binding site is 
necessary for Hfq to accelerate the rate of RNA-IN:OUT pairing. Note that we developed 
an alternative means to purify untagged HfqWT and HfqK56A (see Materials and Methods), 
as the his6-tagged forms gave inconsistent pairing results. We mixed Hfq (WT or K56A), 
32P-labeled RNA-OUT and 32P-labeled RNA-IN-160 and incubated them for the 
indicated times before processing and analysis on a native polyacrylamide gel. Processing 
involved phenol extraction (mixing, centrifugation and recovery took ~ 15 seconds) and 
then immediately loading the samples on a native polyacrylamide gel. This step was 
included to remove Hfq from the paired product so that identification of this species was 
unambiguous. The ratio of RNA-OUT to RNA-IN was fixed (10:1) to roughly reflect the 
ratio of these RNAs in vivo. The Hfq concentration used (45 nM) was set from a 
preliminary experiment where we determined the minimum concentration of Hfq that 
yielded an enhancement in RNA-IN:OUT pairing (relative to the absence of Hfq) at the 
above ratio of RNA-OUT to RNA-IN (see Figure S2.5).  
We show in Figure 2.8 that addition of 45 nM HfqWT increased the rate (kobs) of RNA-
IN:OUT pairing approximately 19-fold relative to no Hfq addition (kobs = 1.51 min-1 for 
HfqWT versus 0.080 min-1 in the absence of Hfq). By comparison, the rate enhancement 
was less than 2-fold when HfqK56A was used (kobs = 0.14 min-1). These results indicate 
that the K56A mutation negatively impacts RNA-IN:OUT pairing under these specific 
conditions, consistent with the proximal surface playing an important role in the 
enhancement of antisense pairing in vitro.  
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Figure 2.8. RNA-IN:RNA-OUT pairing reactions. 
(A) 32P-labeled RNA-IN (0.85 nM) was mixed with excess 32P-labeled RNA-OUT (8.5 
nM) and, where indicated, untagged WT or K56A Hfq (45 nM). At the indicated time 
points, pairing reactions were stopped by treatment with a phenol/water mix and 
immediately loaded onto a 6% native polyacrylamide gel. (B) The amount of RNA-
OUT:RNA-IN complex (OUT:IN) was determined as a percentage of total RNA-IN for 
each time point and plotted as a function of time. Error bars represent the standard error 
from three experiments. The observed rate constant (kobs) is indicated for each reaction. 
These values were derived from curves corresponding to the equation describing the rate 
of exponential association, presented in Materials and Methods. 
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2.2.5 IS10-kan transposition is derepressed in strains expressing 
Y25A and K56A forms of Hfq 
While Hfq increases the rate of RNA-IN:OUT pairing substantially in vitro, it is difficult 
to know if effective antisense inhibition of transposase expression requires this 
enhancement in the RNA pairing rate in vivo. To address this issue we asked if untagged 
HfqK56A (which is impaired in its ability to promote IN:OUT pairing in vitro) is also less 
effective than wild type Hfq at repressing IS10 transposition. We also assessed the ability 
of the distal-impaired HfqY25A to repress transposition of IS10. We used a ‘mating out’ 
assay to measure the frequency of IS10-Kan transposition from a multi-copy plasmid in 
different genetic backgrounds. In this assay, the frequency of transposition of IS10-Kan 
from a multi-copy plasmid to the F plasmid in the donor strain is measured (see Materials 
and Methods). For the mating out experiments, the Hfq status was manipulated by 
transforming the donor strain (DBH16; hfq-) with a plasmid expressing untagged WT, 
Y25A or K56A forms of Hfq from a native hfq promoter. As controls, we also measured 
the frequency of IS10-Kan transposition in hfq+ (DBH33; full repression) and hfq- (no 
repression) strains.  
 The results of the mating out analysis are presented in Figure 2.9 where we report 
the fold-change in transposition frequency relative to the average transposition frequency 
calculated for hfq+. In both the hfqK56A and hfqY25A strains, IS10-Kan transposition was de-
repressed to about the same level as in hfq-. Importantly, these deficiencies cannot be 
attributed to differential levels of Hfq expression in the different strains as Western 
Blotting confirmed that plasmid-encoded WT, Y25A and K56A forms of Hfq were 
present at comparable levels in the respective donor strains (Figure S2.6). These results 
show that Hfq mutants that are partially defective in binding RNA at specific surfaces, 
one of which (K56A) is impaired in its ability to catalyze RNA-IN:OUT pairing in vitro, 
are unable to repress IS10 transposition in vivo. 
 Hfq is also known to stabilize trans-encoded sRNAs (reviewed in (Vogel & Luisi, 
2011)) and such an activity could influence the effectiveness of RNA-OUT in the 
Tn10/IS10 antisense system. We performed a rifampicin time-course experiment to look 
at this possibility. We show in Figure S2.7 that the half-life of RNA-OUT actually  
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Figure 2.9. IS10-kan transposition is derepressed in E. coli encoding Y25A and 
K56A forms of Hfq. 
E. coli cells (hfq+ or hfq-) were cotransformed with pDH602 (encodes IS10-kan) and a 
compatible plasmid encoding untagged Hfq (WT, K56A, or Y25A) or the corresponding 
“empty vector” control. Relative transposition frequencines were measured using the 
conjugal mating out assay. An average transposition frequency (4.03 x 10-3 events per mL 
of mating mixture) was calculated for the hfq+ strain (hfq+/emp.vect.) from 15 
independent “donour” colonies across four independent experiments, and this was value 
was set to 1. All other transposition values are expressed relative to this value where Hfq-
directed repression of transposition is at its maximal level. Bars indicate the mean; the 
error bars indicate standard error on the mean. From left to right, the n value for each 
treatment group is 15, 15, 14, 16, 11 – these were compiled from at least two (and up to 
four) independent experiments. An asterisk (*) indicates that means were significantly 
different from the hfq+ control group; p-values are indicated above the corresponding 
bars. 
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decreased by about 2.5-fold in an hfq+ relative to an hfq- strain. Accordingly, we can rule 
out the possibility that Hfq contributes to the antisense system by stabilizing RNA-OUT.  
 
2.3 Discussion 
Tn10/IS10 transposition is negatively regulated by an asRNA (RNA-OUT) that pairs 
with the 5’ TIR of the transposase mRNA (RNA-IN) to inhibit transposase expression. 
Hfq is also a negative regulator of Tn10/IS10 transposition that down-regulates 
transposase expression in vivo. The effect of disrupting hfq on Tn10/IS10 transposition is 
diminished in a system with reduced RNA-OUT expression. In vitro, Hfq binds RNA-IN, 
RNA-OUT, forms a ternary complex with these RNAs and increases the rate of RNA-
IN:OUT pairing. Taken together, these observations are consistent with Hfq regulating 
Tn10/IS10 by operating on the antisense mechanism. In the current work we have further 
characterized the interactions between Hfq, RNA-IN and RNA-OUT with regard to 
binding affinity, binding sites within Hfq that govern these RNA contacts and the impact 
mutating one of these binding sites has on RNA-IN:OUT pairing. We have also begun to 
define Hfq-binding sites within each RNA, as well as the impact Hfq binding has on the 
structure of these RNAs.  
2.3.1 RNA-IN and RNA-OUT bind Hfq like a prototypical sRNA-
mRNA pair 
The Hfq binding affinities we have measured for RNA-IN and RNA-OUT are consistent 
with what is typically seen for canonical trans-encoded sRNA-mRNA pairs. For example, 
KD1 for RNA-OUT is 19.6 nM and KD1 for Hfq binding to DsrA is 21 nM (Mikulecky et 
al, 2004). Hfq binds RNA-IN with sub-nanomolar affinity (apparent KD1 0.24 nM), which 
is comparable to the tightest Hfq-mRNA interactions described to date (OmpC 0.9 nM, 
(Fender et al, 2010); SodB 0.3 nM, (Geissmann & Touati, 2004); RpsO 90 pM, (Folichon 
et al, 2003)).  
 We also investigated determinants in Hfq responsible for RNA-IN and RNA-OUT 
binding. Hfq possesses at least two distinct RNA-binding surfaces; the distal site 
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generally binds A-rich RNA/mRNA while the proximal site binds U-rich sRNAs 
(Ishikawa et al, 2012; Mikulecky et al, 2004; Soper et al, 2011).  Both competition and 
binding experiments (with Hfq variants) revealed that Hfq binds RNA-OUT exclusively 
through its proximal RNA-binding surface. For RNA-IN, both the distal and proximal 
binding sites in Hfq contribute to RNA-IN binding, although the distal site is the higher 
affinity site. In canonical sRNA-mRNA systems there is competition between sRNA and 
mRNA binding at the proximal site and this appears to be required for the formation of 
the paired species (Hwang et al, 2011). Competition is ensured by the individual RNAs 
having similar binding affinities for the proximal site and in general these affinities are 
much weaker than those for the distal site. The high affinity interaction for the mRNA 
with the distal site effectively tethers the mRNA to Hfq, allowing other parts of the 
mRNA to interact relatively weakly with the proximal site and this increases the 
probability that the mRNA and sRNA can occupy the proximal site at the same time 
(Hopkins et al, 2011). As discussed above the Hfq:RNA interactions in the IS10 system 
are consistent with this general model. A recent study defined a third RNA-binding site in 
Hfq (the lateral surface) that may be important in allowing the mRNA to simultaneously 
bind distal and proximal sites (Sauer et al, 2012). Our competition studies indicate that 
the lateral surface alone is not sufficient for binding RNA-IN or RNA-OUT.  
 We have not defined the number of Hfq hexamers present in any of the Hfq:RNA-
IN or Hfq:RNA-OUT complexes. The KD values discussed above relate only to the 
complexes formed at the lowest Hfq concentrations in each titration. For RNA-IN, at 
least four distinct Hfq complexes were detected, raising the possibility that at least four 
Hfq hexamers may be accommodated within the first 160 nucleotides of RNA-IN. 
Results from hydroxyl radical footprinting support the existence of multiple Hfq binding 
sites in RNA-IN. One such site may extend from position 29-46 and appears to be the 
highest affinity site identified by hydroxyl radical footprinting, as it was occupied at a 
lower Hfq concentration relative to the other sites. For RNA-OUT, two distinct Hfq-
bound species were detected. Results from RNase footprinting revealed only one strong 
candidate for an Hfq binding site within RNA-OUT. This site is located within the U-rich 
segment of bulge 2. We do not yet know which Hfq binding site(s) in RNA-IN or OUT 
are biologically relevant. Work in other systems is consistent with the idea that maximal 
72 
 
pairing of an mRNA:sRNA pair can require the mRNA to bind multiple Hfq hexamers 
(Salim & Feig, 2010; Soper & Woodson, 2008). Mutagenesis of potential Hfq-binding 
sites in RNA-IN and RNA-OUT is currently under way to test the importance of 
individual sites in IS10 transposition.  
2.3.2 A proximal site mutation impacts on RNA-IN:OUT pairing and 
IS10 transposition 
The rate of RNA-IN:OUT pairing was substantially enhanced by HfqWT but not HfqK56A. 
A limitation of this analysis was that we measured kobs under one specific set of 
parameters as opposed to measuring a second order rate constant. We used excess RNA-
OUT relative to RNA-IN (10:1), and a small excess of Hfq relative to both (less than 5-
fold). As ‘available’ Hfq is thought to be limiting in the cell (Hussein & Lim, 2011; 
Moon & Gottesman, 2011) we feel this is a reasonable approximation of in vivo 
conditions. Under these conditions, the kobs value was 10.6-fold lower for HfqK56A versus 
HfqWT. 
 We also measured the impact of the Hfq proximal and distal site mutations on 
IS10 transposition. IS10 transposition was derepressed in both hfqK56A and hfqY25A strains 
relative to hfqWT. RNA-IN:OUT pairing in vitro was enhanced ~19-fold by HfqWT relative 
to no Hfq, and the magnitude of de-repression of IS10 transposition in hfq- relative to 
hfq+ was ~10-15-fold. Furthermore, in vitro pairing was ~10-fold faster in the presence of 
HfqWT relative to HfqK56A, and in vivo transposition was de-repressed ~12-fold for hfqK56A 
relative to plasmid-borne hfq+. Taken together these results are consistent with Hfq 
playing a significant role in the pairing component of the IS10 antisense system. Another 
way in which Hfq might facilitate the IS10 antisense system is through the stabilization 
of RNA-OUT. However, this possibility is not supported by our observation that RNA-
OUT stability is actually reduced in an hfq+ compared to an hfq- strain. Finally, Hfq 
might directly interfere with IS10 transposase translation. We think this is unlikely 
because as previously noted the large increase in Tn10/IS10 transposition from a multi-
copy plasmid in hfq- is tightly linked to the expression of RNA-OUT. 
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2.3.3 How might Hfq promote pairing in the IS10 antisense system? 
The simplest scenario for how Hfq promotes RNA pairing in the IS10 antisense system is 
that, through simultaneous binding of RNA-IN and RNA-OUT, Hfq acts as a pairing 
catalyst by increasing the local concentration of these two RNAs. In addition to providing 
a single surface to which both RNAs bind, Hfq might actively alter the structure of RNA-
IN and RNA-OUT to promote pairing. In fact, our structure-probing data supports an 
Hfq-dependent restructuring model (Figure 2.10). On the left-hand side of Figure 2.10 we 
show how RNA-IN and RNA-OUT might interact in the absence of Hfq. Structure 
probing experiments with RNA-IN and RNA-OUT revealed that the pairing region of 
both RNAs is at least partly sequestered in secondary structure. In this pathway a total of 
8 base-pairs between RNA-IN and RNA-OUT could readily form without any RNA 
restructuring (structure vii). In the right-hand panel we show how pairing could occur 
with RNAs (structures iii and vi) that have been restructured by Hfq. In the presence of 
Hfq the pairing region of both RNAs is largely single-stranded leading to the formation 
of a paired species (structure viii) that contains 30 base-pairs between RNA-IN and OUT. 
Notably, only in structure viii is the TIR sequestered through base-pairing with RNA-
OUT. We anticipate that upon Hfq dissociation, RNA-OUT will adopt its native structure 
(transition from structure iii to structure i). However, the capacity of the 3’ end of RNA-
IN to form a stable secondary structure in the presence of Hfq may prevent Hfq-bound 
RNA-IN (structure vi) from converting back to structure iv upon Hfq release. As Hfq 
rapidly cycles on and off of RNAs (Fender et al, 2010) the formation of the 3’ stem-loop 
structure could maintain RNA-IN in a ‘pairing competent’ state after Hfq release. 
Consistent with genetic data, the ‘Hfq pairing pathway’ includes pairing of the 5’ 
terminus of RNA-IN with the hairpin loop of RNA-OUT. Also, the internal loop of RNA-
OUT has been shown to be important for the antisense response (Case et al, 1989; Jain, 
1995; Kittle et al, 1989). In the Hfq-independent pathway nucleotides within this loop 
can directly pair with RNA-IN facilitating further propagation of pairing. In the Hfq 
pathway we suggest that internal loop residues directly participate in Hfq binding and are 
therefore important in the restructuring of RNA-OUT.  
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Figure 2.10. Model for RNA-IN:OUT antisense pairing in the presence vs. absence 
of Hfq. 
The Hfq-independent pairing pathway is shown on the left-hand side (structures i, iv, and 
vii) and the Hfq-dependent pathway is shown on the right-hand side (structures iii, vi, 
viii). In structures (ii) and (v) Hfq is shown bound to RNA-OUT and RNA-IN, 
respectively, but conformational changes in the RNAs have not yet taken place. Other 
structures are described in the text. Hfq hexamers are indicated by green circles. The start 
codon (AUG) and Shine-Dalgarno sequence (SD) are indicated by asterisks (*) at the first 
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nucleotide of each sequence. Intramolecular base-pairs in RNA-OUT/IN are indicated by 
blue and red, respectively. Intermolecular base-pairs between RNA-OUT and RNA-IN 
are in grey.  
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An active remodeling role for Hfq has been well documented in other systems. 
Hfq alters the structure of RpoS mRNA such that the sequence that base-pairs with DsrA 
becomes single stranded (Soper et al, 2011). The pairing region within SodB mRNA is 
also sequestered in a stem-loop structure; Hfq binding is required to disrupt this stem-
loop, resulting in formation of a large loop that is then competent to pair with the sRNA, 
RyhB (Geissmann & Touati, 2004). 
 In other systems the presence of base-pairing discontinuities in structured regions 
of asRNAs has also been shown to be critical for antisense regulation (see (Wagner et al, 
2002)). At this point it is unclear if these discontinuities are sufficient for a robust 
antisense response in vivo and in this regard it will be interesting to see if the 
effectiveness of other antisense systems shows any reliance on Hfq.  
 In the current work we have provided additional insight into how Hfq interacts 
with the RNA components of the IS10 antisense system and provided further evidence 
that these interactions ultimately influence this system. To date only one other antisense 
system is known to be Hfq-regulated. Hfq regulates the expression of the chromosomally 
encoded gadX gene, which is involved in acid tolerance in E. coli. An sRNA called GadY 
is antisense to the 3’ UTR of GadX and it has been shown that GadY expression 
increases the stability of the GadX transcript. Importantly, Hfq binds to the GadY 
transcript and stabilizes it (Opdyke et al, 2004). However, it has not been established if 
Hfq plays a direct role in promoting pairing of GadY and GadX RNAs. With regard to 
other transposons it should be noted that antisense RNAs to the transposase have been 
identified, including IS30  (Arini et al, 1997) and IS200 (Sittka et al, 2008). Additionally, 
a recent study identified 5 transcripts in Mycobacterium smegmatus that bind Hfq and are 
antisense to transposase mRNAs (Li et al, 2013). It will be interesting to see if any of 
these transposons are regulated by Hfq. Notably, Hfq regulation of other transposons 
might not be limited to systems encoding asRNAs. Trans-encoded sRNAs frequently 
target more than just one mRNA (reviewed in (Repoila et al, 2003)) and as such there is 
the potential for ‘off-target’ effects wherein a trans-encoded sRNA might fortuitously 
target a transposase mRNA. This could provide the host with a previously unrecognized 
pathway to either down- or up-regulate transposon mobilization. Furthermore, as the 
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induction of the transcription of sRNA genes if often linked to various cellular stresses 
(Repoila et al, 2003) and this induction can temporarily limit the availability of Hfq in the 
cell (Hussein & Lim, 2011; Moon & Gottesman, 2011), there is the potential to indirectly 
regulate transposition reactions through stress response pathways. 
 
2.4 Materials and Methods 
2.4.1 Strains, plasmids, and primers 
All E.coli strains and plasmids used in this study are listed in Table 2.3. Oligonucleotides 
used are listed in Table 2.4.  
To express Hfq in vivo we cloned a fragment that included the hfq gene with its 
P3 promoter into the low-copy cloning vector pWKS30 (Wang & Kushner, 1991) The 
aforementioned fragment was generated by PCR using genomic DNA from DBH33 and 
primers JR15 and JR16, which include XbaI and HindIII sites, respectively. After 
digestion of the PCR product with XbaI-HindIII, the ‘hfq’ fragment was ligated into 
XbaI-HindIII digested pWKS30, creating pDH700. We then used pDH700 as a template 
for site-directed mutagenesis to create pDH701 and pDH713, which encode HfqK56A and 
HfqY25A, respectively. For purification of C-terminal his6-tagged Hfq (WT, HfqY25A and 
HfqK56A) the hfq gene was cloned into pET28a as described in (Mikulecky et al, 2004). 
2.4.2 Hfq purification and quantitation 
Untagged Hfq was purified as described in (Ross et al, 2010), but included a treatment of 
the lysate with DNase I (100 units) and RNase A (100 µg) for 1 hour on ice before heat 
treatment of the lysate at 85˚C. His6-Hfq proteins were purified as described in 
(Mikulecky et al, 2004).  Untagged HfqWT and HfqK56A for the experiments presented in 
Figure 2.8 were expressed from pDH700 and pDH701 and purified on a TALON Cobalt 
column as described in (Soper et al, 2010), followed by further purification on a polyA 
column as described in (Ross et al, 2010). Purified Hfq was dialyzed against Hfq 
storage/binding buffer (50 mM Tris, pH 7.5, 1 mM EDTA, 250 mM NH4Cl, 10% (v/v) 
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Table 2.3. List of E. coli strains and plasmids used in Chapter 2. 
Strain or 
plasmid 
Relevant genotype Use Source/Reference 
E. coli    
HB101 F- leu- ; StrR Mating out recipient (Bolivar & 
Backman, 1979) 
DBH33 NK5830; recA- arg-  / F’ 
pro+ 
Mating out donor (Ross et al, 2010) 
DBH16 NK5830 hfq-1::Ωcat; 
CmR  
Mating out donor (Ross et al, 2010) 
DBH5a recA-  Plasmid propagation  Invitrogen 
BL21 recA- / DE3 T7 RNA 
polymerase 
Hfq overexpression (Studier & Moffatt, 
1986) 
    
Plasmids    
pDH602 pACYC184-derived; 
IS10-Kan ; CmRKanR 
Mating out assays (Ross et al, 2010) 
pDH631 pET3a derived;  T7-hfq 
; ApR  
Hfq over-expression (Ross et al, 2010) 
pWKS30 pSC101-derived; low 
copy-number ori ; ApR 
Empty vector for 
Hfq expression 
(Wang & Kushner, 
1991) 
pDH700 pWKS30-P3-hfqWT ; 
ApR 
HfqWT expression This study 
pDH701 pWKS30-P3-hfqK56A ; 
ApR 
HfqK56A expression This study 
pDH713 pWKS30-P3-hfqY25A ; 
ApR 
HfqY25A expression This study 
pDH686 pET28a-derived; C-
terminal his6-tagged 
HfqWT; kanR 
HfqWT 
overexpression 
(Mikulecky et al, 
2004) 
pDH688 pET28a-derived; C-
terminal his6-tagged 
HfqK56A; kanR 
HfqK56A 
overexpression 
(Mikulecky et al, 
2004) 
pDH697 pET28a-derived; C-
terminal his6-tagged 
HfqY25A; kanR 
HfqY25A 
overexpression 
(Mikulecky et al, 
2004) 
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Table 2.4. List of oligonucleotides used in Chapter 2. 
Name Sequence (5’ to 3’) Use 
JR1 TAATACGACTCACTATAGGCGAAAAATCA
ATAATCAGACAACAAG 
Forward primer (includes T7 
promoter) for in vitro 
transcription template (RNA-
IN) 
JR2-2 CAAGTTCGGTAAGAGTGAGAG Reverse primer for above 
(RNA-IN-160) 
JR3 GAATTGTAATACGACTCACTATAGGGCTC
GCACATCTTGTTGTC 
Forward primer (includes T7 
promoter) for in vitro 
transcription template (RNA-
OUT) 
JR4 GGATACACATCTTGTCATATGATCA Reverse primer for above 
JR15 NNTCTAGANNCAGGTTGTTGGTGCTATC Forward primer for pDH700 
construction 
JR16 NNAAGCTTNNTTATTCGGTTTCTTCGCT 
 
Reverse primer for above 
JR17 AGCCAGATGGTTTACGCGCACGCGATTTC
TACT 
 
Forward primer for K56A 
quikchange mutagenesis 
JR18 AGTAGAAATCGCGTGCGCGTAAACCATCT
GGCT 
 
Reverse primer for abov 
JR19 GTTCCAGTTTCTATTGCTTTGGTGAATGG
TATTAAG 
 
Forward primer for Y25A 
quikchange mutagenesis 
JR20 CTTAATACCATTCACCAAAGCAATAGAAA
CTGGAAC 
Reverse primer for above 
JR21 TAATACGACTCACTATAGGCAACACATCA
GATTTCCTGGTGTAACGAATT 
Forward primer (includes T7 
promoter) for in vitro 
transcription template (DsrA) 
JR22 AAATCCCGACCCTGAGGGGGTCGGGAT Reverse primer for above 
 
 
 
 
 
80 
 
glycerol). SDS-PAGE revealed that the Hfq was ~ 95% pure (Figure S2.6B). Hfq 
concentration was determined by Bradford assay. 
2.4.3 In vitro transcription and RNA purification 
Linear DNA templates for run-off transcription of RNA-IN (nucleotides 1-160) or RNA-
OUT (nucleotides 1-69) were amplified from pDH602 by PCR with primers JR1/JR2-2 
or JR3/JR4 respectively; note that for each primer pair the forward primer includes the T7 
core promoter. The same approach was used to make templates for in vitro transcription 
of DsrA (primers JR21/JR22). Our standard in vitro transcription reaction for generating 
unlabeled RNA was performed in a 30 µL volume with 200 ng DNA template, 2.5 mM 
rNTPs, 10 mM DTT, 1X T7 RNA polymerase reaction buffer (NEB), 100 U RNasin 
(Promega), 2.5 U yeast inorganic pyrophosphatase (NEB) and 100 U T7 RNA 
polymerase (NEB). For preparing 32P-labeled RNA, in vitro transcription was performed 
in a 20 µL volume as above except that UTP was added to only 50 nM, and 2.5 µCi [a-
32P]UTP was added. Reaction mixtures were incubated at 37°C for 1 hour before adding 
0.1 U of Turbo DNase (Ambion) per µL of reaction and continuing incubation for 20 
minutes. RNAs were purified using denaturing PAGE and after elution from gel slices 
were concentrated by ethanol precipitation and finally re-suspended in Hfq 
storage/binding buffer. RNA concentrations were determined using a 
NanoSpectrophotometer (IMPLEN). Purity of in vitro transcribed RNA was assessed by 
high resolution denaturing PAGE. A18 was purchased from Sigma-Aldrich and dissolved 
in Hfq storage/binding buffer. 
2.4.4 Hfq-RNA binding assays 
In our standard Hfq-RNA binding reaction we mixed 32P-labeled RNA (0.1-0.4 nM) with 
Hfq (0.05-1856 nM) in Hfq storage/binding buffer (total reaction volume 10 µL) for 15 
minutes at 37˚C. In the case of ‘competitor’ experiments, unlabeled competitor RNAs 
(0.5-4000 nM) were mixed with Hfq for 5 minutes as described above and then either 
32P-labeled RNA-IN (0.17 nM) or RNA-OUT (0.4 nM) was added. Incubation was 
continued at 37˚C for an additional 15 minutes. Prior to mixing RNA with Hfq, the 
various RNA species were incubated at 95°C for 2 minutes, placed on ice for 2 minutes, 
81 
 
and equilibrated to 37°C. At the reaction end points samples were mixed with 0.3 
volumes of gel load dye (21 mM Tris-HCl pH 7.5, 10 mM DTT, 100 mM KCl, 30% (v/v) 
glycerol, 0.05% (w/v) bromophenol blue) and applied to a 6% native polyacrylamide gel. 
Electrophoresis was carried out at 14 V/cm for 70 minutes whereupon the gel was dried 
and exposed to a phosphorimager screen. Gel images were obtained using the STORM 
phosphorimager. 
 For measuring the equilibrium dissociation constant (KD) in binding reactions, 
bands representing shifted and unshifted RNA species were quantified (ImageQuant 
software) and the percentage of counts for a given shifted species (relative to total counts 
for all bands in the lane) was plotted on the y-axis and Hfq concentration on the x-axis 
(Prizm software). The resulting curve was fit by non-linear regression to the equation: 
𝑃: 𝐿 = 	𝑃: 𝐿&'(×[𝑃],𝐾., + [𝑃],  
where P and L are Hfq and RNA, respectively, P:L is the percentage of RNA shifted by 
Hfq, [P] is the concentration of Hfq6 in nM, KD is the equilibrium dissociation constant 
and h is the Hill Coefficient. To calculate KD1, the percentage of all shifted species were 
summed to yield the appropriate curve (e.g. the curve marked ‘total’ in Figure 2.2B,D). 
To calculate KD2 for RNA-OUT, the percentage of all species representing complex 2 
were plotted (e.g. the curve marked ‘Hfq:OUT*2’ in Figure 2.2B). To calculate KD2 for 
RNA-IN-160, the total percentage of all species other than free RNA-IN-160 or 
Hfq:IN*1 were plotted (i.e. the curve marked ‘Hfq:IN*2’ in Figure 2.2D). To calculate 
KD3 for RNA-IN-160, the total percentage of all species other than free RNA-IN-160, 
Hfq:IN*1 or Hfq:IN*2 were plotted (i.e. the curve marked ‘Hfq:IN*3 in Figure 2.2D).  
For calculating IC50 values (i.e. the concentration of competitor RNA that inhibited 
Hfq:RNA-IN or Hfq:RNA-OUT complex formation by 50%), bands representing 
Hfq:RNA* complexes (* denotes radiolablelled RNA-IN or RNA-OUT) and unshifted 
RNA* were quantified and the percentage of Hfq-shifted RNA* at 0 nM competitor was 
set at 0% competition. The percentage of Hfq-shifted RNA* remaining at increasing 
concentrations of competitor was subtracted from 100% to give the percent competition 
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(0% shifted complex = 100% competition). Percent competition was plotted on the y-axis 
and competitor concentration on the x-axis (Prizm). The resulting curve was fit by non-
linear regression to the equation: 
𝑃𝐶 = 	𝑃𝐶&'(×[𝐶]𝐼𝐶23 + [𝐶]  
where PC is Percent Competition, [C] is the concentration of competitor RNA in nM and 
IC50 is the concentration of competitor RNA giving 50% competition.  
2.4.5 RNA structure-probing and footprinting 
In vitro transcribed RNA-IN and RNA-OUT were gel purified, treated with Antarctic 
Phosphatase (NEB) and 5’ end-labeled with [γ-32P]ATP (Perkin Elmer) and OptiKinase 
(USB). 5’-labeled RNA was gel purified, ethanol precipitated and finally re-suspended in 
RNA Storage Buffer (20 mM MES pH 7.0, 150 mM NaCl, 1 mM EDTA). RNA 
concentrations were determined using a NanoSpectrophotometer (IMPLEN). RNA and 
Hfq were mixed in RNA Structure Buffer (20 mM MES pH 7.0, 150 mM NaCl, 1 mM 
EDTA, 10 mM MgCl2) to a final volume of 9 µL. Binding reactions took place at 37˚C 
for 15 minutes. For RNase footprinting, 1 µL of dilute RNAse A, T1, or V1 (Ambion) 
was added to each binding reaction. For RNA-OUT 0.04 ng RNase A, 0.03U or 0.04 U of 
RNAse T1 (- or + Hfq respectively), and 0.00005U or 0.0001U of RNase V1 (- or + Hfq 
respectively) was added. For RNA-IN 0.004 or 0.01 ng of RNAse A (- or + Hfq 
respectively), 0.01U of RNAse T1, and 0.00005U or 0.0001U of RNAse V1 (- or + Hfq 
respectively) was added. G-lanes were produced by T1 digestion of RNA following the 
manufacturer’s directions (Ambion). RNase reactions proceeded for 15 minutes at 25˚C 
before RNA was ethanol precipitated and resuspended in 7 µL formamide load dye 
(97.5% deionized formamide (v/v), 10 mM EDTA, 0.5x TBE, 3% xylene cyanol (w/v)) 
and ~2 µL was loaded onto a high resolution 10% polyacrylamide denaturing gel. 
Hydroxyl radical footprinting was performed as previously described (Jain & Tullius, 
2008). Briefly, following binding reactions, 1 µL of freshly prepared H2O2 (2.5% (v/v)), 
Fe(II)EDTA (32 mM ferrous ammonium sulfphate, 88 mM EDTA; Bio Basic), and 
sodium ascorbate (60 mM; Bio Basic) was added to each 9 µL binding reaction. The final 
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concentration of hydroxyl radical reagents in each 12 µL reaction were: H2O2, 0.21% 
(v/v); Fe(II), 2.67 mM; EDTA, 7.33 mM; sodium ascorbate, 5 mM. Following incubation 
at 25˚C for 10 min, samples were processed as described above for RNase treatment. For 
footprinting reactions, RNA-OUT was at a final concentration of 65 nM, RNA-IN at 45 
nM, and Hfq6 at a final concentration of 99-4380 nM. Gels were dried and imaged with a 
phosphorimager (GE Healthcare). A sample of each binding reaction (RNA-IN and 
RNA-OUT, each Hfq concentration) was run on a 6% polyacrylamide gel to monitor 
complex formation under the conditions used (Figure S2.1). Quantitation of RNA-IN 
hydroxyl radical footprinting was performed using ImageQuant software. 
2.4.6 Determination of RNA-OUT:RNA-IN pairing rates 
RNA-IN:OUT pairing reactions were carried out by spotting 3.5 µL of 32P-labeled RNA-
IN and RNA-OUT onto separate faces of an Eppendorf tube, mixing them with 24.5 µL 
of Hfq storage/binding buffer, and immediately removing 9 µL to separate tubes 
containing 1 µL of Hfq (or Hfq storage buffer), as indicated. Mixing was achieved by 
rapid pipetting. Final concentrations of reactants were: RNA-IN*, 0.85 nM; RNA-OUT*, 
8.5 nM; Hfq, 45 nM. Incubation was at 37°C and, after the indicated times, each 10 µL 
reaction was added to tubes containing 30 µL H2O and 40 µL phenol:chloroform:isoamyl 
alcohol. These were immediately vortexed (8 seconds) and centrifuged (3 second pulse-
spin) before removing 10 µL of the aqueous phase and loading it directly on a 6% native 
polyacrylamide gel at 7 V/cm. After the last sample was loaded, electrophoresis was 
continued at 13 V/cm for 45 minutes. Gels were dried and imaged as described above. 
Bands representing RNA-OUT:IN paired species or free RNA-IN were quantified 
(ImageQuant). The percentage of paired species (relative to total RNA-IN counts) was 
plotted on the y-axis and time on the x-axis (Prizm). The resulting curves were fit by non-
linear regression to the equation: 𝐴: 𝐵6 = 𝐴: 𝐵&'((1 − 𝑒;<=>?×6) 
where A:Bt is the percentage of binary complex at time t and kobs is the observed rate 
constant. 
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2.4.7 Mating out assay 
Mating out experiments were carried out with DBH33 (hfq+) and DBH16 (hfq-) as donor 
strains and HB101 as the recipient strain. Plasmids encoding IS10-Kan (pDH602) and 
Hfq (pDH700, 701, 713 and pWKS30 as the ‘empty vector’ control) were co-transformed 
into donor strains and transformants were selected on M9-Glucose plates supplemented 
with arginine, kanamycin (50 µg/ml) and ampicillin (50 µg/ml). Donors and recipient 
strains were grown in liquid media as previously described in (Ross et al, 2010) and 
mating was allowed to proceed for 1 hour whereupon mating mixes were pelleted and re-
suspended in 0.85% saline. Re-suspended mating mixes were then plated on M9 media 
supplemented with glucose, leucine and streptomycin (150 µg/ml) or streptomycin plus 
kanamycin (50 µg/ml). Plating on the former gave the mating frequency and plating on 
the latter gave the number of transposition events. Relative transposition frequencies 
were calculated by dividing the number of colonies present on ‘streptomycin/kanomycin 
plates’ by the number of colonies on ‘streptomycin plates’. For statistical analysis, we 
first carried out an F-test to demonstrate that the variances between the hfq+ control group 
and the other treatments were not equal (hfq+ vs hfq-/hfqWT, P = 0.001; hfq+ vs all other 
treatments, P < 0.0001). We then conducted a two-tailed t test with Welch’s correction 
(does not assume equal variances) to compare the various treatments to the hfq+ control 
group. All statistical analyses were carried out in Prizm. Sample numbers and P values 
for the t-test are reported in Figure 2.9.  
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2.5 Supplemental Material  
 
Figure S 2.1. RNA footprinting EMSAs. 
Following binding reactions (see Materials and Methods) for RNA-OUT (A) and RNA-
IN (B) footprinting experiments (shown in Figures 3 and 4 respectively), a sample was 
run on a 6% polyacrylamide gel to monitor RNA:Hfq complex formation. The final 
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concentration of RNA-OUT was 65 nM, RNA-IN was 45 nM, and Hfq concentrations are 
reported per hexamer.  
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Figure S 2.2. RNA-IN-160 RNase footprinting 
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5’ 32P-IN-160 (65 nM) was incubated in the absence (-) or presence (+) of Hfq (365 nM) 
before digestion with RNase A, T1, or V1 (lanes 5-10) or hydroxyl radical (3,4). A G-
lane (G, 1) and untreated RNA (UT, 2) are shown. Changes in reactivity in the presence 
of Hfq are indicated by upward- or downward-facing triangles (increased and decreased 
reactivity, respectively). Sensitivity to single- strand specific nuclease A/T1 are indicated 
in red, while sensitivity to double-strand specific V1 is indicated in blue.  
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Figure S 2.3. Structure of RNA-OUT and RNA-IN in the presence of Hfq. 
5’ end-labeled RNA-OUT (A) and RNA-IN (B) was probed with RNase A/T1/V1 in the 
presence of Hfq (see Figures 3 and 4). Nucleotides indicated in red and blue represent 
mFold constraints for ssRNA and dsRNA, respectively. These structures formed at 37oC 
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in the presence of 10 mM MgCl2. Putative Hfq-binding sites were entered as single-
stranded constraints.  
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Figure S 2.4. IC50 determinations for A18 and/or DsrA competition experiments. 
The percentage inhibition of Hfq:IN-1 (A-C) and Hfq:OUT-1 (D-E) complex formation 
by competitor RNAs (DsrA, A18 or DsrA+A18) is plotted as a function of competitor 
concentration. The data is derived from experiments in Figures 6 and 7 plus additional 
experiments not shown. Data were fit to sigmoidal curves to obtain the IC50 values 
(reported in Table 2.2).  
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Figure S 2.5. Measurement of RNA-OUT:RNA-IN pairing as a function of Hfq 
concentration. 
RNA-IN:RNA-OUT pairing reactions were performed in the presence of the indicated 
concentrations of Hfq (WT or K56A) as described in Figure 2.8 for a 2 minute reaction. 
As 45 nM gave an enhancement in RNA-IN:OUT pairing, this concentration of Hfq was 
used in the experiments summarized in Figure 2.8.  
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Figure S 2.6. Hfq western blots. 
(A) Hfq expression in donor strains used in mating out assays. Just prior to mating, 
aliquots of donor cultures were pelleted and resuspended in denaturing SDS load mix 
(2% SDS, 10% glycerol, 50 mM Tris-HCl pH 6.8, 0.25% bromophenol blue and 0.8 M 
β-mercaptoethanol). After heating at 95°C for 5 minutes, cell lysates were subjected to 
SDS-PAGE on a 14% polyacrylamide gel. Proteins were transferred to a PVDF 
membrane (Roche) and Hfq was detected by Western blot with a polyclonal rabbit anti-
Hfq antibody (Gift of G. Storz). The primary antibody was diluted to 1:4000 in TBST; 
the secondary antibody (anti-rabbit IgG-HRP conjugate; Promega) was used at 1:10,000. 
Hfq was visualized with a SuperSignal West Pico kit (Thermo Scientific) and an 
AlphaImager. The position of monomeric Hfq and species (X) that cross react with the 
antibody are shown. Samples analyzed are described in Figure 2.9. (B) SDS-PAGE to 
assess the purity of Hfq preparations. Purified Hfq at the indicated concentrations was 
mixed with an equal volume of denaturing SDS load mix, heated to 95°C for 5 minutes, 
and 20 µL were run on a 12% SDS polyacrylamide gel. The gel was stained with 
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Coomassie R250 and destained with 10% Acetic acid/30% Methanol (v/v). The species 
corresponding to monomer, and a species we presume to be hexamer, are indicated to the 
right of the image. The Hfq in lanes 9-11, denoted “CP”, were purified by cobalt column 
chromatography and polyA resin as described in Materials and Methods.  
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Figure S 2.7.  RNA-OUT half-life analysis in isogenic hfq+/- backgrounds. 
Rifampicin-sensitive strains DBH116 (hfq+) and DBH117 (hfq-) were transformed with 
plasmid pDH502 (ApRKanR, source of IS10-Kan; (Ross et al, 2010)). Cells were grown 
to mid-log phase in 20 mL LB supplemented with 25 µg/mL kanamycin. (A) Two ‘time 
0’ samples (600 µL) were removed to tubes containing 300 µL ‘Stop solution’ (1.5% 
[w/v] SDS, 300 mM Sodium Acetate, 30 mM EDTA), boiled for 1 minute and stored on 
ice. Rifampicin was immediately added to the remaining cells (final concentration: 200 
µg/mL), and 600 µL samples were removed at the indicated time and processed as above. 
After all samples were collected on ice, total RNA was extracted by the ‘hot phenol’ 
method, treated with Turbo DNase (Ambion) and ethanol precipitated. Samples were 
resuspended in nuclease- free water and quantified by spectroscopy. RNA-OUT levels 
were assessed by primer extension with 32P- labeled JR4; cDNA was fractionated by 
denaturing PAGE. OUT (+69)* indicates full-length primer extension product; OUT 
(primer)* indicates unextended primer. Note that the top panel is an over-exposure of the 
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region of the gel where +69* migrated. (B) The area of the bands corresponding to full-
length RNA-OUT and unextended primer were quantified (ImageQuant) and RNA-OUT 
(+69) was divided by unextended primer for each lane; these values were normalized to 
time 0 in the hfq+ strain and plotted on the y-axis, with Time (after rifampicin addition) 
on the x-axis. To obtain half-lives, the resulting curves were fit by non-linear regression 
to the equation describing exponential decay (Prizm); note that the plateau was set to zero 
RNA-OUT remaining:  
P = Span·e-k·t  
Where P is the proportion of RNA-OUT remaining, Span is 1.0, t is Time (in minutes) 
and k is the rate of decay in units of min-1. The half-life (t1/2) is equal to 0.6932/k.  
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Chapter 3  
3 Hfq binds directly to the ribosome binding site of IS10 
transposase mRNA to inhibit translation2 
3.1 Introduction 
Hfq is an abundant RNA-binding protein that acts at the core of complex post-
transcriptional regulatory networks in many bacteria and is critical for stress and 
virulence responses (Sobrero & Valverde, 2012; Storz et al, 2011; Vogel & Luisi, 2011). 
It is found in at least 50% of sequenced bacteria (Sun et al, 2002) and has been predicted 
to be involved in the regulation of 269 mRNAs in Escherichia coli and at least 20% of all 
genes in Salmonella Typhimurium (Ansong et al, 2009; Guisbert et al, 2007; Sittka et al, 
2008). Hfq is important for the function of trans-encoded small regulatory RNAs 
(sRNAs) that base-pair with partially complementary mRNAs. Hfq binds sRNAs and 
their partner mRNAs and facilitates intermolecular base-pairing. This typically affects 
translation and/or transcript stability. Hfq contains three RNA-binding surfaces all of 
which play a role in promoting base-pairing between RNAs. The ‘top’ and ‘bottom’ of 
the toroidal-shaped Hfq homohexamer are termed the proximal and distal RNA binding 
surfaces, respectively. The proximal surface binds short U-rich sequences typically found 
in sRNAs while the distal surface binds longer ARN repeats (where A is an adenine, R is 
a purine, and N can be any nucleotide) typically found in mRNAs (Link et al, 2009; 
Mikulecky et al, 2004). The proximal surface is proposed to be critical for sRNA stability 
through interactions with the 3’poly(U) tract following a Rho-independent terminator 
(Ishikawa et al, 2012; Sauer & Weichenrieder, 2011). The third, less defined surface 
consists of the outer rim or lateral RNA binding surface. This surface connects the 
proximal and distal RNA-binding sites. The lateral surface is extremely basic in E. coli 
and may be important for binding internal U-rich sequences of sRNAs (Sauer et al, 
                                                
2
 The work in this chapter is reproduced (with permission, Appendix A) from: Ellis MJ, Trussler RS, 
Haniford DB (2015) Hfq binds directly to the ribosome binding site of IS10 transposase to inhibit 
translation. Mol Microbiol 96: 633-650.  
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2012). One model for Hfq-catalyzed pairing predicts simultaneous binding of a cognate 
sRNA and mRNA pair via the proximal and distal surfaces, respectively.  Hfq binding 
sites are often just outside of RNA pairing sequences so simultaneous binding would 
tether the RNAs to Hfq while keeping seed regions available for pairing (Panja & 
Woodson, 2012). The RNAs can then initiate pairing by interacting in either the lateral or 
proximal surfaces and the RNAs are released as pairing proceeds (Hopkins et al, 2011; 
Hwang et al, 2011; Panja et al, 2013).  
    In addition to a role in sRNA-based regulation, Hfq has been shown to directly 
affect translation. In the case of sdhC mRNA, the sRNA Spot42 recruits Hfq to an AU-
rich region in the translation initiation region (TIR) to inhibit translation. As the Spot42 
pairing region in sdhC is too far upstream of the TIR to influence translation, it was 
inferred that stable association of Hfq with sdhC was sufficient to compete with 30S 
ribosomal subunit binding (Desnoyers & Masse, 2012). In another example, Hfq was 
shown to bind to a translational enhancer in cirA mRNA and block translation. 
Interestingly, in this case translation repression was relieved by the upstream binding of 
an sRNA (RyhB) that caused restructuring of the mRNA within the 5’ untranslated 
region (5’UTR), which ultimately prevented Hfq binding (Salvail et al, 2013). Finally, 
evidence has been presented in two different organisms that Hfq autoregulates expression 
by binding its own TIR (Sobrero & Valverde, 2011; Vecerek et al, 2005). No sRNAs 
have been implicated in this autoregulatory loop, supporting the contention that Hfq can 
act directly to inhibit translation. In the above examples, Hfq binding to the TIR of an 
mRNA is the effector of translational control, in contrast to sRNA-dependent regulation 
where the stable sRNA-mRNA duplex is responsible for blocking ribosome binding. 
Unlike sRNA-dependent regulation, the role of each RNA-binding surface of Hfq in 
direct translational repression is largely unknown. However, Hfq binding to the TIR of 
target mRNAs would presumably require the distal surface, which preferentially binds 
purine rich sequences such as the Shine-Dalgarno sequence. 
 In addition to its role as an important regulator of endogenous gene expression, 
Hfq was recently found to suppress Tn10/IS10 transposition in E. coli (Ross et al, 2010). 
Tn10 is a composite transposon containing genes encoding for tetracycline resistance  
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(Figure 3.1A).  Its component insertion sequence IS10-Right encodes a functional 
transposase that catalyzes the chemical steps in Tn10/IS10 transposition (Chalmers et al, 
2000; Foster et al, 1981; Halling et al, 1982). Expression of IS10 transposase is regulated 
by Dam methylation as well as a 69 nt antisense RNA (asRNA) that is transcribed from 
the opposite strand of DNA relative to the transposase (Roberts et al, 1985; Simons & 
Kleckner, 1983). The first 35nt of this asRNA (RNA-OUT) is perfectly complementary 
to the TIR of the transposase mRNA (RNA-IN), and pairing of these two RNAs inhibits 
translation by preventing ribosome binding (Figure 3.1A) (Ma & Simons, 1990). 
Antisense control of transposase expression increases with IS10 copy-number, a 
phenomenon termed ‘multi-copy inhibition’ (MCI). MCI can be explained by the fact 
that transposase is a cis acting protein whereas the asRNA is trans acting (Jain & 
Kleckner, 1993). Accordingly, increasing transposon copy-number essentially serves to 
increase the amount of trans acting inhibitor while the effective concentration of 
transposase per element remains constant. Importantly, a single-copy IS10 element is not 
subject to antisense control of transposase expression (Kleckner, 1990). 
 Hfq was initially linked to Tn10/IS10 transposition when it was found that IS10 
transposition increased in the order of 80-fold in an hfq- strain of E. coli harbouring IS10 
on a multi-copy plasmid. In contrast, the impact of Hfq-deficiency on transposition was 
greatly reduced (7-fold increase), but not completely abrogated, when transposition was 
measured for IS10 in single copy. These observations were consistent with Hfq 
contributing to MCI, but also playing a role in down-regulating IS10 transposition 
independent of the MCI pathway (Ross et al, 2010). Subsequent work demonstrated that 
Hfq bound both RNA-IN and RNA-OUT in vitro, and accelerated the rate of IN-OUT 
pairing almost 20-fold, observations that are consistent with Hfq working through its 
prototypical RNA pairing pathway to promote the MCI response (Ross et al, 2013). It 
remains to be determined how Hfq regulates Tn10/IS10 transposition when MCI is not in 
play. However, it has been shown that: (i) in the absence of RNA-OUT transposase 
expression increased 6-fold in hfq-, (ii) there is an Hfq binding site in RNA-IN that 
overlaps the TIR and (iii) Hfq status has only a subtle effect on steady-state RNA-IN  
104 
 
 
Figure 3.1. Overview of the Tn10/IS10 system. 
(A) The structure of Tn10 is shown (Chalmers et al, 2000). IS10R encodes a functional 
transposase protein that catalyzes the chemical steps in Tn10/IS10 transposition. In 
addition to transposase mRNA (RNA-IN, blue), IS10 encodes an asRNA (RNA-OUT, 
red) that represses transposase translation by blocking ribosome binding. Hfq represses 
transposase translation by facilitating antisense pairing as well as through an antisense-
independent mechanism. OE and IE are outside and inside ends respectively. (B) 
Schematic of the three IS10R constructs used in this work. The promoters for RNA-IN 
(pIN) and RNA-OUT (pOUT) are indicated with blue and red boxes respectively and the 
transcriptional start sites are shown. RNA-OUT terminates at nucleotide 47 of IS10, 
which is indicated with a dashed line. The DNA sequence of pIN is shown with the 
location of two nucleotide changes (R5 and HH104) that each destabilize RNA-OUT. 
The DNA adenine methyltransferase (DAM) site, which overlaps with the -10 region, is 
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also shown. The IS10HH104-kan construct consists of a kanamycin resistance gene inserted 
downstream of the transposase stop codon but upstream of the IE and both translational 
dusions consist of the indicated portion of IS10R fused to codon 10 of lacZ. In A and B, 
black arrows indicate the polarity of each open reading frame (ORF). 
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transcript level (Ross et al, 2013; Ross et al, 2010). Taken together it seems likely that 
Hfq functions in the MCI-independent pathway by inhibiting translation of RNA-IN. The 
goal of the current work was to test this hypothesis and to further characterize how Hfq 
interacts with RNA-IN.  
 
3.2 Results 
3.2.1 Antisense-independent regulation of transposase expression 
requires the distal surface of Hfq 
To gain further insight into how Hfq regulates IS10 transposase expression (independent 
of its cis-encoded sRNA) we asked if regulation was maintained when RNA-binding 
surfaces of Hfq were mutated. Our expectation was that if a trans-encoded sRNA is 
involved in this pathway, all three surfaces would be critical for regulation. In particular, 
we expected the proximal surface to be important for stabilizing any involved sRNAs and 
the lateral surface for catalyzing pairing with RNA-IN.  
 To assess the function of each Hfq binding surface in antisense-independent 
regulation of transposase expression, we assayed the ability of wild-type and mutant 
forms of Hfq to complement an hfq- phenotype. We constructed a chromosomal IS101-339-
lacZ translational fusion with a single bp change (HH104) in the promoter for RNA-IN 
which increases transcription ~100-fold (Figure 3.1B) (Case et al, 1988). The HH104 
mutation also destabilizes RNA-OUT; however, a single-copy transposase-lacZ 
translational fusion would not normally be regulated by the cis-encoded RNA-OUT so 
the net effect of this mutation is to simply increase RNA-IN expression to detectable 
levels (Case et al, 1989). Expression of transposase-lacZ was measured in an hfq- strain 
of E. coli harbouring plasmids expressing HfqWT or Hfq deficient in RNA-binding at the 
distal (Y25A), proximal (K56A), or lateral (R17A) surface (Mikulecky et al, 2004; Panja 
et al, 2013). 
 We show in Figure 3.2A that transposase-lacZ expression increased almost 13-
fold in the absence of Hfq, and that regulation was fully restored when HfqWT was  
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Figure 3.2. Impact of mutant forms of Hfq on IS10 transposase expression and 
transposition. 
(A) Transposase expression was measured in the context of a chromosomal transposase-
lacZ translational fusion (parent strain DBH298) with the indicated forms of Hfq 
expressed or in the absence of Hfq expression. The bars show b-galactosidase activity 
(Miller units) with standard error of the mean, measured in mid-exponential phase in LB 
(n=8). Where indicated, the hfq- strain (DBH299) was transformed with a low-copy 
plasmid encoding Hfq from its native promoter (P3). The mean relative expression for 
each strain is indicated at the top of the graph, where transposase-lacZ in hfq+ was set at 
1. (B) Transposition of a chromosomal IS10HH104-kan was measured by the conjugal 
mating out assay (see Materials and Methods) in an hfq- strain (DBH337) transformed 
with one of the indicated Hfq-encoding plasmids. The mean relative transposition 
frequency for each strain is indicated at the top of the graph, where transposition in the 
presence of HfqWT was set at 1. Error bars indicate the standard error of the mean for two 
independent experiments (n=8). 
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expressed from a plasmid. In contrast, none of the Hfq variants were able to fully 
complement hfq-, with HfqY25A being the most impaired and HfqR17A functioning the most 
like WT. Importantly, the reduced function of the mutant proteins cannot be attributed to 
protein expression as the Hfq levels were not significantly different for WT versus the 
mutant forms of Hfq (Figure S3.1). As the results showed that the integrity of the lateral 
site is not important for regulation and the integrity of the proximal site is less important 
than that of the distal site, our data suggested that Hfq repression was sRNA-independent.  
 We also performed the Hfq complementation experiment in the context of an IS10 
transposition assay. As IS10 transposition frequency is directly proportional to 
transposase expression (Morisato et al, 1983), this experiment allowed us to indirectly 
measure the effect of Hfq mutations on native transposase expression. Transposition of a 
single-copy IS10HH104-kan element (Figure 3.1B) in an hfq- strain of E. coli was repressed 
13-fold in the presence of HfqWT and close to full repression was achieved in the presence 
of HfqK56A and HfqR17A (Figure 3.2B). However, in accordance with the expression data 
(Figure 3.2A), HfqY25A was the least effective of the mutant Hfq forms in repressing 
transposition.  
It is notclear why the HfqK56A functioned essentially as WT in the transposition 
assay (Figure 3.2B) while exhibiting a moderate defect in repressing transposase-lacZ 
expression (Figure 3.2A). However, the concordance of the other Hfq variants between 
the two experiments lead us to conclude that the distal surface is critical for repressing 
transposase expression in the absence of RNA-OUT, while the proximal and lateral 
surfaces are dispensable for regulation.  
3.2.2 The distal surface of Hfq binds the RBS of RNA-IN in vitro 
We have previously shown that Hfq binds a 14nt A-rich region of RNA-IN which 
overlaps with the ribosome binding site (RBS), as well as an 8nt U-rich region 
overlapping with codons 5-8 of the transposase coding region (Ross et al, 2013). Based 
on the results from the previous section, we anticipated that the A-rich binding site within 
the TIR would be the critical site for Hfq regulation as it has the signature of a distal 
binding site. To further characterize the two Hfq binding sites in the 5’ segment of RNA-
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IN, we carried out chemical and enzymatic RNA footprinting. Purified WT, Y25A, and 
K56A Hfq were incubated with an RNA corresponding to the first 160nt of RNA-IN (IN-
160) followed by partial digest with lead acetate (Pb2+), RNase T1, or RNase V1.  
Within the first 70nt of RNA-IN three regions of cleavage reagent protection were 
detected in the presence of HfqWT (Figure 3.3). The most upstream region (relative to the 
start codon) spans the ribosome binding site (RBS), extending roughly from nt -20 to -4; 
hereafter this site will be referred to as site 1. Additional regions of protection 
downstream of this include residues 13-20 and 32-34; hereafter referred to as sites 2 and 
3, respectively. Another region spanning nt 3-7 became hypersensitive to RNase T1 and 
showed reduced RNase V1 cleavage, consistent with Hfq binding inducing a structural 
transition in this region from dsRNA to ssRNA. In contrast, in reactions with HfqY25A, 
site 1 showed greatly reduced protection from both V1 and lead cleavage, consistent with 
the distal surface of Hfq making contacts with this site. The V1 and lead cleavage pattern 
in site 1 for HfqK56A was very similar to that of HfqWT. As HfqK56A retains a fully 
functional distal binding surface, this result further supports our conclusion that the distal 
surface of Hfq contacts site 1.  
At sites 2 and 3 the K56A mutation greatly reduced protection from both V1 and 
lead cleavage whereas the Y25A mutation did not. This is consistent with the proximal 
surface of Hfq binding both sites 2 and 3.  
Finally, the T1 hypersensitivity at positions 3-7 was lost only in the reaction with 
HfqY25A. Accordingly, we infer that the structural transition in this region is dependent on 
the distal face of Hfq binding to site 1.  
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Figure 3.3. RNA-IN footprinting with WT and mutant forms of Hfq. 
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5’32P-labeled RNA-IN (40 nM) was incubated with his-tagged WT, Y25A or K56A Hfq 
(750 nM Hfq hexamer) before treatment with Pb2+, RNase T1, or RNase V1. Untreated 
RNA was also incubated with or without WT Hfq (lanes 1-2). Nucleotide numbering is 
relative to the translational start codon (AUG), where the A is position 1. Positions that 
were protected from cleavage by WT and K56A but not Y25A are indicated with red 
arrows, while positions protected by WT and Y25A but not K56A are indicated with blue 
arrows. RNase T1 hypersensitivities are highlighted with black arrows. The nucleotide 
sequence of the first 160nt of RNA-IN is shown below the gel image with distal and 
proximal specific-binding sites indicated in red and blue respectively. The RBS and start 
codon are underlined. 
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3.2.3 Hfq binding to site 1 is critical for regulation of transposase 
expression in vivo 
As the distal surface of Hfq is most critical for repression of transposase expression and 
transposition, our footprinting data suggests that Hfq primarily exerts its regulatory role 
by binding site 1, which overlaps the RBS of RNA-IN. We set out to further test this 
hypothesis by analyzing the impact of nucleotide changes in site 1 and site 2 on Hfq 
interactions and ultimately transposase expression. 
 Our first objective was to define the relative binding affinity of sites 1 and 2 for 
Hfq. We show by EMSA in Figure 3.4 that in the presence of non-specific competitor 
RNA, HfqWT forms two distinct complexes with RNA-IN-160, which we term IN:Hfq-1 
and IN:Hfq-2. IN:Hfq-1 was detected at the lowest Hfq concentrations and appears to be 
converted into IN:Hfq-2 as Hfq concentrations increased. Apparent KD values were 
calculated to be 0.2 nM for IN:Hfq-1 and 46.2 nM for IN:Hfq-2. Multiple mutations in 
site 1 were required to reduce formation of IN:Hfq-1. For example, the M5 mutant 
contains 8 nucleotide changes in site 1 and increased the KD for IN:Hfq-1 by just over 30-
fold and essentially abrogated the formation of IN:Hfq-2. In contrast, the site 2 mutant 
M2, which contains 5 nucleotide changes, had little impact on IN:Hfq-1 formation, but 
increased the KD for IN:Hfq-2 almost 4-fold. Note that because of the manner in which 
these mutants were identified we do not know if all the nucleotide changes are necessary 
for the observed effects (see Materials and Methods).  
 Based on these results, as well as footprinting experiments (Figure S3.2), we 
conclude that IN:Hfq-1 is formed through Hfq binding to site 1 and IN:Hfq-2 is formed 
through Hfq binding to both site 1 and site 2; note we have not looked at the importance 
of site 3 in IN:Hfq complex formation. Moreover, Hfq binds site 1 with a much higher 
affinity than it binds site 2 and Hfq binding to site 2 appears to be dependent on Hfq first 
binding site 1. Since formation of IN:Hfq-2 increased in a concentration-dependent 
manner, it is likely that occupancy of site 2 depends on recruitment of a second Hfq 
hexamer to IN:Hfq-1, as opposed to the unoccupied proximal surface of an Hfq hexamer 
bound at site 1 engaging site 2. 
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Figure 3.4. Effect of RNA-IN mutations on Hfq binding. 
(A) Sequence of the first 50nt of RNA-IN with the RBS and start codon indicated in blue 
and the sequence of two Hfq-binding sites (site 1 and site 2) underlined. Nucleotide 
changes for M5 and M2 mutants are shown. (B) Hfq binding to 32P-labeled INWT-160, 
INM5-160, and INM2-160 was measured by EMSA. Binding reactions contained 20 ng/µl 
of total yeast RNA, the indicated concentrations of Hfq (reported per hexamer) and ~1 
nM RNA-IN. Band intensitities of the representative gel images shown were quantified 
and the percent complex fomed was plotted against Hfq concentration to calculate 
apparent dissociation constants (KD). Hfq-RNA-IN interactions for IN:Hfq-1 and IN:Hfq-
2 are described by KD1 and KD2 respectively. 
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 We next looked in vivo at the impact of disrupting Hfq interactions with sites 1 
and 2. To do this we introduced the M5 and M2 mutations into an IS101-242-lacZ 
translational fusion on a multi-copy plasmid. A multi-copy transposase-lacZ translational 
fusion would normally be highly repressed by the cis-encoded RNA-OUT. To separate 
the role of Hfq in direct repression of transposase expression from its role in facilitating 
antisense pairing, we introduced a single nucleotide mutation (R5) into the promoter 
region of RNA-IN which destabilizes RNA-OUT while having only a subtle effect on 
RNA-IN transcription (Figure 3.1B) (Case et al, 1988). Based on our earlier results 
(Figure 3.2A,B), our expectation was that the M5 mutation would make IS10-lacZ 
expression insensitive to Hfq status. As the two mutants have multiple nucleotide 
substitutions, we were concerned that these changes could have indirect effects on 
transposase expression. Accordingly, we also isolated RNA from cells used in the 
reporter assays and performed primer extension analysis to monitor steady-state transcript 
levels (Figure 3.5). 
  We show in Figure 3.5 that both M5 and M2 mutants exhibited reduced Hfq 
regulation, with the degree of dysregulation being stronger for M5 versus M2. In this 
reporter set-up there was a 3.2-fold decrease in transposase expression in the presence 
versus the absence of Hfq, consistent with Hfq having a negative regulatory role. In 
contrast, for the M5 reporter, expression levels were essentially the same in hfq+ and hfq- 
and for the M2 reporter, expression decreased about 1.5-fold in the presence of Hfq.  
 In the above experiment the ratio of transposase-lacZ expression (β-galactosidase 
assay) to the steady state level of fusion transcript provides a measure of the translation 
efficiency. For example, if expression was low and transcript levels were high, this would 
be indicative of low translation efficiency. The presence of Hfq in cells expressing the 
WT reporter decreased translation efficiency approximately 2.5-fold, consistent with Hfq 
interfering with transposase translation. For the M5 reporter, translation efficiency was 
greatly reduced compared to the WT reporter, which is not unexpected given that 5 of the 
8 nt changes in this construct are in the RBS. Importantly, the translation efficiency did 
not further decrease in the presence of Hfq. Thus Hfq is unable to down-regulate 
translation when site 1 is mutated. Translation efficiency for the M2 reporter was  
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Figure 3.5. Impact of mutant forms of RNA-IN on transposase expression in 
hfq+/hfq- strains. 
Plasmids encoding WT and mutant forms of a transposase-lacZ translational fusion were 
transformed into hfq+ (DBH107) or hfq- (DBH12) cells and after growth of transformants 
to mid-exponential phase in LB media, b-galactosidase activity was measured. Error bars 
show the standard error of the mean for three independent experiments (n=12). RNA was 
extracted from cells immediately before the Miller assay and RNA-IN was detected by 
primer extension (lower panel). lpp mRNA was used as a loading control. The relative 
transcript level from two isolates of each strain was quantified and normalized to WT 
RNA-IN in hfq+ (set at 1). ITR (lane 1) refers to in vitro transcribed RNA-IN and served 
as a positive control for primer extension, and ‘-‘ (lane 2) is RNA from cells without a 
IS10-lacZ plasmid. The relative translation efficiency for each strain was calculated by 
dividing Miller units by relative transcript levels (shown as circles on the graph). 
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intermediate to that of the WT and M5 reporters indicative of site 2 playing a more minor 
role compared to site 1 in Hfq-directed repression of translation.  
3.2.4 Hfq blocks 30S ribosome binding to RNA-IN in vitro 
Our results thus far show that Hfq inhibits IS10 transposase expression in vivo, and that 
the most important Hfq-RNA interaction for this response is between the distal surface of 
Hfq and site 1, which includes the RBS of RNA-IN. In addition, results from Figure 3.5 
are consistent with Hfq down-regulating IS10 transposase expression by interfering with 
IS10 transposase translation. To further test the hypothesis that Hfq binding to site 1 
inhibits RNA-IN translation, we performed in vitro toeprinting assays. We show in 
Figure 3.6A (lane 6) that addition of the 30S ribosomal subunit and initiator tRNA to 
RNA-IN resulted in a strong block of reverse transcription at position +16 relative to the 
RNA-IN start codon, with minor pauses at nts +17/+18 as has previously been reported 
(Ma & Simons, 1990). These observations are consistent with a stable translation 
initiation complex forming on RNA-IN. When Hfq was added prior to addition of the 
30S ribosome and initiator tRNA (lanes 7-12), there was a decrease in the toeprint signal, 
the magnitude of which was dependent on the Hfq concentration. For example, at an Hfq 
concentration of 200 nM, where Hfq and RNA-IN are present at a 1:1 molar ratio, the 
toeprint signal decreased greater than 90% relative to the signal observed in the absence 
of Hfq (Figure 3.6A,B). In contrast, when the same experiment was performed with lpp 
or usg mRNA, inhibition of the toeprint signal was significantly weaker (Figure S3.3A). 
For example, at the same ratio of Hfq:mRNA that gave greater than 90% inhibition for 
IS10, only 50% inhibition was observed for lpp and usg (Figure 3.6B). Although Hfq 
plays a role in repressing lpp expression by stabilizing the sRNA MicL (Guo et al, 2014), 
there is no evidence that Hfq directly interacts with lpp mRNA in vivo (Bilusic et al, 
2014; Chao et al, 2012) (see also Figure  3.9). Similarly, Hfq does not interact with usg in 
vivo (Beisel et al, 2012). Accordingly, the toeprinting results in Figure 3.6A are 
consistent with Hfq acting specifically to block translation initiation in the IS10 system. 
We presume that the relatively low level of toeprint inhibition observed in the lpp and 
usg experiments is the result of non-specific interactions between Hfq and components of 
the 30S ribosome and thus represents ‘background noise’ in the assay. 
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Figure 3.6. Impact of Hfq on initiation of RNA-IN translation in vivo. 
(A) 30S ribosome binding to RNA-IN +/- Hfq is shown in a toeprint assay (for details see 
Materials and Methods). Addition of 30S ribosomal subunits and initiator tRNA is 
indicated by +. The toeprint signal is indicated (+16/+17/+18) with numbering relative to 
the translational start codon. CUAG refers to sequencing reactions generated from the 
same RNA used for toeprinting. (B) Quantitation of RNA-IN (A), lpp, and usg (Figure 
S.3.3) toeprints. Toeprint signal was normalized to the combined band intensity 
(+16/+17/+18 for RNA-IN; +15/+16 for lpp and usg) in the absence of Hfq, which was 
set at 100. The dashed line highlights 50% inhibition of the toeprint signal. (C) Toeprint 
analysis of RNA-IN with distal (A18) and proximal (U7) site-specific competitor RNAs. 
In addition, RNA-IN toeprint was also analyzed for reactions containing Y25A versus 
WT Hfq. Note that for this latter comparison, Hfq contained a C-terminal 6x-His epitope 
tag. The competitor RNAs alone had no effect on ribosome binding (not shown). (D) 
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Band intensities in C were quantified and normalized to the toeprint signal in lane 5 
where no competitor or Hfq was added.  
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We reasoned that since the distal surface of Hfq interacts with site 1 of RNA-IN, 
then the distal surface of Hfq would be critical for blocking 30S ribosome binding to 
RNA-IN. Accordingly, a competitor RNA that is specific for the distal RNA binding face 
of Hfq should relieve the ‘toeprint repression’ afforded by Hfq. We show in Figure 3.6C 
and D that when Hfq was pre-incubated with A18, a distal site binding RNA, prior to its 
addition to RNA-IN the toeprint signal increased approximately 2.5-fold relative to a 
control reaction where no competitor was added (compare lanes 6 and 7). Also, if a 
proximal face binding RNA (U7) was used instead of A18, there was no increase in the 
toeprint signal (compare lanes 6 and 8). We also show in Figure 3.6C and D that HfqY25A 
failed to reduce the toeprint signal (compare lanes 9 and 10 with lanes 11 and 12). Taken 
together, the results in this section show that Hfq can inhibit 30S ribosome binding to 
RNA-IN in vitro and that this inhibition requires an available distal surface on Hfq. 
Furthermore, as we have shown that there is a high affinity Hfq binding site (site 1) that 
spans the RBS of RNA-IN and engages the distal binding surface of Hfq, we conclude 
that Hfq binding to this site is responsible for blocking translation initiation.  
3.2.5 Hfq binds native RNA-IN in vivo and this binding is inhibited by 
site 1 mutations 
As Hfq is a pleiotropic regulator of gene expression in E. coli there is a concern that any 
phenotype observed in an hfq- strain might be the result of dysregulation of a factor under 
Hfq control. As we are proposing that Hfq binds directly to the 5’UTR of RNA-IN to 
block translation, we thought it important to look for Hfq-RNA-IN binding in vivo where 
RNA-IN would have to compete with other cellular RNAs for Hfq binding. We 
performed an Hfq-RNA immunoprecipitation experiment (RIP) with hfq- cells containing 
a chromosomal copy of IS10HH104-kan and a plasmid encoding FLAG-tagged Hfq (Figure 
3.7A). Importantly, this experiment used the same full-length RNA-IN as that used in our 
transposition experiments. 
 RNA recovered from an Hfq IP was subject to RT-PCR where RNA-IN was 
amplified from total cDNA with gene specific primers (see Materials and Methods and 
Figure S3.4). PCR reactions were then analyzed on an agarose gel. We show that RNA-
IN was strongly enriched in the Hfq IP compared to control reactions (Figure 3.7A).  
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Figure 3.7. Hfq-RNA-IN immunoprecipitation (RIP) assay. 
(A) hfq- cells containing a chromosomal IS10HH104-kan element (DBH337) were 
transformed with plasmids expressing HfqWT (pDH904) or HfqWT-3xFLAG (pDH909; C-
terminal 3xFLAG tagged Hfq). Hfq was immunoprecipitated (IP) from cell lysates with 
ANTI-FLAGÒ M2 magnetic beads; untagged Hfq (HfqWT) served as a negative control. 
The first 160nt of RNA-IN (top panel) or nts 1071-1425 of 16S rRNA were detected by 
RT-PCR. Samples were analyzed on a 2% agarose gel that was stained with ethidium 
bromide. No reverse transcription (-RT) controls are shown (lanes 2, 4, 6, and 9). L is a 
DNA ladder (lane 1). (B) hfq- cells (DBH337) were co-transformed with HfqWT-3xFLAG 
plasmid and a plasmid encoding either WT or M5 transposase-lacZ. Hfq RIPs were 
performed as in A. band intensities for the input and IP RT-PCR signal were quantified 
with an AlphaImager 3400 (Alpha Innotech). 
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Specifically, when cells expressing an untagged Hfq (HfqWT) were subject to RIP, no Hfq 
was detected in the IP fraction (Figure S3.4A) and accordingly no RNA-IN was detected 
by RT-PCR (Figure 3.7A). We therefore conclude that RNA-IN is a bona fide Hfq 
binding partner in vivo.  
 We also performed an Hfq IP with cells containing either the WT or M5 IS10-
lacZ translational fusion on a multi-copy plasmid. RT-PCR analysis of these samples 
revealed a 2.3-fold reduction in the recovery of INM5-lacZ compared to INWT-lacZ in the 
IP. This result is consistent with the Hfq binding site within the 5’UTR of RNA-IN (site 
1) providing important determinants for Hfq binding in vivo (Figure 3.7B). 
3.2.6 ChiX overexpression titrates Hfq away from RNA-IN 
Overexpression of Hfq-binding RNAs can impinge on other regulatory networks by 
titrating available Hfq away from other mRNAs and sRNAs (Hussein & Lim, 2011; 
Moon & Gottesman, 2011; Papenfort et al, 2009). Given our finding that RNA-IN can 
compete with other cellular RNAs for Hfq binding (Figure 3.7), we wondered if 
induction of an sRNA might increase transposase expression by sequestering Hfq away 
from RNA-IN. Although most sRNAs interact with the proximal surface of Hfq, an 
overexpressed sRNA that can bind the distal surface of Hfq might block Hfq’s 
association with the RBS of RNA-IN and therefore increase transposase translation by 
allowing the ribosome to bind. To test this prediction we screened a library of Hfq-
binding sRNAs to see if any increased transposase-lacZ expression. 
 We transformed hfq+ cells containing the chromosomal IS101-339-lacZ 
translational fusion with a plasmid expressing one of 14 sRNAs (Sgrs, ChiX, RybB, 
FnrS, MicC, RydC, MgrR, RprA, RyeB, CyaR, MicF, GlmY, MicA, and GcvB) or a 
vector control (Mandin & Gottesman, 2010). Transformants were subject to blue-white 
screening on X-gal plates. Our screen identified a single sRNA, ChiX, which increased 
IS10 transposase expression. Notably, the distal surface of Hfq has been previously 
shown to be important for ChiX stability and Hfq binding in vivo (Zhang et al, 2013).  
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 We next quantified the level of IS10 transposase up-regulation by measuring β-
galactosidase activity with overexpression of ChiX. As a control, we included SgrS, as 
this sRNA did not give a blue colony color in our screen. As shown in Figure 3.8A, 
overexpression of ChiX increased transposase-lacZ expression almost 12-fold compared 
to a vector control, while SgrS overexpression had no effect on transposase expression. 
We also analyzed RNA extracted immediately before the Miller assay by Northern blot 
and primer extension to measure sRNA induction and transposase-lacZ transcript levels, 
respectively (Figure 3.8B,C). Consistent with previous results, a low amount of 
endogenous ChiX was detected in all samples (Figueroa-Bossi et al, 2009; Vogel et al, 
2003), but there was a large increase in the presence of the ChiX plasmid (52-fold). This 
induction is comparable to that seen as cells transition to stationary phase (Vogel et al, 
2003). Importantly, ChiX induction resulted in only a 2-fold increase in transposase-lacZ 
transcript levels relative to the vector control (Figure 3.8C). As ChiX overexpression 
increased transposase expression 12-fold while having only a subtle effect on steady-state 
transcript levels, we conclude that ChiX increases transposase translation and not 
transcription or mRNA stability.  
 ChiX may increase transposase translation by one of two mechanisms: (i) ChiX 
may base-pair with RNA-IN to increase ribosome accessibility, as seen in the rpoS 
system (Brown & Elliott, 1997; Soper et al, 2010), or (ii) ChiX may bind Hfq with high 
affinity and block Hfq-binding to RNA-IN. We used in vitro lead footprinting with 
5’labeled ChiX and purified Hfq to define Hfq binding sites on ChiX. We also included 
RNA-IN in the footprinting reactions to determine if ChiX base-pairs with RNA-IN.  
 In the absence of Hfq, ChiX exhibited high reactivity to lead with the exception of 
nucleotides 17-22, 56-65, and 70-78, which is consistent with a mostly unstructured RNA 
containing a 5’stem-loop and a Rho-independent terminator (Figure 3.8D, lane 5 and 
right panel). In the presence of Hfq, two regions of reduced lead cleavage consisting of 
nucleotides 24-33 and 48-52 were observed (Hfq-I and Hfq-II, compare lanes 5 and 6). 
Binding reactions were also analyzed by EMSA (shown beneath footprinting gel image) 
and showed that Hfq forms a single complex with ChiX sRNA (ChiX:Hfq, lane 2 and 3). 
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Figure 3.8. ChiX positively regulates IS10 transposase translation. 
(A) hfq+ containing a chromosomal IS101-339-lacZ translational fusion were transformed 
with a plasmid expressing ChiX (pDH765), SgrS (pDH764), or a vector control 
(pDH763). Transformants were growtn to mid-exponential phase in LB media and b-
galactosidase activity was measured. Error bars show the standard error of the mean for 
two independent experiments (n=7) and the relative expression is shown above the graph, 
where transposase-lacZ in the presence of vector was set to 1. RNA was extracted 
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immediately before the Miller assay. (B) 3.5 µg of total RNA (three biological isolates) 
was used for a Northern blot using a 5’32P-labeled oligonucleotide (SgrS) or internally 
labeled antisense RNA probe (ChiX, 5S rRNA). (C) Primer extension analysis of 10 µg 
of total RNA (four biological isolates) was used to detect RNA-IN-lacZ transcript and lpp 
was analyzed as an internal control. The ratio of IN-lacZ:lpp was normalized to the 
vector control and is shown with standard error of the mean as a graph above the gel 
images. (D) 5’32P-labeled ChiX RNA (100 nM) was incubated with purified Hfq or Hfq 
and in vitro transcribed RNA-IN before limited cleavage with Pb2+. An RNase T1 
sequencing lane (G; lane 1) and untreated controls (lanes 2-4) are shown. An aliquot of 
binding reactions was analyzed on a 6% native polyacrylamide gel (bottom panel). The 
secondary structure of ChiX is shown (right panel) with three Hfq-binding sites (Hfq-
I/II/III) highlighted in red. 
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We also performed footprinting experiments with Hfq binding face mutants and 
ChiX RNA (Figure S3.5). We show that the distal surface of Hfq binds Hfq-I, while 
binding of Hfq-II requires an intact proximal surface. In addition, a third Hfq binding site 
(Hfq-III) was identified that includes the poly(U) tract following the Rho-independent 
terminator, which accordingly interacts with the proximal surface of Hfq.  
 In the presence of Hfq and a 5- or 7-fold molar excess of RNA-IN to ChiX there 
were no additional regions protected from lead cleavage (compare lane 5 to 7 and 8). This 
indicates that ChiX does not base-pair with the first 160nt of RNA-IN, a conclusion that 
is also supported by the absence of an additional complex (i.e. ChiX:RNA-IN binary 
complex or ChiX:Hfq:RNA-IN ternary complex) in the EMSA (bottom panel). Addition 
of RNA-IN did however reduce the lead footprint in the A-rich Hfq binding site of ChiX 
(compare lane 6 with lanes 7-8) and the amount of ChiX:Hfq complex formed (compare 
lanes 3 and 4 in the EMSA), consistent with ChiX and RNA-IN competing for Hfq 
binding.  
 Based on our in vitro data that RNA-IN can compete with ChiX for Hfq binding 
we performed an RIP in hfq- cells containing the IS101-339-lacZ translational fusion, 
FLAG-tagged Hfq, and the ChiX overexpression plasmid or a vector control. RNA 
recovered from the Hfq IP was analyzed directly by northern blot or primer extension to 
detect ChiX and IN-lacZ respectively; the 5S rRNA and lpp were also analyzed as 
negative controls (Figure  3.9). Overexpression of ChiX resulted in a 4.5-fold reduction 
in the amount of RNA-IN associated with Hfq. This experiment also allowed us to 
compare the relative binding affinities of ChiX and RNA-IN for Hfq. In the presence of 
the vector control, ChiX binds Hfq about 30-fold better than RNA-IN in vivo. Based on 
the differences in the amount of RNA analyzed (10 µg Input RNA, 0.3 µg IP RNA) we 
calculated that ChiX was enriched 365-fold in the Hfq IP, while RNA-IN was enriched 
12-fold. We presume that the relatively low amount of 5S rRNA and lpp mRNA that 
were detected in the IP represent non-specific interactions with Hfq in vivo or during the 
IP procedure. 
  
126 
 
 
Figure 3.9. ChiX competes with RNA-IN for Hfq-binding in vivo. 
hfq- cells containing the chromosomal IS101-339-lacZ translational fusion (DBH299) were 
co-transformed with a plasmid encoding HfqWT-3xFLAG (pDH909) and a plasmid 
expressing ChiX (pDH765) or vector control (pDH763). Hfq was immunoprecipitated 
from cell lysates with ANTI-FLAGÒ M2 magnetic beads. Total input RNA (10 µg) or 
RNA recovered from the IP (0.3 µg) was analyzed by Northern blot for ChiX and 5S 
rRNA, or primer extension for RNA-IN and lpp. Band intensities were quantified using 
ImageQuant. 
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Since ChiX was the only sRNA in our screen that titrated Hfq away from RNA-
IN, and ChiX is unique amongst sRNAs in that it contains a distal Hfq binding site, we 
wondered if other RNAs that interact with the distal surface of Hfq would increase 
transposase expression through an Hfq-titration mechanism. Most Hfq-binding mRNAs 
(including sodB, ptsG, and maeA) interact solely with the distal surface of Hfq (Zhang et 
al, 2013). We overexpressed the first 300nt of sodB, ptsG, or maeA mRNA and measured 
the impact on transposase expression. Note that the mRNAs were expressed from the 
same plasmid background as the sRNA overexpression library. Unexpectedly, 
transposase expression was mostly unaffected by mRNA overexpression (2.4-fold 
increase for sodB, 1.3-fold increase for ptsG and maeA) (Figure S3.6).  
 Together, the above results are consistent with ChiX activating IS10 transposase 
translation by titrating Hfq away from RNA-IN. ChiX does not interact with RNA-IN but 
does bind Hfq with high affinity and specificity and can compete with RNA-IN for Hfq 
binding in vitro and in vivo. Since overexpression of mRNAs containing a distal-binding 
site did not affect transposase expression, we think it likely that the ability of ChiX to up-
regulate transposase expression is due to the fact that this sRNA possesses both distal and 
proximal Hfq binding sites.  
 
3.3 Discussion 
3.3.1 Direct repression of IS10 translation by Hfq 
Hfq typically regulates translation by catalyzing pairing of an sRNA to the TIR of an 
mRNA. In the simplest model, Hfq simultaneously binds an sRNA and cognate mRNA 
near or overlapping the pairing sequences (also known as seed regions), and as pairing 
proceeds, Hfq is released from the sRNA-mRNA duplex, whereupon it can catalyze 
additional pairing reactions (Fender et al, 2010; Hwang et al, 2011; Panja & Woodson, 
2012; Tree et al, 2014). The role of each Hfq binding surface in sRNA-dependent 
regulation has been studied extensively. A study of 7 different sRNA-mRNA pairs found 
that the proximal surface (in particular lysine 56) is critical for Hfq chaperone activity 
and sRNA stability (Zhang et al, 2013). The lateral surface of Hfq also interacts with 
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sRNAs and is important for sRNA stability as well as providing a favourable surface for 
nucleating pairing (Panja et al, 2013; Sauer et al, 2012; Sauer & Weichenrieder, 2011); 
however this surface of Hfq is dispensable for some systems. Unlike the proximal 
surface, the distal RNA-binding site is not an absolute requirement for sRNA-dependent 
regulation and in some cases may simply serve as a way to tether Hfq to target mRNAs 
(Sauer, 2013; Zhang et al, 2013). The role of each RNA-binding surface of Hfq in sRNA-
independent regulation has not been studied.  
We first measured the impact of Hfq binding face mutations on IS10 transposase 
expression and transposition. The finding that the proximal surface is only partially 
required for regulation suggested that Hfq is functioning independent of a trans-encoded 
sRNA. The moderate effect of the K56A mutation on Hfq is likely a result of reduced 
binding to site 2 in RNA-IN, which is supported by decreased regulation in the presence 
of the M2 mutations. Additionally, the lateral surface was not required for repressing 
transposase expression or transposition. Alone, the R17A phenotype does not exclude 
sRNA-dependent regulation. In the case of rpoS, multiple mutations to the lateral surface 
resulted in the strongest decrease in sRNA-mediated activation of rpoS expression (Panja 
et al, 2013). Additionally, the lateral surface was only important for about half of the 
sRNA/mRNA pairs tested previously (Zhang et al, 2013). However, a dispensable lateral 
surface is consistent with sRNA-independent regulation in the IS10 system. Unlike most 
sRNA-dependent regulation, the distal surface is critical for repressing transposase 
translation and mutations that block the interaction between the TIR of RNA-IN and the 
distal site on Hfq strongly de-repressed transposase expression in vivo. Additionally, an 
available distal surface on Hfq was required for blocking 30S ribosome binding to RNA-
IN in vitro. We therefore suggest that sRNA-independent regulation by Hfq requires 
mRNA binding through the distal surface and not the proximal or lateral surfaces. 
For Hfq to be an effective direct inhibitor of translation, we think some very 
specific requirements must be met. Firstly, there needs to be an Hfq binding site in the 
TIR of an mRNA. Interestingly, a recent survey of RNA sequences bound by Hfq in vivo 
included repeated trinucleotide motifs (ARN) that were frequently associated with the 
Shine-Dalgarno sequence. Notably, 18% of all Hfq associated mRNAs contained Hfq-
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binding sites located within the TIR (Tree et al, 2014). Secondly, the Hfq binding site 
within the TIR should be a high affinity site to ensure in vivo binding. Thirdly, there must 
be sufficient available Hfq to act stoichiometrically on TIRs. Given that Hfq is a highly 
expressed protein, this third factor might not appear to be a limitation. However, there is 
growing evidence that despite being highly abundant (5,000-10,000 hexamers per cell) 
(Ali Azam et al, 1999; Argaman et al, 2012; Kajitani et al, 1994) the amount of unbound 
Hfq at any given time might in fact be limiting for RNA binding (Azam & Ishihama, 
1999; Hussein & Lim, 2011; Moon & Gottesman, 2011. Hfq has a large number of 
specific mRNA and sRNA targets and may also be sequestered through mostly non-
specific DNA interactions {Updegrove, 2010 #313). Accordingly, for translational 
repression where a sustained interaction with an mRNA is required to block 30S 
ribosomal subunit binding, it is likely critical that Hfq bind with extremely high affinity 
to the TIR which might compensate for limited availability of Hfq. We found this to be 
the case in the IS10 system as Hfq bound the TIR with an affinity of approximately 0.2 
nM. This represents one of the highest affinity interactions between Hfq and an mRNA 
(cf. ompA 1nM, ompC 0.9nM, ompF 4nM (Fender et al, 2010), sodB 0.3nM (Geissmann 
& Touati, 2004), rpoS ~50nM (Peng et al, 2014; Soper et al, 2011)). Moreover, we found 
that a moderate increase in expression of ChiX sRNA was sufficient to de-repress 
transposase expression. Given our evidence that: (i) ChiX possesses a distal Hfq binding 
site; (ii) its overexpression did not substantially influence RNA-IN steady-state levels, 
(iii) ChiX does not base-pair with RNA-IN, and (iv) ChiX overexpression reduces the 
amount of RNA-IN bound by Hfq in vivo, we think the results of the ChiX 
overexpression experiment are most easily explained by a ChiX-Hfq titrating mechanism. 
That is, despite the high affinity of site 1 in RNA-IN for Hfq, moderate overexpression of 
ChiX was sufficient to deplete the pool of available Hfq such that there were insufficient 
amounts to repress RNA-IN translation. The implications of Hfq titration by ChiX are 
discussed below. 
3.3.2 Hfq regulation of IS10 in single and multi-copy 
All of the in vivo experiments reported in this work were performed under conditions 
where the naturally occurring antisense RNA (RNA-OUT) was not produced. This was 
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meant to mimic a situation where IS10 is in single copy, where the antisense RNA has 
little to no effect on transposase expression (Kleckner, 1990). The HH104 mutation was 
introduced to the single-copy IS10 elements to increase transposase transcription to 
detectable levels, and although this mutation also eliminates the small amount of cis-
encoded RNA-OUT there would be little antisense control to begin with. We propose that 
under these conditions Hfq acts in a stoichiometric manner to limit RNA-IN translation 
(Figure 3.10). However, when IS10 is present on a multi-copy plasmid stoichiometric 
action of Hfq on RNA-IN might not be sufficient to limit translation because of the 
increase in the number of RNA-IN transcripts. In support of this, when we compared Hfq 
regulation of a chromosomal IS10-lacZ fusion to a high-copy translational fusion, the 
extent of Hfq-mediated repression was attenuated from 13- to 3-fold (Figures 3.2A and 
3.5).  With a high-copy IS10 element, the MCI pathway comes into play and RNA-OUT 
becomes an important negative regulator of RNA-IN translation and stability (Case et al, 
1990). We have previously shown that Hfq binds RNA-OUT and promotes its 
restructuring to expose sequences important for RNA-IN pairing (Ross et al, 2010). As 
Hfq facilitates RNA-IN:OUT pairing in a catalytic cycle, we think that when IS10 is in 
multi-copy, this mechanism would predominate over the ‘stoichiometric’ inhibition 
pathway. We eliminated RNA-OUT from the multi-copy IS101-242-lacZ translational 
fusion so we could study antisense-independent regulation by Hfq, and our results show 
that stoichiometric repression can still occur albeit regulation is weaker for multi-copy 
IS10. We therefore think that Hfq is a negative regulator of IS10 regardless of copy-
number. This model may also explain previous results where it was found that Hfq is a 
stronger negative regulator of transposition when IS10 is present in multi-copy compared 
to single-copy (Ross et al, 2010). Our model would predict that in this scenario Hfq is 
repressing predominantly by a catalytic mechanism involving Hfq-mediated RNA-
IN:OUT pairing, which presumably is more efficient than the stoichiometric repression 
that is confined to the single copy situation. 
  This dual-model for Hfq repression may be applicable to other members of the 
Hfq regulon. In the absence of a cognate sRNA, we suggest that Hfq would repress 
translation of mRNAs containing an Hfq-binding site in the TIR by a stoichiometric  
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Figure 3.10. Model for dual role of Hfq in repressing IS10 transposase translation. 
When IS10 is present in single copy (left side), transposase expression is not subject to 
antisense control by RNA-OUT. Hfq binding to the RBS in RNA-IN represses translation 
by preventing ribosome binding (‘stoichiometric’ repression). Multi-copy IS10 is subject 
to antisense control by increases concentrations of RNA-OUT (right panel). Hfq may still 
participate in stoichiometric repression by also facilitates antisense pairing in a ‘catalytic’ 
manner. Hfq binding to RNA-IN and RNA-OUT alters RNA secondary structure (not 
shown for RNA-IN), exposing sequences involved in pairing. 
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mechanism. The strength of this regulation would be governed primarily by the affinity 
of Hfq for that site relative to other cellular mRNAs. This model might also explain the 
conflicting data concerning regulation of ompA expression. Work in the Bläsi lab 
suggested that Hfq directly represses ompA translation by binding the TIR in a manner 
analogous to that described here for IS10 (Vytvytska et al, 2000). This is supported by 
several surveys of Hfq-binding mRNAs that have identified ompA as an Hfq-binding 
mRNA (Sittka et al, 2008; Tree et al, 2014; Zhang et al, 2003). The characterization of 
the stationary-phase sRNA MicA by the Wagner lab suggested that the primary role of 
Hfq in regulating ompA expression was to promote sRNA-mRNA pairing (Udekwu et al, 
2005). Our model would combine both mechanisms and suggest that Hfq exerts some 
basal repression of ompA translation that is strengthened in stationary phase by promoting 
MicA pairing with ompA. Additionally, our model is applicable to the sdhC system where 
Hfq had an sRNA-independent effect on expression that is presumably a result of direct 
repression of translation (Desnoyers & Masse, 2012). 
3.3.3 Hfq titration by the sRNA ChiX 
Induction of Hfq-binding sRNAs can impinge on other Hfq-dependent post-
transcriptional networks. In the simplest model, induction of an sRNA would provide 
enough sRNA molecules to bind all available Hfq and even compete with other Hfq-
binding RNAs. Hfq titration was first proposed as a mechanism for OxyS repression of 
rpoS expression, which was later verified (Moon & Gottesman, 2011. ChiX 
overexpression also resulted in increased rpoS-lacZ expression, and this effect was 
proposed to be a result of Hfq titration {Mandin, 2010 #308; Zhang et al, 1998). 
Additionally, overexpression of ArcZ in Salmonella was shown to have a pleiotropic 
effect on gene expression (altering expression of 757 genes) in part by decreasing the 
number of mRNAs bound to Hfq as well as specific competition with the sRNAs CyaR 
and InvR (Papenfort et al, 2009). Our studies with ChiX overexpression have provided 
another example of an sRNA sequestering sufficient amounts of Hfq to produce a 
biological effect; de-repression of RNA-IN translation.  
ChiX (previously named SroB, RybC, and MicM) is a negative regulator of genes 
involved in chitobiose utilization. ChiX is constitutively expressed but its levels increase 
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substantially in stationary phase (Figueroa-Bossi et al, 2009; Papenfort & Vogel, 2014; 
Vogel et al, 2003). The fact that ChiX was the only sRNA of 14 screened to have an 
impact on expression of RNA-IN under anti-sense independent conditions fits fully with 
our model of stoichiometric inhibition resulting from Hfq binding the TIR of RNA-IN 
(site 1) through its distal binding site. ChiX is somewhat unique amongst E. coli sRNAs, 
as (according to our footprinting data) it possesses both distal and proximal Hfq binding 
sites. Moreover, in a recent study that compared the ability of a set of sRNAs to compete 
for Hfq binding, it was established that ChiX was at the top of the hierarchy, while SgrS 
was at the bottom. This same work also showed that the A-rich region of ChiX that we 
designated Hfq-I interacts with the distal surface of Hfq and provides important 
determinants for Hfq competition (Malecka et al, 2015). This fits fully with our data 
showing that ChiX overexpression titrated Hfq away from RNA-IN while SgrS did not.  
ChiX is unique amongst sRNAs as it acts catalytically to repress its target mRNA 
(chiP, previously known as ybfM), and ChiX levels are regulated by an ‘anti-sRNA’, 
chbBC (Overgaard et al, 2009). It is therefore unexpected that ChiX levels would 
increase so dramatically during stationary phase. Given the current work, it is tempting to 
speculate that ChiX has a yet unidentified role during the transition to stationary phase; 
notably, ChiX constitutes 24-26% of Hfq-bound sRNAs during early stationary phase 
(Chao et al, 2012). Based on ChiX’s distinct interaction properties with Hfq, it is worth 
considering the possibility that ChiX expression could influence the entire Hfq regulon 
during the transition to stationary phase. 
 
3.4 Materials and Methods 
3.4.1 Bacterial strains, phage, plasmids and oligonucleotides 
All bacterial strains, phage, and plasmids used in this study are listed in Table S3.1 and 
oligonucleotides are listed in Table S3.2.  
 For mating out experiments, DBH33 was lysogenized with lDBH504 to create 
DBH331 (hfq+). P1 transduction was then performed to convert DBH331 to DBH337 
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(hfq-). lDBH504 was created by crossing IS10HH104-kan from pNK1223 onto lNK1039 
in DBH60; kanR lysogens were selected by replica plating and then phage stocks 
(lDBH504) were prepared from these lysogens. For β-galactosidase assays with 
chromosomal IS10HH104-lacZ, DBH107 was lysogenized with lRS271 (obtained from 
DBH90 via spontaneous phage release) to create DBH287. DBH287 was subjected to 
recombineering (details available upon request) to remove the G8 mutation creating 
DBH298. P1 transduction was then performed to convert DBH298 (hfq+) to DBH299 
(hfq-).  
 The Hfq expression plasmids used for complementation experiments were made 
by amplifying the hfq gene (including the P3 promoter) from pDH700, pDH701, and 
pDH713 (Ross et al, 2013) with primers oDH518 and oDH519. The PCR product was 
digested with HaeIII and cloned into the XmnI/ScaI sites of pACYC184. The R17A 
mutation was first introduced into pDH700 by overlap PCR using primers oDH518, 
oDH519, oDH520, and oDH521. The PCR product was cloned into the XbaI/HindIII 
sites of pDH700 to make pDH874, and HfqR17A was then subcloned into pACYC184 as 
above. Hfq was amplified from pDH904 with oDH184 and oDH479 to add a C-terminal 
3xFLAG tag and this amplicon was cloned directly into XmnI/ScaI digested pACYC184. 
 The multi-copy IS10-lacZ translational fusion is a derivative of pNK2974 (Jain, 
1995). First, IS10 was amplified with primers oDH502 and oDH503 and this amplicon 
was cloned into the EcoRI/HindIII sites of pNK2974 to produce pDH858 which contains 
the first 242nt of IS10R fused in frame to codon 10 of lacZ. All subsequent mutations 
were introduced into pDH858 using overlap PCR with primers oDH505 and oDH13 and 
the relevant mutagenic primers; R5 (oDH506, oDH507), M2 (oDH498, oDH499), and 
M5 (oDH508, oDH509). PCR products were digested with EcoRI and HindIII and cloned 
into the same sites in pDH858. M5 and M2 were originally identified as increased 
expression mutants in a transposase expression screen. The transposase gene used was 
derived from a library of sequences generated by mutagenic PCR.  
 Plasmids overexpressing sodB, ptsG, and maeA were constructed as previously 
described (Zhang et al, 2013). MC4100 genomic DNA served as a template for PCR with 
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the following primers: oDH558 and oDH559, sodB; oDH560 and oDH561, ptsG; 
oDH562 and oDH563, maeA. PCR products were digested with AatII and EcoRI and 
cloned into the same sites of pDH765. 
3.4.2 Hfq footprinting and EMSA 
 In vitro transcription templates were generated by PCR using plasmids pDH866 
(IN-160), pDH868 (INM2-160), pDH875 (INM5-160) and primers oDH515 (IN-160 and 
INM2-160) or oDH510 (INM5-160) with oDH199. RNA-IN was generated by in vitro 
transcription and internally labeled with [α32P]-UTP (for EMSA) or 5’labeled with [γ32P]-
ATP (for footprinting) as previously described (Ross et al, 2013). Wild-type Hfq was 
purified by heat treatment and poly(A) affinity purification, and his-tagged Hfq variants 
were purified by Ni2+-IMAC as previously described (Ross et al, 2013). RNA-
footprinting was performed as previously described (Ross et al, 2013, except that 
reactions were in 1X RNA Structure Buffer (Ambion) and Pb2+ footprinting used 10 mM 
Lead(II)Acetate (Sigma-Aldrich) for 3 min at ambient temperature which was stopped by 
addition of EDTA to a final concentration of 50 mM. Following ethanol precipitation, 
RNA footprinting samples were resuspended in denaturing load dye (95% [v/v] 
formamide, 0.5X TBE, 3% [w/v] xylene cyanol) and resolved on a 10% polyacrylamide 
gel containing 7M urea. EMSA was performed essentially as described (Ross et al., 2013) 
except that binding reactions included 20 ng/µL total yeast RNA (Ambion). Apparent 
dissociation constants were determined as previously described {Ross, 2013 #28). 
 The ChiX in vitro transcription template was generated with primers oDH528 and 
oDH529 with a genomic DNA template. Lead footprinting was performed as above. A 
3.5 µL aliquot of ChiX, ChiX-Hfq, or ChiX-Hfq-RNA-IN (700 nM) was removed from 
binding reactions, mixed with native load dye (20 mM Tris-HCl, pH 7.5, 10 mM DTT, 
100 mM KCl, 30% glycerol [v/v], 0.05% bromophenol blue [w/v]), and resolved on a 6% 
polyacrylamide TBE gel. 
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3.4.3 β-galactosidase assays 
Cells were grown in LB supplemented (where necessary for plasmid selection) with 
ampicillin (100 µg/mL) and tetracycline (10 µg/mL). Saturated overnight cultures were 
used to seed subcultures (1:40 dilution), which were grown to mid-log phase (OD600 = 
0.4-0.6). IPTG (1 mM) was added to the subculture to induce sRNA expression. The 
Miller assay was performed as previously described (Ross et al, 2010).  
 
3.4.4 Conjugal mating out assay 
 The mating out assay was performed essentially as previously described (Ross et 
al, 2010). Plasmids encoding the Hfq variants (pDH904, pDH905, pDH906, and 
pDH907) or a vector control (pDH900) were transformed into the donor strain DBH337 
(hfq-; contains IS10HH104-kan lysogen) and plated on M9-glucose supplemented with 
thiamine (1 µg/mL), arginine (40 µg/mL), kanamycin (50 µg/mL) and tetracycline (15 
µg/mL). Donor colonies were grown overnight to saturation in LB supplemented with 
kanamycin (50 µg/mL) and tetracycline (15 µg/mL) and the recipient strain (HB101) was 
grown in LB supplemented with streptomycin (150 µg/mL). Donor and recipient strains 
were subcultured in LB without antibiotics, and then grown and mixed for mating as 
previously described (Ross et al, 2010). Mating was stopped by vigorous vortexing after 
1 hr and 1 mL of mating mixture was washed and then serially diluted in saline (0.85% 
[w/v] NaCl). Cells were plated on M9-glucose supplemented with thiamine, leucine (40 
µg/mL) and streptomycin (150 µg/mL) or streptomycin plus kanamycin (50 µg/mL) for 
‘total exconjugates’ and ‘hops’ respectively. The transposition frequency was calculated 
by dividing the number of SmRKanR colonies by SmR colonies (‘hops’ per 
‘exconjugate’). 
3.4.5 RNA extraction and primer extension analysis 
 Cells were grown in LB supplemented with ampicillin (100 µg/mL) to OD600 = 
0.6 at which time 600 µL of cells were added to 300 µL of RNA lysis buffer (1.5% [w/v] 
SDS, 300 mM sodium acetate, 30 mM EDTA) and boiled for 1 min. Samples were 
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chilled on ice for 30s and then sequentially extracted twice with acid phenol (pH 4.3), 
once with phenol:chloroform:isoamyl alcohol (25:24:1) and once with 2-butanol 
followed by ethanol precipitation. Residual genomic DNA was removed with TURBO 
DNase (Ambion) prior to primer extension analysis. 5 or 10 µg of total RNA (Figure 5B, 
8C and 9 respectively) was subject to primer extension analysis with 5’32P-labeled 
oDH511 (RNA-IN) and oDH482 (lpp) and SuperScript III (Invitrogen) according to the 
manufacturer’s instructions.  
3.4.6 Toeprinting 
 The 30S ribosomal subunit was prepared as previously described (Fechter et al, 
2009). In vitro transcribed RNA (2 pmol) was annealed to 5’32P-labeled oDH511 (RNA-
IN), oDH482 (lpp) and oDH555 (usg) in buffer SB (10 mM Tris-acetate, pH 7.6, 1 mM 
DTT, 100 mM potassium acetate) by heating to 95oC for 1 min followed by snap-cooling 
on ice for 2 min. While on ice, magnesium acetate was added to a final concentration of 
10 mM and dNTPs to 0.5 mM. Reactions were then incubated at 37oC for 5 min. Hfq 
(0.5-4 pmol of hexamers) or buffer was added to reactions which were incubated for 
another 15 min at 37oC, followed by addition of 30S ribosome (3.6 pmol for RNA-IN and 
usg, 2.7 pmol for lpp) and incubation at 37oC for 5 min. Initiator fMet-tRNA (10 pmol; 
Sigma-Aldrich) was added and reactions were incubated for a further 15 min before 
addition of 200U of SuperScript II (Invitrogen) and a final incubation of 10 min at 37oC. 
Reactions were stopped by addition of 100 µL of stop solution (50 mM Tris-HCl, pH 7.5, 
0.1% SDS [w/v], 10 mM EDTA) followed by phenol:chloroform:isoamyl alcohol 
extraction and ethanol precipitation. Samples were resuspended in denaturing load dye 
(95% [v/v] formamide, 0.5X TBE, 3% [w/v] xylene cyanol) and resolved on a 10% 
polyacrylamide gel containing 7M urea. Dried gels were exposed to a phosphorimager 
storage screen, imaged with a Storm imager and quantitated with ImageQuant (GE 
Healthcare). 
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3.4.7 Hfq-RNA immunoprecipitation (RIP) 
 DBH337 (hfq-; contains IS10HH104-kan lysogen) was transformed with plasmids 
expressing untagged Hfq (pDH904) or Hfq with a C-terminal 3xFLAG tag (pDH909). 
Cells were grown to mid-exponential phase (OD600 = 0.5) in LB supplemented with 
tetracycline (15 µg/mL) at which point 50 OD600 of cells was collected by centrifugation 
and washed once in TBS (50 mM Tris-HCl, pH 7.4, 150 mM NaCl) and resuspended in 
400 µL of lysis buffer (20 mM Tris-HCl, pH 8.0, 150 mM KCl, 1 mM MgCl2) with 40U 
of RNasin (Promega) and 2U of TURBO DNase (Ambion). Cells were mixed with 400 
µL of zirconia/silica beads (0.1 mm, BioSpec) and lysed by vortexing (30 s burst, 30 s 
ice; 10 cycles) after which 800 µL of lysis buffer was added followed by centrifugation 
(10 min, 13,500 RCF, 4oC). An aliquot of the cleared lysate (100 µL) was phenol 
extracted and ethanol precipitated (‘Input RNA’). ANTI-FLAG® M2 magnetic beads (25 
µL packed resin; Sigma-Aldrich) were added to 800 µL of cleared lysate and samples 
were incubated at 4oC with rotation for 4 h. Beads were washed 5 times with 1 mL of 
lysis buffer, and resuspended in 400 µL of lysis buffer. Hfq-bound RNA (‘IP RNA’) was 
recovered by phenol extraction and ethanol precipitation. Following precipitation, 
residual DNA was removed with TURBO DNase (Ambion) and samples were ethanol 
precipitated and finally resuspended in DEPC treated ddH2O. RNA concentration was 
determined with a NanoPhotometer (Implen). 
 For the RIP with WT and mutant IS10-lacZ (Figure 3.7B) DBH12 was 
transformed with pDH909 (Hfq-3xFLAG) and pDH866 (INWT-lacZ) or pDH875 (INM5-
lacZ). Cells were grown in LB supplemented with tetracycline and ampicillin (100 
µg/mL) and IP was performed as above. 
 The RIP with ChiX overexpression used DBH337 (hfq-; contains IS10HH104-kan 
lysogen) transformed with pDH909 (Hfq-3xFLAG) and pDH765 (ChiX) or pDH763 
(vector). IP was performed as above. Total input RNA (10 µg) or RNA recovered from 
the IP (0.3 µg) was analyzed directly by northern blot (ChiX and 5S rRNA) or primer 
extension (RNA-IN and lpp). 
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3.4.8 RT-PCR 
 An RNA adapter (oDH486; 100 pmol) was ligated to input (10 µg) or IP (1 µg) 
RNA using T4 RNA ligase. Adapter-ligated RNA was purified with an RNeasy Mini Kit 
(Qiagen), eluted in 30 µL of DEPC ddH2O, and 10 µL of RNA was converted to cDNA 
using an adapter specific primer (oDH352) and SuperScript III (Invitrogen) according to 
the manufacturers instructions. Enzyme was omitted for the no reverse transcription 
controls (-RT). Reverse transcription reactions were purified with a PCR purification kit 
(Qiagen) and eluted in 50 µL of ddH2O. The first 160 nt of RNA-IN was detected by 28 
cycles of PCR using 4 µL of cDNA as a template and primers oDH199 and oDH483 
(WT) or oDH517 (M5). A portion of the 16S rRNA (nt 1071-1425) was detected by 18 
cycles of PCR using primers oDH204 and oDH205. PCR reactions were analyzed on a 
2% agarose TBE gel. 
3.4.9 Northern Blot 
 3.5 µg of total RNA (Figure 3.8B) was denatured in load dye (95% [v/v] 
formamide, 0.5X TBE, 3% [w/v] xylene cyanol) and then separated on a 10% 
polyacrylamide gel containing 7M urea. RNA was electroblotted to a Hybond-N nylon 
membrane (Amersham) in 0.5X TBE at 200 mA for 1 hr. RNA was UV cross-linked to 
the membrane and then probed for SgrS with 5’32P-labeled oDH298 in ULTRAhyb-oligo 
buffer (Ambion) at 42oC. ChiX and the 5S rRNA were detected by probing the 
membrane with an internally 32P-labeled antisense RNA (templates were generated by 
PCR with genomic DNA template and primers oDH234 and oDH235 (5S rRNA) or 
oDH308 and oDH309 (ChiX)) in ULTRAhyb buffer (Ambion) at 68oC. Membranes were 
washed according to the manufacturer’s instructions. Northern blots were exposed to a 
phosphorimager storage screen and imaged with a STORM imager (GE Healthcare). 
3.5 Supplemental Material 
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Table S 3.1. Strains, plasmids, and bacteriophage for Chapter 3 
Name Description Notes 
E. coli   
DBH12 MC4100 hfq-1::ΩCm; StrRCmR G. Storz; β-galactosidase assays 
and source of hfq-1 allele for P1 
transductions  
DBH13 HB101 [F- leu- pro-]; StrR Mating out recipient 
DBH33 NK5830 [recA- arg -ΔlacproXIII nalR 
rifR/ F’ lacpro+] 
Parent strain for mating out donors 
DBH60 C600 Used for plasmid-l crosses  
DBH90 DBH33 λRS271 (G8, HH104); KanR Chromosomal IS10-lacZ 
translation fusion marked with 
kanR; HH104 mutation increases 
transposase transcription and G8 
mutation increases RNA-OUT 
expression to maintain antisense 
control 
DBH107 MC4100; StrR β-galactosidase assays 
DBH287 DBH107 lRS271 (G8; HH104); 
StrRKanR 
Parent strain 
DBH298 DBH107 lRS271 (HH104); StrRKanR  Chromosomal IS10-lacZ 
translational fusion marked with 
KanR, G8 removed by 
recombineering, no RNA-OUT; b-
galactosidase assays (wt) 
DBH299 DBH298 hfq-1::ΩCm; KanRStrRCmR b-galactosidase assays (hfq-) 
DBH313 MRE600 [F- Δrna] Steitz Lab; Strain for 30S ribosome 
purification 
DBH331 DBH33 lDBH504 (HH104); KanR Chromosomal IS10-Kan HH104; 
mating out donor strain, no RNA-
OUT (wt) 
DBH337 DBH331 hfq-1::ΩCm; KanRCmR Mating out donor strain and source 
of native RNA-IN for RIP 
experiments, no RNA-OUT (hfq-)  
DH5a  Cloning and plasmid propagation 
   
Plasmids   
pDH858 pUC119 derived; IS101-242-lacZ 
translational fusion; ApR 
WT IS10-lacZ translational fusion, 
expresses RNA-OUT 
pDH866 pDH858 + R5 WT RNA-IN, RNA-OUT 
destabilized by R5 mutation 
pDH868 pDH866 + M2 Mutated Hfq binding site 2 on 
RNA-IN 
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pDH875 pDH866 + M5 Mutated Hfq binding site 1 on 
RNA-IN 
pDH700 pWKS30-p3-HfqWT; ApR Parent plasmid; expression vector 
for HfqWT  
pDH701 pDH700-HfqK56A Parent plasmid; expression vector 
for HfqK56A  
pDH713 pDH700-HfqY25A  Parent plasmid; expression vector 
for HfqY25A  
pDH874 pDH700-HfqR17A Parent plasmid; expression vector 
for HfqR17A 
pDH900 pACYC184 with ScaI/XmnI fragment 
removed; TetRCmS 
Vector control for Hfq 
complementation experiments 
pDH904 pDH900-p3-HfqWT Expression vector for HfqWT 
pDH905 pDH900-p3-HfqY25A Expression vector for HfqY25A 
pDH906 pDH900-p3-HfqK56A Expression vector for HfqK56A 
pDH907 pDH900-p3-HfqR17A Expression vector for HfqR17A 
pDH909 pDH900-p3-HfqWT-3xFLAG Expression vector for HfqWT-
3xFLAG 
pDH763 pBR-pLlacO; ApR Vector control for sRNA 
expression 
pDH764 pBR-pLlacO-sgrS; ApRTetR SgrS expression 
pDH765 pBR-pLlacO-chiX; ApRTetR ChiX expression  
pDH766 pBR-pLlacO-RybB; ApRTetR RybB expression 
pDH767 pBR-pLlacO-FnrS; ApRTetR FnrS expression 
pDH768 pBR-pLlacO-MicC; ApRTetR MicC expression 
pDH769 pBR-pLlacO-RydC; ApRTetR RydC expression 
pDH770 pBR-pLlacO-MgrR; ApRTetR MgrR expression  
pDH771 pBR-pLlacO-RprA; ApRTetR RprA expression 
pDH772 pBR-pLlacO-RyeB; ApRTetR RyeB expression  
pDH773 pBR-pLlacO-CyaR; ApRTetR CyaR expression  
pDH774 pBR-pLlacO-MicF; ApRTetR MicF expression 
pDH775 pBR-pLlacO-GlmY; ApRTetR GlmY expression 
pDH776 pBR-pLlacO-MicA; ApRTetR MicA expression  
pDH777 pBR-pLlacO-GcvB; ApRTetR GcvB expression  
pDH920 pBR-pLlacO-sodB-56 to +244; ApRTetR sodB expression 
pDH921 pBR-pLlacO-ptsG-102 to +230; ApRTetR ptsG expression 
pDH922 pBR-pLlacO-maeA-73 to +241; ApRTetR maeA expression 
   
l phage   
lRS271 Source of IS10-Kan HH104 G8  
lNK1039 Encodes his operon plasmid-l crosses 
lDBH504 lNK1039 with IS10-Kan HH104  Product of recombination between 
lNK1039 and pNK1223 
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Table S 3.2. List of Oligonucleotides for Chapter 3 
Name Sequence (5’ à 3’) Use 
oDH502 GGATCGGAATTCCGATCTTCCCTGATGA
ATCCCCTAATGATTTTGG 
Fwd primer for making pDH858 
oDH503 CCCCCCAAGCTTGGCGCCAAGTTCGGTA
AGAGTGAGAGTTTTACAGTC 
Rev primer for making pDH858 
oDH505 GGATCGGAATTCCGATCTTCC IS10R Fwd primer used for 
introducing mutations into pDH866 
oDH13 CCAGTCACGACGTTGTAAAAC LacZ reverse primer used for 
introducing mutations into pDH866 
oDH506 CCAGTCACGACGTTGTAAAAC Mutagenic primers for introducing 
R5 mutation into pDH858 oDH507 GACAAGATATGTATCCACC 
oDH498 CTCGACACCCCACACGACTCTC Mutagenic primers for introducing 
M2 mutation into pDH866 oDH499 GAGAGTCGTGTGGGGTGTCGAG 
oDH508 GTCAGTCTGCGGATCACAAGATG Mutagenic primers for introducing 
M5 mutation into pDH866 oDH509 CATCTTGTGATCCGCAGACTGAC 
oDH515 TAATACGACTCACTATAGGCGAAAAAT
CAATAACAG 
Fwd primer for making IN-160 an 
INM2-160 ITR templates; contains 
T7 core promoter 
oDH199 CAAGTTCGGTAAGAGTGAGAG Rev primer for making IN-160 ITR 
templates; Rev primer for PCR 
amplification of RNA-IN cDNA 
oDH510 TAATACGACTCACTATAGGCGAAAAGT
CAGTCTG 
Fwd primer for making INM5-160 
ITR template; contains T7 core 
promoter 
oDH511 TGTTGAGTCTCGTTTTAAGTGTA Primer for making RNA-IN-100 
cDNA (primer extension and 
toeprinting) 
oDH513 UUUUUUU RNA oligo; proximal site 
competitor 
oDH514 AAAAAAAAAAAAAAAAAA RNA oligo; distal site specific 
competitor 
oDH480 TGTAATACGACTCACTATAGGGCTACAT
GGAGATTAAC 
Fwd primer for making lpp ITR 
template; contains T7 promoter 
sequence 
oDH482 CACGTCGTTGCTCAGCT Reverse primer for making lpp ITR 
template; also used for lpp primer 
extension and toeprinting 
oDH184 NNTCTAGANNCAGGTTGTTGGTGCTATC Fwd primer for Hfq gene 
oDH479 TTACTTGTCGTCATCGTCTTTGTAGTCCT
TGTCGTCATCGTCTTTGTAGTCCTTGTCG
TCATCGTCTTTGTAGTCTTCGGTTTCTTC
GC 
Rev primer for adding C-terminal 
3xFLAG tag  
oDH486 5'[Phos]GCUGAUGGCGAUGAAUGAACAC
UGCGUUUGCUGGCUUUGAUGAAA 
RNA adapter; ligated to total RNA 
for reverse transcription 
oDH483 GCGAAAAATCAATAATCAGAC Fwd primer for RT-PCR of RNA-
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IN 
oDH517 GCGAAAAGTCAGTCTGAGAC Fwd primer for RT-PCR of RNA-
INM5 
oDH204 CGTGTTGTGAAATGTTGGGTTAAGT Primer pair for RT-PCR of 16S 
rRNA (nt 1071-1425) oDH205 AACCCACTCCCATGGTGTGACGGGC 
oDH518 GCCAGCTGGCGAAAGG Primer pair for amplifying MCS of 
pWKS30 derived plasmids; used 
for introducing R17A mutation into 
pDH700 
oDH519 TAATGCAGCTGGCACGACAGG 
oDH520 GCACTGCGTGCGGAACGTGTTCC Mutagenic primers for introducing 
R17A mutation into pDH700 oDH521 GGAACACGTTCCGCACGCAGTGC 
oDH352 TTTCATCAAAGCCAGCAAACGC RNA adapter specific primer used 
for cDNA synthesis 
oDH353 CAAACGCAGTGTTCATTCATCGCC RNA adapter specific nested 
primer used for PCR of total RNA-
IN cDNA  
oDH234 TAATACGACTCACTATAGGCCTGGCAGT
TCCCTACTCTCG 
Fwd primer for making antisense  
5S rRNA (rrfA) ITR template for 
Northern blot; contains T7 
promoter sequence 
oDH235 CGGCAGTAGCGCGGTG Reverse primer for above 
oDH308 TAATACGACTCACTATAGGGAAAAAAA
TGGCCAATATCGCTATTG 
Fwd primer for making antisense 
ChiX ITR template for Northern 
blot; contains T7 promoter 
sequence 
oDH309 ACACCGTCGCTTAAAGTGACG Reverse primer for above 
oDH298 CGGGTGATTTTACACCAATAC Oligonucleotide for SgrS Northern 
blot 
oDH528 TAATACGACTATAGACACCGTCGCTTAA
AGTGAC 
Fwd primer for making ChiX ITR 
template; contains T7 promoter 
sequence 
oDH529 AAAAAAATGGCCAATATCGCTATTGGC
CCG 
Reverse primer for above 
oDH554 TAATACGACTCACTATAGGCTCTGCTGT
AACATTGGCAG 
Fwd primer for making usg ITR 
template; contains T7 promoter 
sequence 
oDH555 CCCACAGCGCCAGTTGC Reverse primer for above; also 
used for toeprinting 
oDH558 AATACTGACGTCATACGCACAATAAGG
CTATTG 
Primer pair for amplifying sodB for 
overexpression in pDH920 
oDH559 AATACTGAATTCCAGGCAGTTCCAGTAG
AAAG 
oDH560 AATACTGACGTCATAAATAAAGGGCGC
TTAG 
Primer pair for amplifying ptsG for 
overexpression in pDH921 
oDH561 AATACTGAATTCACGCCATCGTTATTGG 
oDH562 AATATGACGTCGCCGACGCCCTGGCG Primer pair for amplifying maeA 
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oDH563 AATACTGAATTCGGATGTTACGCAGGTA
GATG 
for overexpression in pDH922 
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Figure S 3.1. Hfq expression in an hfq- strain of E. coli (DBH299) used for 
complementation experiments. 
Prior to measuring β-galactosidase activity of IS10-lacZ (Figure 3.2a), an equivalent 
number of cells (0.4 OD600) were pelleted and frozen at -80oC. Pellets were resuspended 
in SDS load-mix (2% SDS, 10% glycerol, 50 mM Tris-HCl pH 6.8, 0.25% bromophenol 
blue and 0.8 M β-mercaptoethanol) and boiled for 5 minutes. Samples were separated on 
a 14% SDS-PAGE gel and then transferred to a PVDF membrane (Roche). Hfq was 
detected by Western Blot using a polyclonal rabbit anti-Hfq antibody and a Pierce ECL 2 
Western Blotting kit (Thermo Scientific). Purified Hfq (0.6 pmol) was loaded as a 
positive control. 
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Figure S 3.2. Mutations to the ribosome-binding site (RBS) of RNA-IN prevent Hfq 
binding. 
5’32P-labeled RNA-IN-160 (150 nM) was incubated -/+ 400 nM Hfq (hexamers) before 
treatment with RNase V1. Untreated controls and a RNase T1 sequencing ladder (lane 1) 
are shown. Nucleotide numbering is relative to the translational start. Four positions that 
are strongly protected from cleavage on wild-type RNA-IN (lanes 4-5) and INM2 (lanes 
12-13) are indicated with red boxes. The corresponding positions that are not protected 
on INM5 are indicated with dashed red boxes. Note that the in vitro transcript for INM5 
contains an extra 5’nt, resulting in a 1nt difference in the migration of RNA fragments 
(indicated by black arrows). Note that certain lanes from this gel were removed for clarity 
(indicated by black vertical lines). 
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Figure S 3.3. Toeprint analyis of 30S ribosome binding to lpp or usg mRNA in the 
presence of Hfq. 
(A) Unlabeled lpp (-38 to +144 relative to the translational start) or (B) usg (-50 to +50 
relative to the translational start) mRNA was incubated with the indicated concentrations 
of purified Hfq before addition of the 30S ribosomal subunit (lpp, 270 nM; usg, 360 nM) 
and fMet-tRNA (5 µM). CAG refers to sequencing lanes produced with the same RNA 
used for toeprinting. The toeprint signal at positions +15/+16 relative to the start codon is 
indicated as well as a band used to normalize loading for quantitation of the lpp toeprint 
(+82). 
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Figure S 3.4. Specificity of Hfq:RNA-IN IP and size distribution of RNA-IN 
molecules containing a 5’end. 
(A) Hfq western blot of fractions from HfqWT and HfqWT-3xFLAG immunoprecipitations. 
Aliquots of total cellular lysate (lanes 2 and 3), supernatant from IP reactions (lanes 3 and 
6), or the ANTI-FLAG® M2 Magnetic Beads following washes (lanes 4 and 7) were 
subject to western blot as described in Figure S3.1. Purified Hfq (0.15 pmol) was loaded 
as a positive control (lane 1). The tagged and untagged Hfq monomers are indicated. (B) 
cDNA from total RNA (lanes 1 and 3) or IP reactions (lanes 2 and 5) was amplified by 24 
cycles of PCR using an RNA-IN specific forward primer and a nested RNA Adapter 
specific reverse primer. PCR products were then resolved on a 2% Agarose/TBE gel and 
stained with EtBr. A DNA ladder (lane 5) was used to determine the size distribution of 
PCR proucts which is indicated with dashed horizontal lines. (C) Schematic of RT-PCR 
used for Hfq IP. Total RNA from the RIP was ligated to an RNA adapter (black box). An 
adapter specific primer was for cDNA synthesis, yielding a mixed population of RNA 
species. The size distribution of RNA-IN molecules with an intact 5’end (B) was 
determined by amplifying PCR with an RNA-IN specific forward primer (blue arrow) 
that anneals to the extreme 5’end and a nested adapter specific primer (black arrow). PCR 
shown in Figure 7 used an RNA-IN specific forward primer (blue) and an RNA-IN 
specific reverse primer (dashed black arrow) to amplify the first 160nt of RNA-IN. 
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Accordingly, the RNA-IN signal shown in Figure 3.7 originates from RNA-IN molecules 
containing at least the first 160nt of RNA-IN. 
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Figure S 3.5. Hfq determinants for ChiX binding. 
5’32P-labeled ChiX (140 nM) was incubated with WT and mutant variants of his-tagged 
Hfq (380 nM) before limited cleavage with Pb2+(lanes 5-8). Untreated controls are shown 
(lanes 1-4). The location of the two Hfq-binding sites identified in Figure 3.9C (Hfq-I and 
Hfq-II) are highlighted along with a third site (Hfq-III) that corresponds to the polyU tail 
after the ρ-independent transcriptional terminator. Sites are defined as interacting with the 
distal surface if they are protected by HfqWT and HfqK56A but not HfqY25A. Likewise, sites 
that show reduced protection with HfqK56A compared to HfqWT/HfqY25A are defined as 
interacting with the proximal surface of Hfq. 
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Figure S 3.6. Impact of mRNA overexpression on transposase expression. 
hfq+ cells containing the chromosomal IS101-337-lacZ translational fusion (DBH298) were 
transformed with a plasmid expressing ChiX (pDH765), sodB-56 to +244 (pDH920), ptsG-102 to 
+230 (pDH921), maeA-73 to 241 (pDH922) or a vector control (pDH763). Transformants were 
grown to mid-exponential phase in LB media and β-galactosidase activity was measured 
by the Miller assay. Error bars show the standard error on the mean for two independent 
experiments (n=6) and the relative expression is shown above the graph, where 
transposase-lacZ expression in the presence of vector was set to 1. 
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Chapter 4 
4 A cis-encoded sRNA, Hfq and mRNA secondary 
structure act independently to suppress IS200 
transposition3 
4.1 Introduction 
Small non-coding RNAs (sRNAs) play an important role in regulating many 
physiological processes in bacteria, including but not limited to metabolism, stress 
response, and virulence (reviewed in (Papenfort & Vogel, 2010; Papenfort & Vogel, 
2014; Storz et al, 2011; Waters & Storz, 2009)). Most sRNAs regulate gene expression 
through complementary base-pairing with target mRNAs, which usually affects 
translation and often transcript stability. The best studied class of sRNAs are expressed in 
trans relative to their target mRNA, and accordingly have only partial sequence 
complementarity. The chaperone protein Hfq is important for the function of most trans-
sRNAs, protecting the sRNA from degradation and facilitating pairing between sRNAs 
and their target(s).  Conversely, cis-encoded sRNAs (also called antisense RNA, asRNA) 
are expressed from the same loci as mRNAs on the opposite strand of DNA. This results 
in perfect and usually extended complementarity between asRNAs and their target 
mRNAs. Hfq is typically thought to be dispensable for asRNA regulation (Georg & Hess, 
2011; Thomason & Storz, 2010), although there are a few systems where this is not the 
case (Opdyke et al, 2004; Ross et al, 2013).  
 The first sRNAs discovered in bacteria were asRNAs involved in plasmid and 
transposon copy-number control (Tomizawa & Itoh, 1981) (Simons et al, 1983). In the 
case of IS10, translation of the transposase mRNA (RNA-IN) is inhibited by the cis-
encoded asRNA, RNA-OUT. Pairing between these RNAs initiates between the 5’end of 
RNA-IN and the terminal loop domain of RNA-OUT. Propagation of the paired species 
                                                
3
 The work in this chapter is reproduced (with permission, Appendix A) from: Ellis MJ, Trussler RS, 
Haniford DB (2015) A cis-encoded sRNA, Hfq, and mRNA secondary structure act independently to 
suppress IS200 transposition. Nucleic Acids Research 43: 6511-6527 
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to ultimately include 35 intermolecular base-pairs blocks 30S ribosome binding to RNA-
IN (Kittle et al, 1989; Ma & Simons, 1990). Since RNA-OUT can act in trans on all 
copies of IS10 in a cell, the strength of antisense regulation increases with IS10 copy-
number and accordingly plays an important role in limiting transposition (Simons & 
Kleckner, 1983).  Identification of new functional sRNAs has been aided by the 
development of RNA-Seq coupled with Hfq immunoprecipitation (Hfq-IP) (Sharma & 
Vogel, 2009). By sequencing sRNAs that interact with Hfq, it is possible to separate 
putative functional sRNAs from spurious transcription products. One surprising 
observation from these Hfq-IP experiments is that Hfq interacts with a number of cis-
encoded sRNAs. The first study to use Hfq-IP for identifying sRNAs in Salmonella 
enterica serovar Typhimurium (hereafter Salmonella) found that about 3% of Hfq-bound 
RNA mapped antisense to protein coding regions (Sittka et al, 2008). More strikingly, 
asRNAs made up the second largest class (25%) of Hfq-binding sRNAs in 
Mycobacterium smegmatis although the significance of this is unclear as no Hfq 
orthologs have been identified in Mycobacterium species so far (Li et al, 2013). 
Escherichia coli may express up to 300 functional asRNAs, although only 67 were 
detected in an Hfq-IP (Bilusic et al, 2014; Lybecker et al, 2014). Hfq may therefore play 
a previously unappreciated role in antisense regulation. Alternatively, the subset of 
asRNAs that interact with Hfq may be trans-sRNAs that just happen to be expressed 
antisense to protein coding genes. 
 We have previously shown that Hfq facilitates antisense pairing between the IS10 
transposase mRNA (RNA-IN) and the cis-encoded sRNA, RNA-OUT (Ross et al, 2013).  
We were interested in determining if Hfq regulated other transposons by a similar 
mechanism and accordingly searched Hfq-IP data sets for evidence of Hfq-interacting 
RNAs that are antisense to transposase mRNAs. IS200 encodes an sRNA (STnc490) that 
is antisense to 90 nucleotides (nt) of the transposase 5’ untranslated region (5’UTR) in 
Salmonella (Kroger et al, 2012; Sittka et al, 2008). The closely related IS1541 element 
from Yersinia pestis also expresses STnc490 (Yan et al, 2013). Promoters for asRNAs 
can arise stochastically, but the conserved expression of STnc490 suggests this is a 
functional asRNA (Raghavan et al, 2012). 
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 IS200 elements are ubiquitous in Enterobacteriaceae and have been identified 
throughout Eubacteria and Archaea (Beuzon & Casadesus, 1997; Beuzon et al, 2004; 
Filee et al, 2007; Gibert et al, 1990). IS200 was first identified as a polar insertion mutant 
in the hisD gene of Salmonella (hisD984; (Lam & Roth, 1983)). Repeated attempts to 
measure IS200 transposition under various laboratory conditions were unsuccessful, and 
environmental samples of Salmonella collected 30 years apart showed no evidence of 
transposition (Beuzon et al, 2004; Casadesus & Roth, 1989; Schiaffino et al, 1996). 
However, IS200 does transpose during long-term stab culture and there is evidence that 
the closely related IS1541 element is active during mouse infection by Y. pestis 
(Cornelius et al, 2009; Lam & Roth, 1983). Taken together these observations have led to 
the conclusion that IS200 is a mostly dormant transposable element (Beuzon & 
Casadesus, 1997; Bisercic & Ochman, 1993). A reasonable presumption would be that 
most IS200 elements are inactive remnants of the active transposon. However, sequence 
comparison of ‘genomic’ IS200 elements and rare transposition products revealed that 
the sequence of ‘active’ and ‘inactive’ elements is almost identical (Beuzon & Casadesus, 
1997). It therefore seems likely that the ‘native’ state of IS200 elements is ‘off’ for 
transposition although specific conditions might lead to sporadic transposition.  
 Transposition of many bacterial transposons is limited by the expression of the 
transposase genes they encode (Kleckner, 1990; Morisato et al, 1983; Nagy & Chandler, 
2004). IS200, the smallest fully autonomous insertion sequence known, contains a single 
open reading frame (ORF) that encodes a transposase protein, TnpA (Figure 4.1A). 
Transcription of the tnpA gene is limited by an intrinsically weak promoter and a bi-
directional rho-independent terminator in the ‘left end’ that protects against impinging 
transcription (Beuzon & Casadesus, 1997; Beuzon et al, 1999). The left end contains a 
second inverted repeat that comprises a portion of the 5’UTR of tnpA. This is most likely 
a cis-regulatory element that represses tnpA translation by sequestering the Shine-
Dalgarno (SD) sequence (Beuzon et al, 1999). Antisense control of tnpA expression 
would therefore be an additional level of regulation for transposase protein.          
 In the current work we asked if IS200 transposase expression is down-regulated 
by the cis-encoded sRNA in E. coli. We show that transposase expression is strongly  
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Figure 4.1. Schematic of IS200. 
(A) IS200 is 707 base-pairs in length. It contains a single protein coding gene 
(transposase; tnpA), transcription of which originates at about nt 40 (Beuzon & 
Casadesus, 1997); tnpA promoter elements have not been defined. The left end contains 
two internal inverted repeats (opposing arrows), one of which acts as a transcription 
terminator (nts 12-34) and the other (nts 69-138) was predicted to encode a stem-loop 
structure in the 5’UTR of the tnpA mRNA that sequesters the Shine-Dalgarno sequence. 
IS200 in Salmonella also expresses a 90 nt sRNA (art200, previously STnc490), which is 
perfectly complementary to the 5’UTR and the first three codons of tnpA. The 
transcription start site and 3’end for art200 in Salmonella (derived from RNA-Seq 
experiments) are shown but promoter elements were not previously defined (Kroger et al, 
2012). (B) The DNA sequence of the first 200 nucleotides of IS200 is shown. The tnpA 
and art200 transcripts are shown in grey and black, respectively. Putative promoter 
elements for art200 are boxed and the Salmonella transcription start site (+1) is shown. 
The former were predicted using a position weight matrix (showing nucleotide identity of 
-10 and -35 promoter elements for E. coli) and the optimal spacing between -10 and -35 
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elements in E. coli (histogram) (data from (Harley & Reynolds, 1987)). The SD sequence 
and start codon for tnpA are shown in bold. Mutations introduced into tnpA/art200 in this 
work (LS and M1) are indicated in italics. A DNA primer used to map the 5’end of 
art200 in  E. coli (Figure 4.2) is depicted with an asterisk followed by a dashed arrow. 
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repressed by STnc490, which we renamed art200 (antisense regulator of transposase 
IS200). Hfq does not play a role in art200-tnpA pairing, although it does repress tnpA 
expression in the absence of art200. This repression appears to be the result of Hfq 
binding to the 5’UTR of tnpA immediately upstream of the SD. We also show that the 
tnpA SD sequence is sequestered in secondary structure and that this inhibits 30S 
ribosome subunit binding. Finally, we demonstrate that IS200 transposition increases in 
E. coli upon disruption of translational control mechanisms. Implications of these results 
are considered in the context of tight regulation of IS200 transposition, a possible role for 
art200 in the control of host gene expression and the potential application of the IS200 
sRNA system in synthetic biology/metabolic engineering. 
 
4.2 Results 
4.2.1 Characterization of the IS200 antisense RNA gene in E. coli 
Salmonella Typhimurium LT2 contains 6 copies of IS200 and expresses STnc490 (an 
RNA that is antisense to the transposase RNA) at high levels under standard laboratory 
growth conditions (Kroger et al, 2012; Sittka et al, 2008). However, the gene encoding 
this transcript was not previously fully characterized. We show below that the IS200 
asRNA is expressed in E. coli and characterized components of the gene encoding this 
transcript. The putative transcription start site for the IS200 asRNA (predicted based on 
RNA-Seq experiments in Salmonella (Kroger et al, 2012)) is shown in Figure 4.1B. We 
scanned upstream of this position for possible promoter elements and based on consensus 
sequences for -10 and -35 elements and the optimal spacing between these elements in E. 
coli (Harley & Reynolds, 1987), we defined putative -10 and -35 promoter elements for 
the IS200 asRNA (Figure 4.1B).  We then introduced various mutations into the promoter 
(PA) of the asRNA (PA-1 to PA-6), which were designed to affect the predicted -10/-35 
elements or the surrounding sequences (in the context of a multi-copy plasmid encoding 
IS200) and performed primer extension analysis (Figure 4.2). The results from our ‘WT’ 
construct revealed two 5’ends for the IS200 asRNA (nts 153 and 154), one of which 
matches the transcription start site previously identified in Salmonella (Kroger et al, 
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2012). Based on the signal intensity it is evident that the IS200 asRNA is abundantly 
expressed and the two start sites are used at roughly an equal frequency. Variants, 
including PA-2, PA-3, PA-4 and PA-6, showing the greatest reduction in asRNA expression 
(Figures 4.2B,C) all had one or more mutations in either the predicted -35 or -10 region, 
supporting our assignment of these promoter elements. We note that relative to other E. 
coli genes the predicted -35 element of the antisense gene is a better match to the 
consensus than is the -10 element, the latter of which was almost unrecognizable. In 
addition to defining fundamental information regarding the IS200 antisense gene in E. 
coli, results from this analysis also provided us with a means of knocking down the levels 
of the IS200 asRNA in E. coli.  
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Figure 4.2. Primer extension analysis of art200 in E. coli. 
(A) The DNA sequence of the 5’end of the art200 gene plus mutations introduced to 
deduce the -35/-10 promoter elements are shown. (B,C) Primer extension reactions 
performed to detect art200 from WT and the indicated mutant forms of tnpA-lacZ are 
shown. Total RNA was isolated from exponential phase cells grown in rich media (LB) 
and the primer (5’end labeled with 32P) shown in Figure 4.1B was used to make cDNA. 
The cells contained IS200 on a multi-copy plasmid. cDNAs were analyzed on a 10% 
denaturing polyacrylamide (sequencing) gel. The image in (B) shows a full gel; M = 
markers, U and C are RNA sequencing reactions. The image in (C) shows only the 
portion of  a gel that includes the art200 primer extension products. For the latter, primer 
extension was multiplexed to include lpp as a loading control. The mutant PA-6 (bold 
letters) was used in subsequent experiments in this work to knock-down art200 levels in 
E. coli. 
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4.2.2 The IS200 antisense RNA inhibits IS200 transposase 
expression 
To measure the impact of the IS200 asRNA on tnpA expression we constructed in a 
multi-copy plasmid an IS200-lacZ translational fusion (TLF) in which codon 60 of the 
tnpA gene was fused to codon 10 of the lacZ gene (Figure 4.3A). In this construct tnpA-
lacZ expression was under the control of native IS200 regulatory elements. We also made 
a version of the TLF plasmid in which the PA-6 mutations (see Figure 4.2A) had been 
incorporated. These TLFs were introduced into a Δlac strain of E. coli (MC4100 
derivative) and tnpA-lacZ expression was measured using the Miller assay. We show in 
Figure 4.3B (compare columns 1 and 5) that knocking down IS200 asRNA expression 
increased tnpA-lacZ expression about 13-fold. We also performed primer extension on 
cells used in the Miller assay and this confirmed that asRNA levels were extremely low 
in the strain containing the PA-6 TLF (compare lanes 1 and 5 in Figure 4.3B).  
A potential drawback of using the PA-6 mutations to knock down IS200 asRNA levels 
was that the tnpA RNA sequence is altered by these mutations and this could affect the 
stability of the tnpA transcript and therefore its expression in the Miller assay. 
Accordingly, we developed an alternative means of knocking down the antisense RNA 
that did not alter the sequence of the tnpA transcript. In this approach we expressed a 
segment of the tnpA mRNA that included a region of the mRNA that was fully 
complementary to the antisense RNA (nt 45-298 of IS200). Pairing of the two RNAs 
would potentially promote the degradation of one or both RNA molecules through the 
action of double-strand specific ribonucleases. This ‘RNA titration’ approach has 
previously been used in the IS10 system to decrease levels of the IS10 encoded asRNA 
and was also used to knock-down endogenous levels of the MicA sRNA in E. coli 
(Simons & Kleckner, 1983; Udekwu et al, 2005). For our purposes we prepared two 
titrator constructs differing only in the strength of the promoters used to drive titrator 
expression (Figure 4.3A; Titrator-high and Titrator-low). We show in Figure 4.3B that 
titrator RNA expression from both constructs increased tnpA expression and the fold 
increase correlated well with the amount of titrator RNA expressed (compare Miller units 
in columns 1-3 and the corresponding lanes in the image from primer extension analysis).  
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Figure 4.3. Impact of art200 and Hfq on tnpA expression. 
(A) An IS200-lacZ translational fusion (TLF) was constructed to measure tnpA 
expression in E. coli. Art200 levels were manipulated by: (i) introducing the PA-6 
mutations into the TLF (down-regulated); (ii) co-expressing an art200 titrator RNA 
(IS200 45-298) with the TLF (down-regulated); or (iii) co-expressing art200 in trans 
relative to the TLF (up-regulated). tnpA expression was entirely under the control of 
native (IS200) regulatory elements. Titrator RNAs were constitutively expressed from 
promoters Ptet (moderate strength) or T7 PA1 (strong). Trans-art200 was expressed from 
its native promoter. (B) b-galactosidase and primer extension assays were performed on 
E. coli cells that had been co-transformed with a TLF plasmid (WT or PA-6) and a 
plasmid encoding titrator RNA, trans-art200 or an empty vector control. Cells were 
grown to mid-log phase in LB supplemented with antibiotics (for plasmid selection) 
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before being processed for b-galactosidase activity measurements (Miller assay) and 
primer extension analysis. Bars show the mean b-galactosidase activity from 3 
independent experiments (n=9), and error bars indicated standard error on the mean. For 
primer extension, primers specific for art200, tnpA/titrator and lpp were used. The latter 
acted as a loding control. (C) tnpA expression was measured as in (B) with isogenic hfq+ 
and hfq- cells harboring either the WT or PA-6 TLF plasmid. Bars show the mean b-
galactosidase activity from 2 independent experiments (n-6) and error bars indicate 
standard error on the mean. 
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We also asked if the IS200 antisense RNA could function in trans to repress tnpA 
expression. For this experiment we cloned the antisense RNA gene into a plasmid 
compatible with our TLF plasmids and co-transformed these plasmids into E. coli cells. 
In the situation where tnpA expression was expected to be relatively high because of the 
PA-6 mutations in the TLF (knock-down antisense RNA expression in cis), expression of 
the antisense RNA in trans reduced tnpA-lacZ expression about 3.5-fold (compare 
columns 5 and 8). 
Based on the results presented in this section we conclude that the IS200 antisense 
RNA does function in vivo to down-regulate IS200 tnpA expression. Accordingly, we 
have renamed this RNA art200 for antisense regulator of transposase IS200.   
 
4.2.3 Hfq negatively regulates tnpA expression but independent of 
art200 
Based on previous work in the Tn10 system where we demonstrated that Hfq promotes 
antisense RNA pairing with the transposase RNA, potentially through restructuring of 
both RNAs (Ross et al, 2013), we wanted to test the possibility that Hfq might play a 
similar role in the IS200 system. Towards this end we repeated the experiment described 
in Figure 4.3B in isogenic hfq+ and hfq- strains of E. coli. We show in Figure 4.3C that 
tnpA-lacZ expression increased approximately 5-fold in the hfq- relative to the hfq+ strain 
in the context of the WT TLF (compare columns 1 and 5). This showed that Hfq does 
repress tnpA expression. Additionally, the PA-6 and hfq mutations acted synergistically to 
de-repress tnpA expression (compare column 1 to 3 and 7), and art200 provided in trans 
was able to repress expression of the PA-6 TLF regardless of Hfq status (compare 
columns 3 and 4 to columns 7 and 8). Finally, we performed primer extension analysis to 
measure tnpA and art200 levels in hfq+ and hfq- cells and found that tnpA levels 
decreased in the absence of Hfq while art200 levels were unaffected (Figure S4.1).   Thus 
we conclude that Hfq and art200 represent two distinct regulatory mechanisms that 
down-regulate tnpA expression independent of one another.  
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4.2.4 art200 and tnpA mRNA interact in vitro 
Given that art200 and tnpA are complementary over 90 nt it seemed likely that art200 
would inhibit tnpA expression through complementary base-pairing. However, based on 
structure probing analysis of art200 and the first 173 nt of tnpA mRNA (tnpA1-173) along 
with secondary structure predictions, it is apparent that both RNAs are highly structured 
and this could limit their ability to pair (Figures S4.2 and S4.3). An alternative possibility 
is that art200 acts via a protein titration mechanism.  We tested for RNA pairing by 
performing lead(II) acetate (Pb2+) footprinting on a mixture of 5’32P-labeled art200 and 
unlabeled tnpA1-173. Both RNAs were generated by in vitro transcription and allowed to 
fold before mixing. Pairing would convert single to double stranded regions and 
consequently there would be a loss of Pb2+ reactivity at these positions. We show in 
Figure 4.4A that a cluster of residues (marked with a green asterisk) in the upper portion 
of the predicted stem-loop of art200 exhibited reduced Pb2+ reactivity upon addition of 
tnpA1-173. Note that most of these residues were in parts of art200 predicted by our model 
to be single stranded. The complementary nucleotides in tnpA1-173 include positions -23 to 
-62.  
  We also performed the complementary experiment with 5’32P-labeled tnpA1-173, 
but in this case used RNases (A, T1, and V1) as structure probes (Figure 4.4B). Both 
RNase A and T1 are single strand specific and accordingly reduced reactivity with these 
enzymes in the presence of unlabeled art200 would provide evidence of base-pairing. 
Comparison of lanes 7 and 8 (RNase A) and lanes 12 and 13 (RNase T1) revealed two 
areas containing the most prominent reactivity decreases including residues -60 to -23 
and -7 to +11 (indicated by red asterisks). The former region encompasses the upper 
stem-loop of tnpA1-173, thus supporting results from the Pb2+ footprinting that were 
consistent with the upper stem-loop region of art200 participating in base-pairing with the 
upper stem-loop of tnpA1-173. Also consistent with this interpretation, there were several 
examples of nucleotides in this region showing increased reactivity to RNase V1 a 
double-strand specific ribonuclease (blue asterisks). A summary of the footprinting data 
is presented in Figure 4.4C (Pb2+, green; RNase A/T1, red; RNase V1, blue).  
 
171 
 
 
172 
 
Figure 4.4. Pb2+ and RNase footprinting of art200, tnpA1-173 and an art200-tnpA1-173 
complex. 
(A) 5’32P-labeled art200 (69 nM) was incubated in the absence or presence of increasing 
concentrations of tnpA1-173 (69, 128, 276, 460, or 1380 nM) before limited treatment with 
Pb2+. Note that each RNA was denatured and allowed to fold before mixing. Positions 
that were most strongly protected from Pb2+ cleavage in a tnpA-concentration dependent 
manner are indicated with a green asterisk. UT is untreated art200 RNA and G is an 
RNase T1 sequencing lane. (B) 5’32P-labeled tnpA1-173 (40 nM) was incubated with wild-
type and mutant variants (LS’ and M1 – see Figure 4.1B) of art200 (600 nM) or folding 
buffer (-) before treatment with RNase A, T1, or V1. tnpA1-173 and art200 RNA were 
denatured and allowed to fold independently before mixing, except for a control reaction 
with WT art200 where RNAs were mixed, denatured and allowed to fold together (FT; 
lanes 6, 11, 16, and 21). Nucleotide numbering is relative to the AUG start codon in tnpA. 
Nucleotides that were most strongly protected from single-strand specific RNase (A/T1) 
in the presence of art200 are indicated with a red asterisk, and positions that showed an 
increased sensitivity to RNase V1 (double-strand specific) are indicated with a blue 
asterisk. (C) Structural constraints derived from footprinting were input into mFold to 
produce structures for art200 and tnpA1-173 (see also Figures S4.2 and S4.3). Residues in 
art200 that showed either weak (green circle) or strong (green circle plus asterisk) 
decreases in Pb2+ reactivity upon mixing with tnpA1-173 are highlighted. Residues in 
tnpA1-173 that showed strong (red circles) decreases in RNase A or T1, or strong increases 
(blue circles) in V1 reactivity upon art200 addition are highlighted. Two residues (-44 
and -47) showed increased V1 sensitivity and decreased A/T1 sensitivity (blue-red 
circles). Nucleotide changes present in M1 and M1’ versions of art200 and tnpA1-173, 
respectively, are shown in bold. 
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The terminal loops of art200 and tnpA1-173 include 4 and 6 unpaired residues 
respectively, and have the highest G-C content of any of the single stranded regions in the 
two RNA molecules. This led us to predict that art200-tnpA1-173 pairing might initiate 
with a kissing loop interaction involving these two loops. Accordingly, we mutated three 
residues in the terminal loop of art200 (art200M1) and asked if this form of art200 could 
still pair with tnpA1-173 using RNase footprinting. For all of the residues that showed 
decreased RNase A or T1 reactivity in the presence of art200WT (red asterisks), we 
observed reduced protection in the presence of art200M1. Similarly, all of the residues that 
showed increased V1 reactivity in the presence of art200WT showed decreased reactivity 
in the presence of art200M1.   We also introduced mutations to the lower stem region of 
art200 (nts 78-84, LS’) and observed an intermediate effect on pairing relative to WT and 
M1 suggesting this region is less important for pairing. 
The above results show that art200 and tnpA do indeed interact in vitro; however 
pairing is limited to loosely structured regions of both RNAs. In particular, the terminal 
loop region of each RNA is important for pairing, which may indicate that pairing 
initiates with these sequences through a kissing loop interaction. 
4.2.5 Base-pairing between art200 and tnpA blocks 30S ribosome 
binding in vitro and inhibits transposase expression in vivo  
Based on our Pb2+ and RNase footprinting experiments we thought it likely that art200 
pairing with the 5’UTR of tnpA would inhibit translation initiation. We tested this 
possibility by performing toeprinting analysis. In this assay purified 30S ribosomal 
subunit plus initiator tRNA (fMet-tRNA) was mixed with tnpA1-173 either in the presence 
or absence of art200. Primer extension with a 5’32P-labeled primer complementary to 
nucleotides +51 - +70 on tnpA1-173 was then performed and reactions were analyzed on a 
sequencing gel. Typically the 30S ribosome leaves a footprint of ~30 nucleotides 
spanning the SD sequence and first 5 codons such that a strong stop is produced in the 
primer extension reaction about 15 nt downstream of the start codon. We show that in the 
absence of art200, a relatively weak stop signal was observed at position +16 when 30S 
ribosome and fMet-tRNA were incubated with tnpA1-173 (Figure 4.5A, lane 6); the weak 
toeprint signal is consistent with previous work suggesting that the tnpA SD sequence is 
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sequestered in a secondary structure element (Beuzon et al, 1999) (see also Figure S4.3). 
Addition of art200 (15:1 molar excess) inhibited formation of the toeprint signal by 
approximately 95% (lane 7 and Figure 4.5B). However, when we used art200M1 instead 
of art200WT inhibition of the toeprint signal was greatly reduced to approximately 50%. 
Given the evidence presented in Figure 4.4 that art200M1 fails to base-pair with tnpA, the 
inability of art200M1 to suppress the toeprint signal to the same degree as art200WT is 
consistent with art200 inhibiting 30S ribosome binding through a base-pairing interaction 
with tnpA.  We also show that when tnpA is mutated to restore complementarity with the 
terminal loop region of art200M1, ribosome binding is blocked by art200M1 but not 
art200WT (compare lanes 12-14 in Figure 4.5A).  
 Finally, the toeprint analysis also provided further details of the tnpA-art200 
pairing interaction. In all of the reactions that included a form of art200 that was fully 
complementary to tnpA (lanes 5, 7, 11 and 13) there were a series of prominent primer 
extension pauses upstream of the SD. These strong pauses can be explained by art200 
pairing with tnpA and thus the experiment reveals that position -25 in tnpA defines a 
‘downstream’ boundary of antisense pairing. This fits well with our structure probe data, 
which was consistent with position -23 being the downstream boundary.  
 We also looked at the impact of terminal loop mutations (art200M1 and tnpAM1’) 
on tnpA-lacZ expression in vivo. We show in Figure 4.6 that when art200 was provided in 
trans (in the PA-6 TLF background) strong repression of tnpA was only achieved when 
the terminal loops of art200 and tnpA were perfectly complementary (compare columns 2 
and 3). Also, trans-art200M1 was capable of repressing expression of tnpAPA-6/M1’-lacZ but 
not tnpAPA-6-lacZ (compare columns 3 and 6). Primer extension analysis on RNA 
prepared from the strains in Figure 6 showed that both forms of trans-art200 were 
expressed at similar levels in these experiments (Figure 4.6, lower panel).  
 Taken together the results from experiments in Figures 4.5 and 4.6 show that 
despite 90 nt of perfect complementarity, the primary determinant for antisense  
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Figure 4.5. Impact of antisense pairing on ribosome binding to tnpA1-173 in vitro. 
(A) 30S ribosome binding to WT and M1’ tnpA1-173 was measured in a toeprint assay. 
Where indicated, WT or M1 art200 (3 µM) was added to tnpA RNA (200 nM) prior to 
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addition of the 30S ribosomal subunit and initiator tRNA. Strong pauses in reverse 
transcription (G+15/G+16) produced upon incubating the above mix with reverse 
transcriptase, dNTPS and a 5’32P-labeled DNA primer (anneals downstream of the tnpA 
start codon) define the toeprint signal. Positions of prominent art200-dependent pauses in 
reverse transcription that occur independent of 30S ribosome addition are also indicated. 
G, A, and C are sequencing lanes and nucleotide numbering is relative to the start codon 
of tnpA. (B) Toeprint signal band intensities from (A) were quantified. The toeprint 
signal for tnpAWT in the absence of art200 was set at 100%. 
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Figure 4.6. Impact of terminal loop mutations on translational repression in vivo. 
A plasmid encoding tnpAPA-6-lacZ or tnpAPA-6/M1-lacZ was co-transformed into DBH323 
with a compatible plasmid expressing art200 (WT or M1) in trans to tnpA-lacZ or an 
empty vector control. b-galactosidase activity was measured in cells grown to mid-
exponential phase in LB media. Bars show the mean expression from two independent 
experiments and error bars indicate standard error on the mean (n=6). The bottom panel 
shows primer extension analysis using RNA extracted from cells grown in the Miller 
assay. lpp was analyzed as a loading control. 
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repression in the IS200 system is complementarity between the upper stem-loop regions 
of tnpA and art200 and that base-pairing between residues in the terminal loops is 
critically important for antisense repression. Although we have not investigated the effect 
of other mutations in single-stranded regions of either RNA (e.g. nt 62 to 65 in art200 and 
-53 to -56 in tnpA) it seems likely that pairing initiates with the 3 G/C base-pairs affected 
by the M1 mutation and then propagates roughly half-way down the respective stems. An 
initial kissing-loop interaction has been shown in many other antisense systems to be 
important for pairing (Brantl, 2002; Franch et al, 1999; Hjalt & Wagner, 1992). Further 
pairing might be inhibited by the absence of bulges in the lower portions of the respective 
stems, as such discontinuities in intramolecular base-pairing have been shown in other 
studies to be important in destabilizing stem structures and allowing intermolecular base-
pairing (Brantl, 2007; Hjalt & Wagner, 1995; Kittle et al, 1989).  
4.2.6 tnpA translation is also repressed by mRNA secondary 
structure 
 Previous work in the IS200 system revealed that deleting the 5’ portion of tnpA mRNA 
(nts -32 to -103) resulted in a ~10-fold increase in tnpA-lacZ expression (Beuzon et al, 
1999). The authors from this study concluded that the increased expression resulted from 
the loss of an inhibitory stem-loop structure; however, their deletion also removed half of 
art200. To determine if RNA secondary structure plays an important role in inhibiting 
tnpA expression, we introduced mutations to the lower stem (nts -69 to -75) and 
evaluated the impact of these mutations on ribosome binding in vitro and on tnpA 
expression in vivo. We show in the toeprinting assay in Figure 4.7A that tnpA1-173 with 
the lower stem mutations (tnpALS) gave a much higher toeprint signal (20-fold increase) 
than tnpAWT (compare lanes 6 and 11; also see Figure 4.7B). This indicates that 
nucleotides comprising the lower stem are important determinants for tnpA translation (as 
previously suggested). We also asked if art200 could still repress ribosome binding in the 
tnpALS background. Both art200WT and art200LS’ strongly repressed ribosome binding 
(compare lanes 12 and 13 with lane 11) but a mutant form of art200 (art200M1) lacking 
full terminal loop complementarity with tnpALS failed to fully block ribosome binding  
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Figure 4.7. Impact of tnpA lower stem (LS) mutations on transposase expression. 
(A) The toeprinting assay was performed on tnpA RNA (WT and LS; 200 nM) in the 
presence or absence of art200 (WT, LS’, or M1; 3µM) as described in Figure 4.5. The 
toeprint signal spans nucleotides 15-17. C, U, A, and G are sequencing lanes. (B) 
Toeprint signal band intensities (G+15, A+16, and G+17) from (A) were quantified. The 
toeprint signal for tnpAWT in the absence of art200 was set at 100%. (C) A plasmid 
encoding tnpAWT-lacZ or tnpALS-lacZ was co-transformed into DBH323 with a 
compatible plasmid expressing art200 titrator RNA (WT or M1) or an empty vector 
control. b-galactosidase activity was measured in cells grown to mid-exponential phase in 
LB media. Bars show the mean expression from two independent experiments and error 
bars indicate standard error on the mean (n=6). 
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(lane 14). These results indicate that the nucleotides comprising the lower stem of tnpA 
are not critical for antisense repression and thus contribute to a distinct mode of tnpA 
translational regulation.       
 We also determined the impact of the LS mutations on tnpA expression in vivo. 
Consistent with the toeprinting assay, the LS mutations increased tnpA-lacZ expression 
50-fold relative to that observed for WT tnpA-lacZ (compare columns 1 and 3 in Figure 
7C). Titration of art200LS’ in this system with the high copy titrator further increased 
expression 4-fold (column 4) indicating that the two regulatory systems can act 
independent of each other to repress tnpA expression.  
 We therefore conclude that in addition to a cis-encoded sRNA, translation of the 
IS200 transposase is strongly repressed by an mRNA secondary structure that can 
directly sequester the SD. 
4.2.7 Hfq blocks ribosome binding to tnpA in vitro 
 Although Hfq is not required for antisense pairing, tnpA-lacZ expression 
increased 5-fold in an hfq- versus hfq+ strain of E. coli. In addition, we have shown that 
this up-regulation in the absence of Hfq did not require the production of art200 (Figure 
4.3C). This indicates that Hfq represses transposase expression in an antisense-
independent manner. Additionally, tnpA levels do not increase in hfq- which indicates 
Hfq acts at the level of tnpA translation (Figure S4.1). We have recently shown that in the 
IS10 system, Hfq binding to the ribosome binding site of transposase mRNA was 
sufficient for repressing translation initiation (Ellis et al, 2015a). We therefore considered 
the possibility that Hfq might be acting directly on tnpA to inhibit translation.  
 We show in Figure 4.8A and B that Hfq inhibited formation of the tnpA1-173 
toeprint in a concentration dependent manner (see also Figure S4.4). At a 1:1 molar ratio 
of Hfq:tnpA, the toeprint signal was reduced 40-50% compared to no Hfq addition and at 
a 4:1 ratio of Hfq:tnpA the toeprint signal was reduced 80%.  Thus, Hfq can block 30S 
ribosomal subunit binding to tnpA1-173 in vitro independent of an sRNA. We note that the  
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Figure 4.8. Hfq inhibits 30S ribosomal subunit binding to tnpA and binds upstream 
of the SD. 
(A) Toeprint assay showing the effect of Hfq on 30S ribosomal subunit to tnpA. Hfq 
(100-400 nM; hexamer concentration) was added to tnpA (200 nM) prior to addition of 
30S ribosomal subunit and initiator tRNA. A section of the gel image including the 
toeprint signal is shown. (B) The percent inhibition of toeprint signal upon incubating 
Hfq with tnpA or an mRNA that does not interact with Hfq (usg, (Beisel et al, 2012)) is 
shown; the usg data comes from (Ellis et al, 2015a). For both mRNAs the toeprint signal 
in the absence of Hfq was set at 100%. Experiment A refers to (A) of this figure while 
Experiment B refers to Figure S4.4. (C) Hydroxyl radical footprinting experiment with 
5’32P-labeled tnpA1-173 (68 nM) and the indicated concentrations of Hfq. Subsequent to 
mixing tnpA and Hfq, limited RNA cleavage by hydroxyl radical treatment was carried 
out as previously described (Ross et al, 2013). UT is untreated RNA and G is an RNA 
cleavage ladder produced by RNase T1. The Hfq footprint between residues -17 and -33 
defined an Hfq binding site in tnpA and the position of this site is highlighted (grey 
circles) in our model for tnpA1-173; the tnpA SD and start codon are in bold.  
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strength of the Hfq block on ribosome binding in the IS200 system is weaker than 
previously seen with the IS10 transposase mRNA (RNA-IN) but slightly stronger than 
observed with a control mRNA, usg (Figure 4.8B) (Ellis et al, 2015a). For example, when 
Hfq is limiting (1:2 ratio of Hfq:mRNA), the toeprint signal was reduced 30% for tnpA 
and only 12% for usg mRNA. However, at higher concentrations of Hfq the toeprint 
signal was reduced a comparable amount for both tnpA and usg.  
We further analyzed the Hfq-tnpA interaction by performing hydroxyl radical 
footprinting on 5’32P-labeled tnpA1-173 mixed with various concentrations of Hfq (Figure 
4.8C). The results of the footprinting were consistent with Hfq binding tnpA in an interval 
extending from position -33 to -17. Together, the above results suggest that Hfq binding 
immediately upstream of the tnpA SD sequence represses tnpA translation by preventing 
ribosome binding. 
4.2.8 IS200 transposition is limited by translational control 
Typically for bacterial transposons, transposition frequency correlates strongly with 
transposase expression (Kleckner, 1990; Morisato et al, 1983; Nagy & Chandler, 2004). 
We measured IS200 transposition by constructing a mini-IS200 element (IS200-kan) and 
using this marked element in mating out experiments (see Figure S4.5 for schematic of 
the mating out assay). IS200 transposase was provided in trans from a plasmid in which 
the tnpA gene was under the control of different regulatory elements (Figure 4.9A). 
We did not detect transposition events when tnpA expression was under the 
control of the fully native regulatory elements. We did detect transposition events when 
tnpA was fused to PBAD and SDBAD24 and arabinose (0.2%) was present during growth 
(construct i).  Notably, the number of events was considerably higher than in a control 
where the tnpA gene contained a mutation in the catalytic tyrosine (construct ii). We 
confirmed that these were authentic transposition events by mapping two independent 
hops from construct (i) using ST-PCR (Chun et al, 1997; Ross et al, 2014)  (Figure 
S4.6A). We therefore conclude that the IS200 TnpA protein from Salmonella is active for 
transposition in E. coli.  
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When we replaced SDBAD24 with the native 5’UTR (construct iii), the 
transposition frequency dropped considerably; a single transposition event was observed 
in one of three experiments. This construct produced a large amount of tnpA mRNA 
suggesting that translational control strongly limits transposition (Figure 4.9B). We then 
introduced mutations into the native 5’UTR to disrupt the tnpA stem-loop (construct iv). 
This increased the frequency of transposition events, although the occurrence of these 
events was still sporadic.  
We next measured transposition from construct (iv) in the presence of the art200 
titrator plasmid or a vector control. Our expectation was that disrupting two regulatory 
pathways (mRNA structure and antisense control) would further increase transposition. 
In the presence of the titrator plasmid, 8/10 donor isolates produced measurable 
transposition while only 5/10 donors produced hops in the presence of the vector control 
(Figure 4.9C). This coincided with a 25-fold increase in the median value of transposition 
when art200 was depleted. Together this data shows that (1) TnpA expression is in fact 
limiting for IS200 transposition, and (2) disrupting translational regulation (mRNA 
secondary structure and antisense control) of tnpA leads to an increase in IS200 
transposition.  
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Figure 4.9. IS200 transposition assays. 
(A) IS200 transposition frequency was measured using the conjugal mating out assay. 
Briefly, E. coli (F+; DBH291) containing a single chromosomal copy of a marked IS200 
element (mini IS200-kan) was transformed with a plasmid expressing TnpA under the 
control of various regulatory elements, including the PBAD promoter, the 5’UTR from 
pBAD24 (includes an optimized SD) and the IS200 5’UTR (constructs i-iv). These donor 
cells were grown in the presence of arabinose (0.2%) to induce tnpA transcription, mixed 
with an F- recipient strain (DBH13) and then the mating mixes were plated on selective 
media for measuring mating efficiency (exconjugants) and transposition events (hops). 
Transposition frequency is the ratio of hop to exconjugant colonies. Transposition 
frequencies for individual donor clones are presented in a stripchart for each TnpA 
construct; grey bars show the median transposition freqeucny for one (constructs i and ii) 
or three (constructs iii and iv) independent experiments. Clones that did yield hops and 
were analyzed by Southern blot analysis are indicated (a-c). LE = left end (bp 1-163), RE 
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= right end (bp 566-707), and kanR = kanamycin resistance gene. (B) Primer extension 
analysis of DBH291 donor cells transformed with construct (iii) and grown to mid-log 
phase in the presence of arabinose. Primer extensions were multiplexed to detect tnpA, 
art200, and lpp (loading control). (C) Mating out assay with conor strains containing 
construct (iv) and either the low expression art200 titrator plasmid or an empty vector 
control. Grey bars show the median transposition frequency for each donor strain from 
three independent experiments; d, e, f, and g are hop colonies subjected to Southern blot 
analysis (Figure S4.6). In (A) and (C) the transposition frequency for donor clones that 
did not produce hop colonies was set at 1 x 10-8. 
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4.3 Discussion 
4.3.1 Translation of the IS200 transposase is repressed by a cis-
encoded sRNA, Hfq and RNA secondary structure 
 IS200 is a very unusual transposable element in that it is widespread in Eubacteria and in 
some species has attained a very high copy-number (see below), yet its ability to 
transpose is exceedingly poor. This correlates with very weak expression of the IS200 
transposase protein. In the current work we have expanded our understanding of how 
IS200 transposase expression is suppressed to include two new levels of post-
transcriptional regulation and further characterization of a predicted cis-regulatory 
element. First, we show that the recently identified sRNA art200 (previously STnc490 
(Sittka et al, 2008)) encoded opposite the transposase 5’UTR represses transposase 
translation by base-pairing with tnpA mRNA and blocking 30S ribosome binding. 
Additionally, we expand on previous work that suggested RNA secondary structure in the 
5’UTR of tnpA inhibits translation by sequestering the SD in a stable stem loop structure 
(Beuzon et al, 1999). Finally, we show that the chaperone protein Hfq is also a negative 
regulator of tnpA expression. Footprinting revealed that Hfq binds immediately upstream 
to the tnpA SD raising the possibility that Hfq could block 30S subunit binding to tnpA. 
Support for this came from toeprinting studies where at low concentrations of Hfq (100 
nM) ribosome binding to tnpA was reduced 30%. It is not clear at this point if this 
reduction is significant as the level of toeprint inhibition was only marginally higher than 
that detected in a control reaction; 15% with usg mRNA. By comparison in another 
system (cirA mRNA) where Hfq was reported to directly interfere with 30S subunit 
binding a similarly small reduction in toeprint signal (20%) was reported at low Hfq 
concentrations (Salvail et al, 2013). Based on this data we suggest that this moderate 
effect on ribosome binding could account for at least a portion of the 5-fold repression 
Hfq has on tnpA-lacZ expression in vivo. Notably, this represents the first example of a 
bacterial ‘host’ protein suppressing IS200 (Beuzon et al, 2004) and the second example 
of Hfq directly repressing translation of a transposase protein (Ellis et al, 2015a).  
An interesting aspect of the regulatory mechanisms described here is that all three 
are capable of acting independently to interfere with 30S subunit binding to tnpA. This 
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conclusion comes from the following observations: (1) art200 repressed tnpA expression 
and ribosome binding in the absence of Hfq (Figures 4.3C and 4.5); (2) art200 suppressed 
30S subunit binding to tnpA under conditions where the inhibitory stem-loop structure is 
destabilized by mutations in tnpA (Figure 4.7A); and (3) the effect of disrupting hfq on 
tnpAWT expression was almost 20-fold less than inhibiting formation of the stem-loop 
structure (compare Figure 4.3C and 4.7C). If Hfq acted to stabilize the stem-loop 
structure one might have expected tnpA expression to be comparable in hfq- and tnpALS 
situations. 
What might be the explanation for this level of functional redundancy? IS200 
tnpA contains an almost perfect Shine-Dalgarno sequence (tnpA, AAGGGGGU; E. coli 
consensus, AAGGAGGU) (Shine & Dalgarno, 1975). However, this sequence is 
sequestered in secondary structure (this work and (Beuzon et al, 1999)). Interestingly, 
upstream of the SD there is a single-stranded C/A-rich sequence (nts -26 to -21) that 
potentially could act as a translational enhancer. Such sequences can provide an initial 
toehold for the 30S ribosomal subunit through a direct interaction between the S1 protein 
component of the 30S complex and the C/A-rich RNA sequence (Komarova et al, 2002; 
Mogridge & Greenblatt, 1998; Ringquist et al, 1995; Sengupta et al, 2001). S1 could 
tether the ribosome to tnpA and expose the downstream SD sequence for 30S subunit 
binding by altering the local RNA structure (Bear et al, 1976; Qu et al, 2012; 
Rajkowitsch & Schroeder, 2007; Studer & Joseph, 2006). As we have shown that art200 
pairs with the C/A-rich containing portion of the tnpA transcript and Hfq binds this same 
region, it is possible that both art200 and Hfq repress the function of this putative 
translational enhancer sequence by sterically occluding S1 binding. The combination of 
sequestration of the SD and interference of translational enhancer function would be 
expected to provide a very strong block (synergistic or at least additive) to translation, 
which we observed here. We have some evidence of the C/A-rich region playing a 
regulatory role in translation as mutations in this region reduced tnpA expression almost 
200-fold (Figure S4.7), although as we were unable to measure steady-state tnpA RNA 
levels because of the extremely low abundance of this transcript we cannot rule out the 
possibility that this decrease resulted from the mutations destabilizing the transcript.  
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Notably, there are several examples in the literature of sRNAs interfering with 
translational enhancer function. The sRNA GcvB represses initiation of translation for 
multiple mRNA transcripts by pairing with C/A-rich translational enhancers (Sharma et 
al, 2007; Yang et al, 2014). In addition, other sequences upstream of the SD have been 
shown to influence 30S subunit binding. In the case of the tisAB transcript, which has its 
SD sequence sequestered in a highly structured region, a genetic element distinct from a 
C/A-rich translational enhancer was shown to provide a ‘standby’ site for 30S binding. It 
was inferred that 30S binding to this sequence opened up the downstream structure for 
subsequent 30S binding to the SD. The sRNA IstR-1 acts as a negative regulator of 
translation in this system by competing with the 30S subunit for the standby site 
(Darfeuille et al, 2007). Art200 and/or Hfq could act in a similar manner in the IS200 
system (Figure 4.10, (i)). 
Finally, it is also possible that art200 and/or Hfq exert their negative regulatory 
effects on the IS200 system by binding close enough to the SD to directly block 30S 
subunit binding.  It has been reported that the maximal ribosome-binding region can 
include nucleotides as far as 39 residues upstream of the start codon (Huttenhofer & 
Noller, 1994) and the art200 pairing site and the Hfq binding site fall within this window. 
If this latter mechanism were in play in the IS200 system, then all three negative 
regulatory systems would be acting at the same step in translation and accordingly the 
reason for this level of redundancy would be less clear. Although one possibility could be 
that there are some circumstances where SD sequestration would be suboptimal. For 
example, under conditions where transcription rates are reduced it is possible that the 
anti-SD sequence in tnpA could pair with an alternative sequence to the SD (one such 
possible structure is shown in Figure S4.8). In this case art200 and/or Hfq could provide 
important back-up functions for limiting 30S binding to tnpA (Figure 4.10, (ii)). 
 Given the current work, it is not surprising that IS200 transposition is 
exceptionally rare. In addition to weak transcription of the transposase gene, tnpA 
translation is suppressed by three independent mechanisms. As we have shown that TnpA 
expression is in fact limiting for transposition (Figure 4.9), we speculate that translation 
initiation represents the main point of regulation for IS200 transposition.  
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Figure 4.10. Model for translational repression of IS200 tnpA. 
30S ribosomal subunit binding to tnpA is inhibited by art200 (purple) and Hfq (green) as 
well as RNA secondary structure which sequesters the Shine-Dalgarno sequence (SD, 
light blue line). Art200 and Hfq may act to (i) block ribosomal protein S1 binding to a 
translational enhancer or (ii) simply prevent the 30S-SD interaction. An alternative 
secondary structure of tnpA where the anti-Shine-Dalgarno (anti-SD, red line) is not 
paired to the SD is derived from secondary structure predictions (Figure S4.8). See 
discussion for more details. 
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4.3.2 Might art200 function as both a cis and trans acting sRNA? 
 We have previously shown that Hfq represses IS10 transposase expression by 
facilitating the pairing between transposase mRNA (RNA-IN) and a cis-encoded sRNA 
(RNA-OUT) (Ross et al, 2013) and this led us to ask if similar regulation would occur in 
the IS200 system with art200. However, the current work shows that Hfq is not required 
for art200-mediated repression of tnpA expression. There are a large number of Hfq-
binding RNAs in vivo and we and others have provided evidence that Hfq is in fact 
limiting for RNA binding (Ellis et al, 2015a; Hussein & Lim, 2011; Moon & Gottesman, 
2011; Papenfort et al, 2009). Since Hfq binding in vivo must therefore be selective, it 
seems likely that the Hfq-art200 interaction is biologically important (Miyakoshi et al, 
2015), although for gram positive bacteria only a subset of Hfq-binding sRNAs seem to 
rely on Hfq for stability and/or riboregulation (Christiansen et al, 2006; Dambach et al, 
2013; Jousselin et al, 2009; Nielsen et al, 2010; Sievers et al, 2014). It is possible that 
art200 also is a trans-acting sRNA, and that this secondary function requires Hfq.  
 In addition to its Hfq binding properties, art200 expression increases during 
stationary phase and under conditions that induce the Salmonella pathogenicity islands 
(Sittka et al, 2008). There is no a priori expectation that expression of an RNA involved 
in repressing transposition would fluctuate in response to external stimuli or growth 
phase. Art200 is also expressed at a level far greater than that required to repress the 
poorly expressed tnpA mRNA (see Figure 4.3B).  
One paradox of IS200 elements is that while these transposons are essentially 
dormant many genomes containing IS200 elements have multiple copies. For example, 
natural isolates of Salmonella and Shigella contain up to 25 and 4 copies of IS200, 
respectively (Gibert et al, 1990) and the Y. pestis 6/69M genome contains at least 30 
copies of the closely related IS1541 (Odaert et al, 1998). In fact, a BLAST search for 
IS200 elements in Salmonella revealed an average of 9.6 (n=33) copies of IS200 per 
genome, while a similar search in Yersinia averaged 39.8 (n=30) copies per genome. In 
contrast, E. coli contains an average of 2.9 (n=31) IS200 elements per genome. The high 
copy-number of IS200 elements in certain species may simply reflect host-specific 
adaptation by the transposon (Siguier et al, 2014). Alternatively, IS200 might have been 
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domesticated by certain host bacteria, in which case IS200 expansion (and utilization of 
art200 as a trans regulator) could be a response to selective pressure. There are several 
examples of Hfq integrating horizontally acquired genes into host regulatory networks 
(Papenfort et al, 2012; Papenfort & Vogel, 2010; Pfeiffer et al, 2007; Shakhnovich et al, 
2009; Sittka et al, 2008; Vogt & Raivio, 2014) and art200 may represent one such case. 
4.3.3 IS200 5’UTR as a platform for designing novel riboregulators of 
translation initiation 
A major goal in the field of synthetic biology is to create tightly controlled gene 
regulatory networks to coordinate the expression of a range of desired protein products. 
The ultimate goal of this field is to produce microorganisms capable of producing 
biomaterials, pharmaceuticals, and biofuels and acting as biosensors for a range of 
applications (Khalil & Collins, 2010). Since these biosynthetic pathways must be tightly 
regulated yet easily manipulated, a great deal of work has been done to design 
riboregulators of transcription and translation. As it is advantageous to adapt naturally 
occurring regulators rather than de novo design, well-studied systems such as the pT181 
transcriptional attenuator and IS10 antisense system have been modified and combined 
for synthetic biology applications (Chappell et al, 2013; Liu et al, 2012; Mutalik et al, 
2012; Qi et al, 2012a; Qi et al, 2012b; Takahashi & Lucks, 2013). 
We propose that the IS200 5’UTR will serve as a convenient platform for modular design 
of orthogonal regulators of protein synthesis. First, we show here that the cis-encoded 
antisense system can be easily re-programmed by altering 3nt in the terminal loop region 
of each RNA. We have not investigated the impact of more extensive changes but predict 
that this could provide greater specificity. Additionally, our work shows that antisense 
regulation can be exploited for negative regulation (i.e. providing art200 in trans) or 
positive regulation (i.e. eliminating art200 through titration). In principle, the tnpA 
5’UTR could be fused to a gene of interest and translation of this downstream gene could 
be modified by an art200 derivative provided in trans. Translation could be further 
regulated by selectively disrupting the secondary structure that naturally occludes the SD 
sequence on tnpA. An RNA which base-pairs with the linear region of tnpA immediately 
5’ to the lower-stem as well as the ‘anti-SD’ sequence could reduce secondary structure 
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in a manner analogous to the LS mutation we described here. This synthetic RNA would 
be similar to the recently described ‘trigger RNA’ which can activate expression of de 
novo designed toehold switches (Green et al, 2014). 
 
4.4 Materials and Methods 
4.4.1 Bacterial strains, plasmids and oligonucleotides 
All Miller assays and related RNA analyses were performed in E. coli K-12 derivatives 
DBH323 (MC4100 ΔrecA774::kan) or DBH326 (DBH323 hfq-1::cat) (Ross et al, 2014). 
Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 was used as a source 
of IS200. For mating out experiments, DBH33 was lysogenized with λDBH881 to create 
the donor strain DBH291 (DBH33 Mini IS200-kan) and DBH13 was used as the 
recipient strain (see Supplemental Materials and Methods for details of strain 
construction). DH5α was used for routine cloning and plasmid propagation. Strains and 
plasmids used in the main text are listed in Table 4.1; all other plasmids and 
oligonucleotides are listed in Tables S4.1 and S4.2 respectively.   
 The IS200-lacZ translational fusion (TLF; pDH861) and mutant derivatives 
consist of the first 323 nt of IS200 fused to codon 10 of the lacZ gene cloned into pGEM-
T easy (Promega). The art200 titrator plasmids (pDH898 and pDH899; Figure 4.3A) 
consist of nt 45-298 of IS200 (no cis-art200) transcribed from either the T7 phage PA1 or 
PTet. The sgrS transcriptional terminator was inserted immediately downstream of IS200, 
and the entire construct was cloned into pACYC184. The plasmids expressing art200 in 
trans (pDH902 and pDH912) consist of nt 45-298 of IS200 cloned into pACYC184. 
Transposase expression in mating out experiments (pDH857, pDH860, pDH896 and 
pDH897) was from pBAD24 derivatives (Guzman et al, 1995) where TnpA was 
expressed from native or exogenous regulatory elements. Further details of constructing 
these plasmids are provided in Supplemental Material. 
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Table 4.1. Strains and plasmids used in Chapter 4. 
Name Description Notes 
E. coli   
DBH13 HB101 [F- leu- pro-]; SmR Recipient strain for mating out 
experiments 
DBH33 NK5830 [recA- arg -ΔlacproXIII nalR 
rifR/ F’ lacpro+] 
Parent strain for mating out 
donor 
DBH291 DBH33 λDBH881 (Mini IS200-kan); KanR Donor strain for mating out 
experiments 
DBH323 MC4100 ΔrecA774::kan; SmRKanR Miller assays (hfq+) (Ross et al, 
2014) 
DBH326 DBH323 hfq-1::cat; SmRKanRCmR Miller assays (hfq-) (Ross et al, 
2014) 
   
Plasmids   
pDH857 pBAD24-SDBAD24-tnpAWT; ApR TnpA expression for mating 
out, pBAD24 regulatory 
elements  
pDH860 pBAD24-SDBAD24-tnpAY125F; ApR TnpAY125F (cat. dead) 
expression for mating out, 
pBAD24 regulatory elements 
pDH861 pGEM-T Easy derived, tnpA-lacZ TLF; ApR tnpAWT-lacZ TLF 
pDH862 pDH861 with lower-stem mutations, tnpALS-
lacZ; ApR 
TLF with disrupted stem-loop 
structure 
pDH880 pDH861 with PA-6 mutation; ApR tnpA-lacZ, no cis-art200  
pDH896 pBAD24-tnpAWT; ApR TnpA expression for mating 
out, WT IS200 5’UTR 
pDH897 pBAD24-tnpALS; ApR TnpA expression for mating 
out, LS IS200 5’UTR 
pDH898 pDH900 with T7 PA1-tnpA45-298; TetR High-copy titrator, no cis-
art200 
pDH899 pDH900 with PTet-tnpA45-298; TetR Low-copy titrator, no cis-
art200 
pDH900 pACYC184 derivative; TetR CmS Vector control 
pDH902 pDH900 with IS20045-298 ; TetR trans-art200 
pDH912 pDH902 with M1 mutations; TetR trans-art200M1 
pDH914 pDH899 with M1 mutations; TetR Low-copy titratorM1’ 
pDH916 pDH861 with M1 mutations; ApR tnpAM1’-lacZ  TLF 
pDH918 pDH880 with M1 mutations; ApR tnpAM1’-lacZ TLF, no cis-
art200 
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4.4.2 RNA footprinting and toeprinting 
 In vitro transcription templates were generated by PCR using plasmids pDH861 
(WT tnpA1-173 and art200), pDH862 (LS tnpA1-173 and art200), and pDH916 (M1 tnpA1-173 
and art200) and primers oDH450 and oDH394 (tnpA1-173) or oDH500 and oDH501 
(art200). RNAs were generated by in vitro transcription and 5’labeled with [γ32P]-ATP as 
previously described (Ellis et al, 2015b). Wild-type Hfq was purified by heat treatment 
and poly(A) affinity purification (Ross et al, 2010). RNase, Pb2+, and hydroxyl radical 
footprinting were performed essentially as previously described (Ellis et al, 2015a; Ellis 
et al, 2015b; Ross et al, 2013). For footprinting reactions studying art200-tnpA pairing, 
each RNA was denatured at 95oC for 2 min and snap-cooled on ice for 3 min. Ambion 
10X RNA Structure Buffer was added to a final concentration of 1X (10 mM Tris-HCl 
(pH 7), 100 mM KCl, 10 mM MgCl2), and the RNAs were incubated separately at 37oC 
for 5 min to fold before mixing. For the control reactions in Figure 4.4B where the RNAs 
were folded together (FT, lanes 6, 11, 16, and 21) 5’32P-labeled tnpA and art200 were 
mixed before the denaturing step. 
Toeprinting was performed essentially as previously described (Ellis et al, 2015a). 
Briefly, unlabeled tnpA (2 pmol) was annealed to 5’32P-labeled oDH394 before 
incubation with purified Hfq (0-8 pmol hexamer) or art200 (30 pmol) at 37oC. This was 
followed by addition of the 30S ribosomal subunit (3.6 pmol) and then initiator fmet-tRNA 
(10 pmol; Sigma-Aldrich) for a final volume of 10 µL. Reverse transcription reactions 
were carried out at 37oC for 10 min with 200U of SuperScript II (Invitrogen). 
  Following ethanol precipitation, samples were resuspended in denaturing load dye 
(95% [v/v] formamide, 0.5X TBE, 3% [w/v] xylene cyanol) and resolved on a 10% 
polyacrylamide gel containing 7M urea. Dried gels were exposed to a phosphorimager 
storage screen, imaged with a Storm imager and quantitated with ImageQuant (GE 
Healthcare). 
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4.4.3 β-galactosidase assays 
Cells were grown in LB supplemented (where necessary for plasmid selection) with 
ampicillin (100 µg/mL) and tetracycline (10 µg/mL). Saturated overnight cultures were 
used to seed subcultures (1:40 dilution), which were grown to mid-log phase (OD600 = 
0.4-0.6). The Miller assay was performed as previously described (Ross et al, 2010).  
4.4.4 RNA extraction, primer extension 
 Cells were grown in LB supplemented (where appropriate for plasmid 
maintenance) with ampicillin (100 µg/mL) and/or tetracycline (10 µg/mL) to OD600 = 0.6 
at which time total RNA was extracted with acid phenol as previously described (Ellis et 
al, 2015a). 10 µg of total RNA was subject to primer extension analysis with 5’32P-
labeled oDH427 (Figure 4.2 and 4.3B) or oDH537 (Figure 4.6) (art200), oDH428 (tnpA), 
and oDH390 (lpp) and SuperScript III (Invitrogen) according to the manufacturer’s 
instructions. Following ethanol precipitation, samples were resuspended in denaturing 
load dye and resolved on a 10% polyacrylamide gel containing 7M urea. Dried gels were 
exposed to a phosphorimager storage screen, imaged with a Storm imager and quantitated 
with ImageQuant (GE Healthcare). 
4.4.5 Conjugal mating out assay 
 The conjugal mating out assay was performed as previously described (Ellis et al, 
2015a; Ross et al, 2010); see Figure S4.5 for schematic. Briefly, DBH291 was 
transformed with pDH857, pDH860, pDH896, or pDH897 and grown on LB agar plates 
containing ampicillin (100 µg/mL), kanamycin (25 µg/mL) and 0.05% arabinose (w/v). 
For the experiments presented in Figure 9C, DBH291 was transformed with pDH897 and 
pDH900 (vector) or pDH898 (titrator) and grown on LB agar plates containing 
ampicillin, tetracycline (10 µg/mL) and 0.05% arabinose (w/v). Individual colonies 
(‘donors’) were grown to saturation in LB containing (where appropriate for plasmid 
selection) ampicillin and tetracycline with 0.05% arabinose (w/v) and were subcultured 
1:20 into LB containing 0.2% arabinose. Following mating with the recipient strain 
(DBH13), cells were plated on M9 glucose plates supplemented with thiamine, leucine 
196 
 
and streptomycin (150 µg/mL) (‘exconjugants’) or streptomycin and kanamycin (‘hops’). 
Transposition frequency was determined by dividing ‘hops’ by ‘exconjugants’. 
 
4.5 Supplemental Material 
4.5.1 Materials and Methods 
4.5.1.1 Strain and plasmid construction  
Supplemental plasmids and phage are listed in Table S4.1. The entire IS200 element 
(tnpA_6, STM4311) was amplified from Salmonella Typhimurium LT2 genomic DNA 
using GoTaq (Promega) and primers oDH378 and oDH379; the amplicon was cloned into 
pGem-T Easy (Promega) to produce pDH882 which served as the IS200 template for all 
further plasmid construction.  
The WT IS200-lacZ translational fusion (TLF) was made by first amplifying 
IS200 from pDH882 with primers oDH130 and oDH535 and then cloning the amplicon 
into the NcoI/PstI sites of pGEM-T easy; the lacZ gene was amplified with primers 
oDH534 and oDH536 and cloned into the PstI site to produce pDH861 which contains 
the first 323nt of IS200 fused in frame to codon 10 of lacZ. All mutations were 
introduced into pDH861 (or pDH880 for pDH918) using overlap PCR with primers 
oDH130 and oDH431 and the relevant mutagenic primers; pA1 (oDH414, oDH415), pA2 
(oDH410, oDH411), pA3 (oDH467, oDH468), pA4 (oDH469, oDH470), pA5 (oDH471, 
oDH472), pA6 (oDH473, oDH474), LS (oDH416, oDH417) and M1 (oDH538, 
oDH539). PCR products were digested with EcoRI and cloned into the same sites in 
pDH861 resulting in pDH827, pDH863, pDH877, pDH878, pDH879, pDH880, pDH862, 
and pDH916, respectively.  
To make the titrator plasmids, the SgrS terminator (amplified from DBH323 
genomic DNA with oDH439 and oDH440) was cloned into the IS200 EcoRI site of a 
pDH880 partial digest. Next, a PCR amplicon containing bp 45-298 of IS200 and the 
sgrS terminator was made using Q5 polymerase (NEB) and primers oDH440 and either 
oDH531 (contains PTet) or oDH530 (contains T7 PA1). The M1 mutation was introduced 
197 
 
using overlap PCR with primers oDH440, oDH538, oDH539, and oDH531. PCR 
products were cloned into XmnI/ScaI digested pACYC184 resulting in plasmids pDH899 
(low-copy titrator), pDH898 (high-copy titrator), and pDH914 (low-copy M1 titrator).  
The trans-art200 plasmids were made by cloning the EcoRI/XmnI fragment of 
pDH882 (WT) or pDH916 (M1) into the same sites of pACYC184 to produce pDH902 
and pDH914.  
For mating out experiments, DBH33 was lysogenized with λDBH881 to create 
DBH291 (DBH33 Mini IS200-kan) (as described in (Ellis et al, 2015a; Ross et al, 2014)). 
First, pDH882 (pGEM-IS200) was digested with EcoRV, treated with Bal31 and ligated 
to kanR to make pDH855. Mini IS200-kan was then cloned into SalI/SphI digested 
pACYC184 to make pDH856. Next, Mini IS200-kan was PCR amplified with primers 
oDH434 and oDH435 and the amplicon was digested with BamHI and cloned into BclI 
digested pNK81 to make pDH881. Finally, pDH881 was crossed onto λNK1039 
(Haniford et al, 1989) to make λDBH881.  
Transposase expression in mating out experiments was from pBAD24 derivatives 
(Guzman et al, 1995). pDH857 was made by amplifying the tnpA ORF from pDH855 
with primers oDH451 and oDH452 and cloning the NcoI digested amplicon into the same 
site of pBAD24. The Y125F mutation was introduced into pDH857 using overlap PCR 
with primers oDH420, oDH421, oDH451, and oDH452 to make pDH860. Plasmids 
expressing TnpA under control of the WT (pDH896) or LS (pDH897) IS200 5’UTR were 
made by replacing the EcoRI/SphI fragment of pDH815 (WT) or pDH835 (LS) with the 
same fragment from pDH857. pDH815 and pDH835 consist of nts 45-323 of IS200 (WT 
or LS) fused in frame to codon 10 of lacZ and cloned into the NcoI/PstI sites of pBAD24. 
IS200 was amplified from pDH882 with primers oDH532 and oDH535 and cloned into 
the NcoI/PstI sites of pBAD24 and codon 10 of the lacZ gene (amplified with primers 
oDH534 and oDH536) was cloned into the PstI site of this plasmid. Finally, the pBAD24 
Shine-Dalgarno sequence (SDBAD24) was mutated from AGGAGG to ACCACC to 
produce pDH815. The LS mutation was introduced to pDH815 by overlap PCR (primers 
oDH532, oDH431, oDH416, and oDH417) to produce pDH835. 
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4.5.1.2 ST-PCR  
Semi-random, two-step PCR (ST-PCR) was used as previously described to map putative 
IS200 insertion sites(Chun et al, 1997; Ross et al, 2014). Briefly, genomic DNA from 
‘hop’ colonies was amplified with a semi-random primer (oDH167) and a kan-specific 
primer (oDH388). PCR products were cloned into pGEM-T easy and sequenced, and then 
mapped to the E. coli MG1655 genome to identify insertion sites. Insertion site specific 
primers were then designed to flank the insertion site (oDH457, oDH458, oDH461, and 
oDH462) which was then amplified, cloned as above, and sequenced. The precise 
junction between each end of IS200 and the insertion site was then determined.  
4.5.1.3 Southern blot  
Genomic DNA was purified from ‘hop’ colonies (SmRKanR) using a Gen Elute Bacterial 
Genomic DNA kit (Sigma-Aldrich). DNA was digested with XmnI which cuts once in 
IS200 and then resolved on a 1% agarose gel. Southern blot for the kanR gene was 
performed as previously described (Ross et al, 2014) with a 32P-labeled riboprobe. 
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4.6 Supplemental Figures 
 
Figure S 4.1. Impact of Hfq on tnpA-lacZ transcript levels. 
RNA isolated from isogenic hfq+/hfq- strains was analyzed by primer extension. To 
facilitate detection of the tnpA-lacZ transcript the fusion was expressed from the PBAD 
promoter. As tnpA levels did not increase in hfq- versus hfq+ we conclude that increased 
tnpA expression in hfq- is not due to an increase in steady-state transcript levels. 
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Figure S 4.2. Lead and RNase structure probing of art200. 
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(A) RNase T1 and V1 structure probing of 5’32P-labeled art200 (90 nM). After folding at 
37ºC, art200 was mixed with dilute RNase T1 or V1 and incubated at ambient 
temperature for 15 min. Positions cleaved by RNase V1 or T1 are indicated with orange 
and purple arrows respectively. Positions sensitive to both RNases are indicated with 
grey arrows. Note that certain lanes from this gel were removed for clarity (indicated 
with white line) (B) Structure constraints from (A) were used with mFold (Zuker, 2003) 
to predict the secondary structure of art200. Coloured arrows show RNase sensitive 
positions. All nucleotide numbering is relative to the transcriptional start site for art200. 
(C). Lanes 1-3 of Figure 4.4A. 5’32P-art200 (69 nM) was allowed to fold at 37ºC before 
limited cleavage with Pb2+ (lane 3). An RNase T1 sequencing reaction (G, lane 1) and 
untreated RNA (lane 2) are shown. Reactivity of each position was scored as strong (red), 
moderate (green), or weak (blue); scoring was relative to the most reactive position (C44) 
and background at each position (lane 2). Lead reactivity was modeled onto the 
secondary structure in (B, coloured letters). 
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Figure S 4.3. RNase structure probing of tnpA1-173. 
5’32P-labeled tnpA1-173 was subject to limited cleavage by RNase A, T1, or V1 for 15 min 
at ambient temperature. Samples were resolved on a 10% denaturing polyacrylamide gel. 
An RNase T1 sequencing lane (lane 1) and untreated RNA (lane 2) are shown. Each 
position was assessed for reactivity to dsRNA specific RNase (V1; blue) or ssRNA 
specific RNase (A/T1; red). Positions sensitive to both types of RNase are highlighted in 
purple. Positions that were highly sensitive to only one type of RNase were used as hard 
203 
 
constraints in mFold (Zuker, 2003) to produce the secondary structure shown on the 
right. The reactivity of each nucleotide is shown on the secondary structure by coloured 
letters. All nucleotide numbering is relative to the tnpA translational start codon. The 
Shine-Dalgarno sequence and translational start codon are indicated in bold. 
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Figure S 4.4. Hfq blocks ribosome binding to tnpA in vitro. 
The impact of Hfq on ribosome binding to tnpA1-173 was measured by a toeprinting assay 
(see also Figure 4.8A,B, ‘experiment B’). The combined toeprint signal (G+15, A+16, and 
G+17) was normalized to positions +25 and +26 which served as loading controls. For 
example, lane 7 has 5-fold more signal at +25/+26 than the average signal for lanes 8, 9, 
11, and 12. Note that these positions are 3’ to the ribosome-tnpA interaction and therefore 
primer extension to this point should be insensitive to ribosome binding. 
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Figure S 4.5. Schematic of conjugal “mating out” assay for IS200 transposition. 
DBH291 (‘donor strain’) contains the Mini IS200-kan element integrated in the 
chromosome as well as an F’ episome marked with lac-pro. DBH291 is transformed with 
a plasmid expressing TnpA under control of the PBAD promoter and various regulatory 
elements (constructs i-iv, see Figure 4.9). TnpA expressed from this plasmid can then 
catalyze transposition of Mini IS200-kan in trans. The donor strain is mated with DBH13 
(recipient strain) which is strR and pro-. Following mating, cells are plated on M9 media 
containing streptomycin but not proline (to select for DBH13 cells which have acquired 
the F’, “exconjugates”), or streptomycin and kanamycin (to select for cells containing the 
F’ with IS200-kan, “hops”). The number of “exconjugates” indicates the mating 
efficiency and the ratio of “hops” to “exconjugates” is the relative transposition 
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frequency. Note that this assay only measures transposition from the chromosome onto 
the F’ episome. 
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Figure S 4.6. Validation of IS200 transposition events (‘hops’). 
(A) The location of the IS200-kan insertion site from two ‘hop’ colonies (construct i; 
Figure 4.9A) was determined by ST-PCR. The sequence of the two insertion sites (yafX 
and ybaA) is shown in black and the ‘left-end’ (LE) and ‘right-end’ (RE) sequence from 
IS200 is shown in red and blue, respectively. (B) IS200 transposition events (construct iii 
and iv; Figure 4.9A) were detected by Southern blot analysis (using a kanR probe) of 
genomic DNA that had been subject to restriction enzyme digestion. a-c refers to 
different mating mixes that gave rise to hop colonies. The fragment in lane 3 defines the 
starting location of IS200-kan in the chromosome of the donor strain. The appearance of 
fragments of different size in hop colony genomic preparations was taken as confirmation 
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that transposition had occurred. Additionally, the observation that all 4 hop colonies from 
mating mix a produced a fragment of (apparently) the same size was taken as evidence 
that these are not independent transposition events. pMini contained genomic DNA from 
the donor strain harbouring IS200-kan on a plasmid (pDH881) and lane 2 contained 
genomic DNA isolated from the donor strain not containing IS200-kan. (C) Southern blot 
analysis of hop colonies from the indicated mating mixes (d-g) described in Figure 4.9C. 
a and b contain genomic DNA from hop colonies derived from mating mixes described in 
part B. 
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Figure S 4.7.Impact of mutations to a putative translational enhancer in tnpA on 
tnpA expression. 
Mutations to C/A rich region (mutations in red, C/A rich region highlighted in blue) and 
the surrounding sequence were introduced into an otherwise wild-type tnpA-lacZ TLF 
(pDH861). β-galactosidase activity was measured by the Miller Assay from three 
independent clones and error bars show standard error on the mean. 
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Figure S 4.8. Predicted alternative secondary structures of the first 120nt of tnpA. 
mFold was used to predict secondary structures of the 5’end of tnpA with a 50nt folding 
window and no other structural constraints (top left) or with the Shine-Dalgarno (SD) 
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sequence forced to be single-stranded. The folding energies of the unconstrained and top 
three alternative structures are shown. The Shine-Dalgarno (SD, blue) and 
complementary sequence (anti-SD, red) are highlighted in each structure along with the 
translational start codon (purple). 
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Table S 4.1. Bacteriophage and supplemental plasmids for Chapter 4. 
Name Relevant genotype Use/ Notes 
λ Phage   
λNK1039 Encodes his operon Plasmid-λ crosses (Haniford et 
al, 1989) 
λDBH881 λNK1039 with Mini IS200-kan Product of recombination 
between pDH881 and 
λNK1039; used for DBH291 
construction 
Plasmids   
pNK81 pBR333 derivative, encodes his operon; 
ApR 
λ crosses  
pDH815 pBAD24-tnpA-lacZ TLF; ApR Arabinose inducible TLF 
pDH827 pDH815 with pA1 mutation; ApR  Mutations to Part200 -10 region 
pDH832 pDH815 with pA2 mutation; ApR Mutations to Part200 -10 region 
pDH835 pDH815 with LS mutation; ApR Constructing pDH897 
pDH855 pGEM-T easy with Mini IS200-kan; 
KanRApR 
Constructing DBH291 
pDH856 pACYC184 with Mini IS200-kan; 
KanRCmRTetS 
Constructing DBH291 
pDH863 pDH861 with pA2 mutations; ApR Mutations to Part200 -10 region 
pDH877 pDH861 with pA3 mutation; ApR Mutations to Part200 -10 region 
pDH878 pDH861 with pA4 mutation; ApR Mutations to Part200 -10 region 
pDH879 pDH861 with pA5 mutation; ApR Mutations to Part200 -35 region 
pDH881 pNK81 with Mini IS200-kan; ; KanRApR Crossing Mini IS200-kan onto 
λNK1039 
pDH882 IS200 cloned into pGem-T easy; ApR Source of IS200 sequence 
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Table S 4.2. List of oligonucleotides for Chapter 4. 
Name Sequence (5’ to 3’) Use 
oDH130 GAATTGTAATACGACTCACTATAG TLF construction 
oDH167 GGCCACGCGTCGACTAGTACNNNNNNNNNNGAT
AT 
ST-PCR - random primer  
oDH378 TTTGTGGTGTAGCGTAACGGTAATTG IS200 amplification from 
LT2 oDH379 GGCATTCGGTAAGTGTTGATGAAG 
oDH388 ACGCCATATGGCCAGTGTTACAACCAATTAACC
AATTCTGA 
ST-PCR - Kan specific 
oDH390 CAGCTGGTCAACTTTAGCGTTCAGAG lpp primer extension 
oDH394 TATTTGGGCGCGAAAACTATG tnpA primer extension 
oDH397 GCTGCCTACTGCCTACGCTTCTC Sequencing IS200 
plasmids 
oDH410 GGGGGACGAGGGGGGCTTGGCG pDH863 construction 
oDH411 CGCCAAGCCCCCCTCGTCCCCC 
oDH414 GGGGGACGACCCGAGCTTAGCG pDH827 construction 
oDH415 CGCTAAGCTCGGGTCGTCCCCC 
oDH416 CCAGTTATTAAAAGGGGAAATGATTTGTTAAAA
C 
pDH862 construction 
oDH417 GTTTTAACAAATCATTTCCCCTTTTAATAACTG
G 
oDH420 GATACAGGACTTCATAAAGCAC pDH860 construction 
oDH421 GTGCTTTATGAAGTCCTGTATC pDH860 construction 
oDH427 CATCTTGCGGTCTGGCAAC art200 primer extension 
oDH428 GTTGCCAGACCGCAAGATG tnpA primer extension 
oDH431 AGGCTGCGCAACTGTTGGG TLF construction 
oDH434 GCGGGATCCGCCGCTTTTTTTGTCTATGG BamHI IS200-LE 
oDH435 GAGGGATCCAATTTATAAAATAAATATCCTC BamHI IS200-RE 
oDH439 TGCTCGGAATTCCTGAAAGTTGACTT titrator construction 
oDH440 TAGCCAGAATTCCTAACCAGTAAGGC 
oDH450 TAATACGACTCACTATAGGCTTTCAGCTTTAAG
CCAG 
Fwd primer for tnpA1-173 
in vitro transcription 
template, contains T7 
promoter sequence 
oDH451 ATACCATGGGGGACGAAAAGAGCTTAGC pDH857 construction 
oDH452 ATACCATGGAACTTCGTTACTTACGGCC pDH857 construction 
oDH453 ACCGTTATTCATTCGTGATTGCG Southern Probe template 
(Kan rev) 
oDH454 TAATACGACTCACTATAGGGAGCGTTGCCAATG
ATGTTACA 
Southern Probe template 
(T7-Kan) 
oDH457 ATCACATTTAACATTAAGAACAGG IS200 Hop verification 
(ybaA) 
oDH458 TCAGCGAAGATTATAATTTTCG IS200 Hop verification 
(ybaA) 
oDH461 TGCGTCTGTGTTGTCATGG IS200 Hop verification 
(yafX) 
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oDH462 AGGCATCCGTACAGACACGG IS200 Hop verification 
(yafX) 
oDH467 GGGGGACGAACGCGGCTTAGCG pDH877 construction 
oDH468 CGCTAAGCCGCGTTCGTCCCCC 
oDH469 GGGGGACGGCCGCGGCTTAGCG pDH878 construction 
oDH470 CGCTAAGCCGCGGCCGTCCCCC 
oDH471 GCACACCCGAGCGCGGTGTAAATATC pDH879 construction 
oDH472 GATATTTACACCGCGCTCGGGTGTGC 
oDH473 CCGATGGAACCGCGGCTATCACATAG pDH880 construction 
oDH474 CTATGTGATAGCCGCGGTTCCATCGG 
oDH500 TAATACGACTATAGGTCCCCCATTGGGACC Fwd primer for art200 in 
vitro transcription 
template, contains T7 
promoter sequence 
oDH501 AACCCCTTTTGATTTGTTAAAAC Rev primer for art200 in 
vitro transcription 
template 
oDH530 TTATCAAAAAGAGTATTGACTTAAAGTCTAACC
TATAGGATACTTACAGCCTCAGCTTTAAGCCAG
TTATTAAA 
pDH898 construction 
oDH531 AAGAATTCTCATGTTTGACAGCTTATCATCGAT
AAGCTTTAATGCGGTAGTCAGCTTTAAGCCAGT
TATTAAA 
pDH899 construction 
oDH532 CACCATGGTCAGCTTTAAGCCAGTTA  
oDH534 GCCTGCAGGTCGTTTTACAACGTCGTGAC pDH861 construction 
oDH535 GTCTGCAGATCTGCACAACATTCTGC 
oDH536 GCCTGCAGAGATTATTTTTGACACCAGA 
oDH537 TGATTTGTTAAAACATCTTGCGG art200 primer extension 
oDH538 GTTAAAACATCTTGCGGTCTCCGAACTGCAAAA
GTTCAAC 
Mutagenic primers for 
“M1” mutation 
oDH539 GTTGAACTTTTGCAGTTCGGAGACCGCAAGATG
TTTTAAC 
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Chapter 5 
5 A transposon derived small RNA regulates gene 
expression in Salmonella Typhimurium4 
5.1 Introduction 
IS200 is the smallest prokaryotic transposon and is widely conserved in 
Enterobacteriaceae and found throughout Eubacteria and Archaea. One unusual feature of 
IS200 elements is the high copy-number achieved in Yersinia and Salmonella spp. 
(Beuzon et al, 2004; Ellis et al, 2015a; Siguier et al, 2006). Many strains of Y. pestis 
contain more than 50 copies of the IS200 ortholog IS1541, while strains of Salmonella 
enterica subsp. enterica serovar Typhimurium (S. Typhimurium) typically contain 5-12 
copies and S. Typhi contains 26 copies of IS200 per genome. In the above cases, all 
IS200 paralogs are 100% conserved and in general IS200 orthologs share >90% identity. 
A highly active transposon might be expected to achieve this high copy-number and 
repeated transposition would maintain sequence identity of paralogs; however IS200 is an 
essentially dormant transposon (Beuzon et al, 2004; Ellis et al, 2015a). Conservation and 
copy-number might therefore reflect a selective pressure on the host bacterium to 
maintain IS200. Transposons can contribute to host fitness in several ways including: (i) 
by mediating DNA rearrangements that influence host gene expression and gene structure 
(Siguier et al, 2014); (ii) contributing passenger genes such as antibiotic resistance 
determinants (Davies, 1994); (iii) providing a rich source of DNA regulatory sequence 
(Feschotte, 2008); (iv) providing proteins and/or protein motifs from transposase proteins 
that can be domesticated by the host (Volff, 2006); and (v) providing regulatory RNAs 
that affect host gene expression (Gomes-Filho et al, 2015; Martens et al, 2013). As a 
simple insertion sequence, IS200 does not encode any passenger genes, and the dormancy 
                                                
4
 The work presented in this chapter has been submitted for publication and is currently in revision: Ellis 
MJ, Trussler RS, Haniford DB. A transposon derived small RNA regulates gene expression in Salmonella 
Typhimurium. Nucleic Acids Research. NAR-02816-Y-2016 
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of IS200 suggests that this element would not contribute transposition-dependent 
functions to the host. 
Non-coding RNAs (ncRNA) play a crucial role in regulating many critical 
processes in bacteria including outer membrane homeostasis, metabolism, and virulence 
(Storz et al, 2011; Wagner & Romby, 2015). The largest class of bacterial ncRNA are 
small RNAs (sRNA) that base-pair with target mRNAs and affect translation and/or 
transcript stability. sRNAs are typically expressed from intergenic regions and therefore 
have limited sequence complementarity with their trans-encoded targets. A related class 
of ncRNA are antisense RNAs (asRNA) which are encoded on the opposite strand of 
DNA to their target mRNA. Accordingly, asRNAs have much more extensive 
complementarity with their cis-encoded targets. The third and smallest class of bacterial 
ncRNAs act by binding to and regulating protein activity (e.g. 6S RNA, CsrB/C). The 
classic distinction between these three classes of ncRNA has been challenged with 
continually emerging examples of dual-function ncRNA, including sRNAs derived from 
mRNAs (Chao et al, 2012; Chao & Vogel, 2016; Guo et al, 2014; Hershko-Shalev et al, 
2016), base-pairing sRNAs acting to modulate protein activity (Ellis et al, 2015b; 
Holmqvist et al, 2016; Jørgensen et al, 2013; van Nues et al, 2016), and asRNAs acting in 
trans to regulate genes expressed from different loci (Jager et al, 2012; Sayed et al, 2012). 
One common feature for base-pairing ncRNAs is that the RNA-binding protein Hfq is 
typically required to facilitate pairing when there is limited complementarity between an 
sRNA and mRNA (Vogel & Luisi, 2011). In general, an interaction between Hfq and an 
mRNA or sRNA indicates that the RNA is involved in post-transcriptional regulation via 
a base-pairing mechanism. 
 IS200 elements express two RNA molecules (Figure 5.1A), the first is an mRNA 
encoding the transposase protein (tnpA), and the second is an asRNA (art200, previously 
named STnc490) that is complementary to the tnpA 5’UTR (Beuzon et al, 1999; Ellis et 
al, 2015a; Sittka et al, 2008). Expression of the IS200 TnpA is strongly repressed by 4 
independent mechanisms. First, the left-end of IS200 contains an inverted repeat that 
forms a strong, bi-directional, Rho-independent transcriptional terminator. This 
regulatory element ensures that impinging transcription does not activate TnpA  
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Figure 5.1. IS200 and experimental approach. 
(A) IS200 encodes a transposase mRNA (tnpA, red) and an antisense RNA (art200, blue). 
The tnpAtrunc-255 transcript encodes the first 255 nt of tnpA fused to the last 108nt of 
SgrS (black, includes an intrinsic terminator) and is expressed from the Tet promoter. (B) 
Approach used to deplete art200. Pairing between tnpA (red) and art200 (blue) results in 
degradation of art200. The M1 mutation alters three critical nucleotides in the terminal 
loop of tnpA and prevents pairing with art200. (C) Heat map showing expected 
expression of IS200 RNAs in S. Typhimurium LT2 containing plasmids over-expressing 
either WT or M1 forms of tnpAtrunc-255. Note that ‘tnpA’ signifies endogenous 
transposase transcript and ‘vector’ is a control plasmid that does not overexpress tnpA. 
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expression and terminates ~85% of upstream transcripts (Beuzon et al, 1999). Second, 
translation of tnpA is strongly repressed by mRNA secondary structure that includes the 
Shine-Dalgarno sequence (SD). This stem-loop element represses tnpA expression 20-
fold by preventing 30S ribosome binding. Third, art200 base-pairs with tnpA to inhibit 
ribosome binding, and reduces translation 15-fold. Lastly, tnpA translation is inhibited 
directly by the RNA-binding protein Hfq, which recognizes a sequence immediately 
upstream of the SD and accordingly stericly occludes ribosome binding. The three post-
transcriptional mechanisms act independently and together suppress translation of tnpA 
by at least 750-fold, ensuring almost no TnpA protein is produced (Ellis et al, 2015a). 
While these regulatory mechanisms appear to be redundant, tnpA expression is 
reasonably high in S. Typhimurium for a transposon (~10% the expression of hfq in mid-
exponential phase (Kroger et al, 2013)). It therefore appears that IS200 elements have 
evolved to maintain moderate transcription of tnpA from an IS200 encoded promoter, but 
close to no synthesis of TnpA. Another noteworthy feature of IS200-encoded RNAs is 
that art200 expression appears to be growth phase regulated, with increased expression 
when S. Typhimurium transitions to stationary phase in rich media, as well as in growth 
media that stimulate Salmonella pathogenicity island (SPI) expression (Figure S5.1; 
(Sittka et al, 2008)). Additionally, art200 interacts with Hfq in vivo, although Hfq is 
dispensable for antisense regulation of tnpA expression.  Intriguingly, while art200 
expression is increased in stationary-phase, tnpA expression decreases ~5-fold (Kroger et 
al, 2013), which may indicate that art200 expression is altered to control tnpA RNA 
levels. One explanation for the unusual characteristics of IS200-encoded RNAs is that a 
moderately expressed but never translated tnpA provides a way in which IS200 
transposition could be rapidly activated under certain conditions. However, previous 
work found that IS200 transposition is remarkably rare, even when post-transcriptional 
regulation is completely eliminated (Ellis et al, 2015a). With respect to art200’s 
expression patterns and Hfq-binding properties, this could simply reflect stochastic 
evolution of the promoter and sequence of a regulatory RNA. A more intriguing 
explanation for the peculiar properties of tnpA and art200 is that one or both IS200-
encoded RNAs serves a regulatory role independent of controlling transposition. In this 
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scenario, an IS200 encoded RNA might provide a selective advantage to Salmonella spp. 
and accordingly explain the conservation and high copy-number of this transposon. 
 In the current work we performed an RNA-Seq experiment to ask if IS200-
encoded RNAs affect gene expression in S. Typhimurium. We provide evidence that the 
5’UTR of tnpA represses many genes including the SPI-1 encoded transcription factor, 
invF. Our data suggests that tnpA base-pairs with invF, and the consequence of this 
interaction is down-regulation of the SPI-1 translocon (sicAsipBC). This work is the first 
demonstration of a bacterial transposon encoding regulatory RNAs that influence host 
gene expression. 
 
5.2 Results 
5.2.1 Profiling changes in S. Typhimurium gene expression in 
response to altered levels of IS200-encoded transcripts 
We used RNA-Seq to analyze gene expression in S. Typhimurium LT2 under conditions 
where levels of tnpA and art200 were altered from native levels. In one strain we 
introduced a plasmid that constitutively over-expresses a truncated form (nt 1-255) of the 
transposase mRNA (tnpAtruncWT-255). This strain produces very low amounts of art200 
because tnpAtruncWT-255 RNA pairs with art200 and this pairing promotes degradation of 
art200 (Figure 5.1B,C; Figure S5.1C). When we looked for differentially expressed genes 
in this strain vs an empty vector control strain, we identified 187 genes with altered 
expression (Figure 5.2A, black dots), 99 of which had at least a 2-fold change in 
expression. This altered pattern of gene expression could arise from either depletion of 
art200 and/or the overexpression of the truncated tnpA mRNA. To distinguish between 
these possibilities, we profiled gene expression in a third strain expressing a truncated 
form of tnpA (tnpAtruncM1-255) that is unable to pair with art200 (Figure 5.2B). Genes 
affected by depletion of art200 would show differential expression when tnpAtruncWT-255 
was overexpressed but not when tnpAtruncM1-255 was overexpressed. When all three 
comparisons were made, only 6 genes appeared to be uniquely regulated by art200 
(Figure 5.2C; glnH, gltI, acs, icdA, hutU, and a predicted asRNA to the 3’end of fadR). In  
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Figure 5.2. Summary of RNA-Seq data. 
(A,B) Expression plot comparing relative abundance (log2 clr) of S. Typhimurium LT2 
transcripts in the presence of an empty-vector (x-axis) or plasmid expressing WT (y-axis, 
A) or M1 (y-axis, B) tnpAtrunc-255. Differentially expressed genes (effect size >2) are 
indicated in black, and dotted lines indicate a two-fold change in expression from the line 
of best fit for the data (A, Pearson’s r = 0.9393; B, Pearson’s r = 0.9348). Reads derived 
from tnpAtrunc-255 mapped o either the IS200 transposase coding sequence (tnpA) or 
5’UTR (tnpA 5’UTR) and are indicated in blue. SPI-1 genes sicA, sipB, sipC, and invF 
are highlighted in red; note that invF was repressed >3-fold by tnpAtruncWT-255 but fell 
below out cut-off for differential expression (effect size = -1.2025). Genes with an effect 
size < 2 are indicated in grey and are not considered to be differentially expressed. (C) 
Venn diagram showing the overlap of genes identified as differentially expressed when 
comparing the empty vector to tnpAtruncWT-255 (blue) or tnpAtruncM1-255 (yellow, or 
tnpAtruncWT-255 to tnpAtruncM1-255 (green). (D) Results of GO Enrichment Analysis. The 
log2 fold change (Vector vs tnpAtruncWT-255) of genes in the three enriched biological 
processes are shown along with the enrichment score and p-value from the PANTHER 
Overrepresentation test. Horizontal bars indicate the median fold-change for each 
biological process. 
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contrast, genes regulated by tnpAtrunc overexpression would show differential expression 
in both WT and M1 tnpAtrunc strains when compared to an empty vector. A total of 73 
genes fit this criteria (Figure 5.2C). Based on this analysis we concluded that transcripts 
derived from IS200 impact on host gene expression and that high levels of a truncated 
form of tnpA that includes the 5’UTR has a greater impact on host gene expression than 
depletion of art200.  
 Lastly, we searched for cellular processes enriched with genes affected by 
tnpAtrunc overexpression. This analysis found that tnpA overexpression significantly 
represses genes involved in pathogenesis, glycerol-3-phosphate metabolism, and 
oxidation-reduction reactions (Figure 5.2D). The strongest change in gene expression in 
any of these pathways was the SPI-1 encoded effector protein, sipC (10-fold repression 
by overexpression of tnpAtruncWT-255). As S. Typhimurium LT2 is avirulent (Swords et al, 
1997), we switched to the virulent SL1344 strain (7 copies of IS200) for subsequent 
studies. 
 
5.2.2 Characterization of tnpA derived RNAs 
Our RNA-Seq analysis revealed that overexpression of the first 1/3 of transposase mRNA 
had a substantial impact on gene expression in S. Typhimurium. While this points to tnpA 
mRNA acting as a regulatory RNA, we thought it more likely that a naturally truncated or 
processed form of tnpA is produced from the 5’end to act as a regulatory RNA. This 
would be in line with other recently discovered mRNA derived sRNAs  (Miyakoshi et al, 
2015b). We initially looked for evidence of an sRNA derived from the 5’end by 
performing a Northern blot (5’UTR probe) on RNA isolated from a strain expressing 
native levels of tnpA (WT) or a strain where tnpA was over-expressed through the fusion 
of the pTet promoter to one copy of tnpA in the chromosome. In the latter strain we 
detected three species, two of which are approximately 90 and 110 nts and the other is 
>310 nts (Figure 5.3A, lane 3). The 90 and >310 nt species were also just detectable in 
the strain expressing tnpA at native levels (lane 1). In contrast, none of these species were 
detected in a strain where 4 of 7 copies of the tnpA gene were deleted (lane 2).  
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Figure 5.3. Processing of the tnpA transcript. 
(A) A northern blot of tnpA RNA isolated from SL1344 strains expressing tnpA at 
endogenous levels (WT), over-expressing tnpA from the tnpA_7 locus (tnpA_7::kan-pTet, 
pTet), or with a reduced number of endogenous copies of tnpA (DtnpA_2/4/6/7, DtnpA). 
Full-length (closed circle) and processed (open circle) forms of tnpA were detected with a 
probe that anneals to the 5’UTR (oDH429). 5S rRNA was used as a loading control. 
(B,D) 5’ends of tnpA were mapped using primer extension. RNA was isolated from the 
above strains (two replicates) and tnpA was detected using a primer that anneals to the 
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5’UTR (nts 46-64, B) or coding sequence (nts 151-171, D). ddNTP sequencing lanes 
were used to determine the nucleotide position of primer extension products relative to 
the transcription start site (+1, ‘Full-length’). (C) tnpA is processed at U17 and A19. RNA 
isolated from the WT or tnpA_7::kan-pTet strains was treated with TEX (+) or incubated 
with buffer (-) before tnpA was detected by primer extension. (E) Summary of primer 
extension experiments. The major primer extension products from part B and D are 
illustrated along with the primer binding sites. The two primers used for primer extension 
would detect different molecules of tnpA based on processing occurring between the 
primer binding sites. From the positions of 5’ends and the size of low molecular weight 
RNA species in the Northern (part A), we infer that the tnpA transcript is processed at 
two sites (red) to produce two stable 5’UTR-containing species (site B, tnpA-110; sites 
A+B, tnpA-90). 
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Additionally, both the 110 and 90nt species were detected by Northern blots on samples 
where tnpAtrunc-255 was overexpressed (Figure S5.1C). Taken together these results show 
that: (i) the native tnpA gene generated one or more sRNAs, (ii) sRNA production does 
not require more than 255 bp of the tnpA gene, and (iii) sRNA production occurs 
independent of the promoter used to drive tnpA transcription. The latter point is 
suggestive of sRNAs being produced through RNA processing of the tnpA transcript. 
We next performed primer extension on the above RNA samples to map 5’ends of 
each species. In one experiment we used a primer that anneals to the 5’UTR (nts 46-64). 
The results show that the majority of tnpA transcripts start at position 19 rather than the 
expected transcription start site (Figure 5.3B). This pattern was observed both when tnpA 
was over-expressed and expressed at native levels. We also show that prior treatment of 
the RNA with 5’monophosphate dependent terminator exonuclease (TEX) resulted in 
loss of the primer extension signal at nt 19, indicating that this 5’end is generated through 
transcript processing (Figure 5.3C). In a second experiment we used a primer that anneals 
in the coding sequence (nts 151-171) (Figure 5.3D). Here we also identified the position 
19 5’end and additional 5’ends surrounding position 108. These alternative 5’ends were 
also lost upon TEX treatment, indicating processing in a second region of the tnpA 
transcript (Figure S5.2A). Processing events at positions 19 and 108 would generate a 
5’UTR containing species of ~90 nt. In contrast, processing at only the downstream site 
would generate a 5’UTR containing species of ~110 nt in length. Based on these 
experiments, we infer that processing at sites designated A and B in Figure 5.3D generate 
stable tnpA encoded sRNAs (Figure 5.3E; Figure S5.2). 
  To test the hypothesis that one or both of the above described sRNAs are actually 
the active molecules for regulating host genes, we made additional tnpAtrunc constructs 
(first 50, 200, and 250 nt of tnpA overexpressed from plasmid) to determine the minimal 
tnpA required for affecting gene expression in S. Typhimurium; both tnpAtrunc-200 and -
250 are processed to produce ~110 and ~90 nt species (Figures S5.2D, S5.3A).  We used 
RT-qPCR to determine which of these truncated tnpA molecules down-regulates a set of 
functionally related genes (sicA, sipB and sipC) identified in our RNA-Seq experiment to 
be repressed by tnpA. All three truncated forms of tnpA down-regulated sicA, sipB and 
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sipC expression (> 2.5-fold) but not the expression of thrS, a gene whose expression was 
not affected by tnpA in the RNA-Seq analysis (Figure 5.4A). From this experiment it is 
evident that over-expression of only the first 50 nt of tnpA is sufficient to negatively 
regulate expression of the aforementioned genes, indicating that either the 110- or 90nt 
processed species is a functional sRNA. It may also be significant that of the three 
truncated forms of tnpA tested in this experiment, tnpAtrunc50 down-regulated expression 
of the target genes to the highest degree and is the only one of the three tnpA RNAs 
incapable of base-pairing with art200 (Figure S5.2D). The latter point may be particularly 
relevant if art200 factors into tnpA transcript processing. 
In the RT-qPCR analysis we also monitored tnpA expression using the primers 
shown in Figure S5.2C. These primers do not amplify tnpA species processed within the 
5’UTR or the tnpAtrunc-50 RNA. However, they do provide a measure of the relative 
abundance of unprocessed tnpA produced in strains with a vector or overexpressing 
tnpAtrunc-200 or -250; in the latter two strains, tnpA was expressed 95- and 6.5-fold higher 
than endogenous tnpA respectively. This is particularly significant because both forms of 
tnpA down-regulated the target genes to the same extent and thus we concluded that tnpA 
levels do not need to be increased by more than 6.5-fold to see an impact on target gene 
expression.  
sicA, sipB, and sipC are the first three genes in a large polycistronic transcript 
encoding secreted effector proteins for the SPI-1 type-III secretion system (T3SS) and are 
required for invasion of non-phagocytic cells (Lostroh & Lee, 2001). To gain insight into 
how tnpA regulates sicAsipBC we searched for predicted base-pairing interactions 
between this transcript and the 5’UTR of tnpA using TargetRNA2 (Kery et al, 2014) and 
IntaRNA (Wright et al, 2014) but no predicted interactions were found. Transcription of 
the sic/sip operon is activated directly by the SPI-1 encoded transcription factor InvF and 
the effect of tnpA on sicAsipBC could therefore be mediated through direct regulation of 
invF. Indeed, all three tnpAtrunc constructs repressed invF, with over-expression of 
tnpAtrunc-50 reducing invF mRNA levels 3.5-fold (Figure 5.4A). We also examined the 
effect of constitutive overexpression of tnpAtrunc on InvF protein levels with a strain of 
SL1344 containing a 3xFLAG tag integrated at the C-terminus of the native invF gene. 
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Figure 5.4. The 5'end of tnpA represses invF mRNA and protein expression. 
(A) RT-qPCR was performed on S. Typhimurium SL1344 cells expression different 
truncated forms of tnpA grown to late-exponential phase (OD600 = 1.2). Note that tnpA 
expression for samples containing pTet-tnpAtrunc-50 reflects the endogenous amount of 
tnpA as this construct lacks both primer binding sites for amplification of tnpA. (B) InvF 
Western blot on SL1344 cells expression tnpAtrunc constructs. Cells contained a 3xFLAG 
tag integrated at the end of the invF gene and cell extracts (prepared at mid-exponential 
phase; OD600 = 0.8) were probed with an a-FLAG antibody. Wild-type SL1344 cells 
provided a negative control, and GroES was used as a loading control. (C) RT-qPCR was 
performed on SL1344 strains expressing full-length tnpA from the native (WT) or Tet 
(tnpA_7::kan-pTet) promoter grown to late-exponential phase (OD600 = 1.2). (D) InvF 
Western blot on SL1344 strains expressing full length tnpA. Extracts were prepared at an 
OD600 of 0.4 or 1.0 from cells expressing tnpA at endogenous levels (-) or constitutively 
overexpressed from the tnpA_7::cm-pTet locus (+). InvF was detected as in (B), and 
DnaK served as a loading control.  
In all panels, error bars show the standard error on the mean for four (A,C) or three (B,D) 
biological replicates 
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Consistent with our RT-qPCR analysis, tnpAtrunc repressed InvF protein levels over 2-fold 
(Figure 5.4B).  
We also looked at the ability of tnpA to inhibit invF expression using over-
expressed full-length tnpA (tnpA_7::kan-pTet, Figure 5.4C,D). We show that in late 
exponential phase this strain expressed tnpA at a level ~65-fold higher than the WT 
strain, and decreased invF transcript and protein levels 2-2.5-fold. For comparison, invF 
levels were decreased 5.7-fold in a DhilA strain. As HilA is a transcriptional activator of 
invF, the DhilA strain provides a measure of uninduced invF expression. Together, the 
above data indicates that a tnpA-derived sRNA inhibits expression of SPI-1 effector 
proteins sicA, sipB, sipC by repressing invF expression. 
5.2.3 Over-expression of tnpA represses expression of SPI-1 in a 
growth phase dependent manner 
We next asked if the regulation of SPI-1 genes by a tnpA-derived sRNA is linked to 
growth phase, as invF expression is induced in late exponential and early stationary 
phase.  
We profiled the expression of invF and other SPI-1 encoded genes (sicA, sipB, 
sipC, and prgH) during 5 different growth phases in a WT or tnpA overexpression strain 
(tnpA_7::kan-pTet). Importantly, there was no difference in growth rate between the two 
strains (Figure S5.4A). Over-expression of tnpA did not affect SPI-1 gene expression in 
cells in lag- or early-exponential phase (Figure 5.5A,B). In both of these growth phases, 
tnpA in the WT strain was expressed higher than invF (Figure 5.5F), suggesting that the 
native expression of tnpA was sufficient for regulating invF. Once cells reached late-
exponential phase, overexpression of tnpA repressed invF (2-fold), sicA (5.5-fold), sipB 
(4-fold), and sipC (2-fold); prgH expression (an InvF-independent SPI-1 encoded gene) 
was not affected by tnpA overexpression (Figure 5.5C). At this growth phase invF is 
moderately induced (~6-fold) relative to early-exponential phase, and is now present at  
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Figure 5.5. Overexpression of tnpA RNA downregulates invF and sicAsipBC in a 
growth phase dependent manner. 
RT-qPCR was performed on SL1344 cells (WT or tnpA_7::kan-pTet) grown to different 
growth phass. LB was inoculated with single colonies of the indicated strains and RNA 
was harvested after 18 hrs (E, deep-stationary phase). The 18 hr cultures were used to 
seed subcultures, and RNA was isolated after 1.25 hrs (A, lag-phase), 2 hrs (B, early-
exponential phase), 3 hrs (C, late-exponential phase), or 4 hrs (D, early-stationary phase). 
Error bars show the standard error on the mean (n = 4). The relative amount of tnpA to 
invF (DDCT) for WT or tnpA_7::kan-pTet strains is shown in a heat map (F). Raw DCT 
values (relative to 16S rRNA) for all genes and growth phases are shown in Figure S5.4. 
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~2-fold excess to tnpA in the WT strain (Figure 5.5F). Here, endogenous tnpA is 
presumably limiting, explaining why this growth phase shows the largest impact of tnpA 
overexpression. Lastly, tnpA overexpression had only a minor effect on invF expression 
during early- and deep-stationary phase growth, which is likely due to the high 
expression of invF relative to tnpA (Figure 5.5D,E,F). 
 Together, these data show that tnpA overexpression affects invF levels only when 
native tnpA is expressed at lower levels than invF. This suggests the stoichiometry 
between both transcripts is important, and is consistent with a direct interaction between 
tnpA and invF. Additionally, the growth phases where tnpA overexpression repressed 
sicAsipBC were the same as those where tnpA repressed invF, providing additional 
support to a model where tnpA acts through invF to repress sicAsipBC. 
 The above results suggested that native expression of tnpA does in fact regulate 
invF. We confirmed this by comparing invF expression in an IS200 knock-out 
(DtnpA_2/4/6/7) or WT strain grown to early- or late-exponential phase. In both growth 
phases, tnpA expression was reduced ~2.5-fold in the IS200 knock-out strain, and this 
correlated with a 2-fold increase in invF expression in early-exponential phase and a 1.5-
fold increase in invF expression in late-exponential phase (Figure 5.6). The smaller effect 
of reduced tnpA expression on invF in late-exponential phase is consistent with the above 
results where invF is present at an excess to tnpA in this growth phase. This experiment 
provides strong evidence that IS200 elements play an important role in controlling invF 
expression in S. Typhimurium. 
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Figure 5.6. Reducing IS200 copy-number increases invF expression. 
RT-qPCR was performed on WT SL1344 and a derivative in which 4 of 7 copies of 
IS200 were deleted (DtnpA_2/4/6/7). RNA was isolated from cells grown to early- or 
late-exponential phase. Expression of each gene was normalized to the WT strain grown 
to early-exponential phase. Error bar show the standard error on the mean (n = 4). 
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5.2.4 Direct interaction between tnpA and invF 
We first used IntaRNA (Wright et al, 2014) to find predicted base-pairing interactions 
between the 5’end of tnpA and invF, and identified a single extended region of 
complementarity between the first 63nt of tnpA and an interval 104-160 nts upstream of 
the start codon on invF (Figure 5.7A). This predicted interaction fits with the above data 
showing that the first 50nt of tnpA is sufficient for repressing invF, and supports tnpA-90 
or -110 acting as an sRNA. We used a gel shift assay to determine if tnpA and the 5’end 
of invF can base-pair in vitro. As the reported transcription start site (+1, TSS) for invF is 
132nt upstream of the start codon (in the centre of the predicted pairing region) (Kroger 
et al, 2012), we elected to start the in vitro transcript for invF at this position. We 
observed a modest shift in 32P-labeled invF upon incubation with increasing 
concentrations of unlabeled tnpA (first 173 nts) (Figure 5.7B, lanes 1-4). Importantly, a 
complex of the same mobility formed when 32P-labeled tnpA was incubated with 
unlabeled invF (lanes 5-8). To determine the specificity of tnpA:invF pairing, we assayed 
the ability of a previously characterized mutant form of tnpA (tnpALS, (Ellis et al, 2015a)) 
to pair with invF; pairing was mostly lost as a consequence of the LS mutations to tnpA 
(lanes 9-11).  
 We next used Pb2+ footprinting to define the region on invF that base-pairs with 
tnpA.  5’32P-labeled invF was incubated with a 5- or 10-fold excess of tnpA (WT or LS) 
before the addition of Pb(II)-acetate. The most substantial region of pairing was a 7nt 
interval located 17-23 nts after the invF TSS (lanes 3-5, Figure 5.7C; red letters, Figure 
5.7A). Importantly, pairing was lost when tnpALS was incubated with invF (cf. lane 3 to 
7), consistent with the gel-shift assay. Interestingly, this region of invF is predicted to 
base-pair with nts 12-19 of tnpA, which is the location of the ‘A’ processing site on tnpA 
(Figure 5.3). Accordingly, processing at nt 19 of tnpA would eliminate the seed sequence 
for the interaction with invF.   There was a second region of protection at nts 34-35 on 
invF, and similar to the main binding site this protection was absent with tnpALS.  
 To test if this interaction occurs in vivo, we introduced mutations into the 
tnpA_7::kan-pTet construct (T1 mutations) that prevent base-pairing with nts 17-23 of 
invF (Supplemental Figure S5). We performed RT-qPCR on RNA extracted from  
239 
 
 
Figure 5.7. Evidence for a base-pairing interactions between invF and tnpA. 
(A) Predicted pairing interaction between the first 63 nt of tnpA and a region of invF 104-
160 nts upstream of the start codon. Note that the main transcription start site (TSS, +1) 
for invF is 132 nts upstream of the start codon. invF nucleotides involved in pairing with 
tnpA are indicated in red; tnpA LS and T1 mutations are shown in bold. (B) Pairing 
between tnpA and invF was measured by EMSA. 32P-labeled invF (-132 to +66 relative to 
the start codon) or tnpA (-103 to +71 relative to the start codon) was incubated with 
increasing concentrations of unlabeled tnpA or invF respectively (labeled RNA, 2.4 nM; 
unlabeled RNA 24, 120, 240 nM) and pairing reactions were analyzed by native PAGE. 
A mutant form of tnpA (tnpALS) was also included in this experiment. Certain lanes have 
been removed from one gel for clarity (vertical white line separating lanes 8 and 9). 
Reactions containing only the labeled RNA (lanes 1, 5, and 9) are indicated with ‘-‘. (C) 
Pb2+ footprinting was used to analyze base-pairing between 5’32P-labeled invF (70 nM) 
and unlabed tnpAWT or tnpALS (same transcripts as in B). An RNase T1 sequencing 
reaction (G, lane 1) was used to assign positions of lead sensitivity (numbers relative to 
the 5’end), and an untreated RNA control (UT, lane 2) is shown. Red bars to the right of 
the gel image highlight tnpAWT-dependent protections on invF. (D) RT-qPCR from RNA 
isolated from the indicated SL1344 strains grown to late-exponential phase (OD600 = 1.4). 
Error bars show standard error on the mean (n = 4). 
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SL1344 WT, tnpA_7::kan-pTet, and tnpA_7::kan-pTet-T1 strains grown to late-
exponential phase. Overexpression of the WT tnpA reduced invF and sicA levels 3.5- and 
2-fold respectively, while the T1 mutant form of tnpA did not affect either of these 
transcripts (Figure 5.7D). Due to the complex transcriptional regulation of invF and the 
location of the pairing region (~20 nts downstream of the TSS) we have not introduced 
compensatory mutations to invF. However, this experiment showed that the effect of 
tnpA on SPI-1 expression is sequence specific; combined with our in vitro pairing 
experiments, the above data strongly suggests that the 5’ends of tnpA and invF base-pair, 
the consequence of which is reduced invF mRNA levels. 
 
5.3 Discussion 
In the current work we asked if IS200 encoded transcripts affect gene expression in S. 
Typhimurium.  IS200 is an unusual transposon in that it is often present in high copy-
number in many Salmonella and Yersinia spp. but the transposon itself is almost 
completely dormant. The low transposition frequency of IS200 can be explained by close 
to no synthesis of the TnpA protein (Ellis et al, 2015a). However, the IS200 transposase 
mRNA (tnpA) is expressed at a moderate level in S. Typhimurium, resulting in a paradox 
where this transposon has evolved to maintain transcription of the transposase mRNA but 
essentially no translation of the protein. Here we provide an explanation for this paradox 
by demonstrating that overexpression of tnpA alters the expression of at least 73 genes in 
S. Typhimurium, including many genes involved in pathogenesis. We provide evidence 
that tnpA is processed to produce a small regulatory RNA that inhibits expression of the 
SPI-1 encoded transcription factor invF by a base-pairing mechanism. 
5.3.1 Ribonucleolytic processing of tnpA mRNA generates an sRNA 
regulator of invF expression 
We began the current study by profiling the effect of tnpA overexpression on gene 
expression in S. Typhimurium. In this experiment we observed strong repression (>2-
fold) of 73 genes, 8 of which (sipC, sipA, sseA, sseL, sigE, sopB, sicA, sipB) are involved 
in pathogenesis. Although tnpA overexpression also represses art200 expression, four of 
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these virulence genes (sicA, sipB, sipC, and sopB) were repressed by a tnpA mutant that is 
unable to down-regulate art200. As tnpA is almost never translated, we speculated that all 
or part of tnpA may act as a non-coding RNA to regulate gene expression in S. 
Typhimurium. 
It is now clear that untranslated regions of mRNAs serve as a rich reservoir of 
sRNAs. As we had observed an effect from overexpressing the 5’portion of tnpA, we 
asked if IS200 expresses a 5’UTR derived sRNA. The typical 5’UTR derived sRNA 
(5’sRNA) is transcribed from the same promoter as an mRNA and transcription 
terminates at an intrinsic terminator upstream of the coding sequence for the mRNA 
(Hershko-Shalev et al, 2016; Loh et al, 2009; Vogel et al, 2003). Although most 5’sRNAs 
terminate at an intrinsic terminator, post-transcriptional processing occurs for several 
previously described 5’sRNAs (Bilusic et al, 2014; Papenfort et al, 2015; Vogel et al, 
2003). Indeed, our primer extension and Northern analysis revealed that the 5’end of 
tnpA contains two processing sites which produce a ~110nt RNA initiating at the tnpA 
promoter and ending at nt 108 (tnpA-110), and a ~90nt species (tnpA-90) that is likely 
generated by processing at nt 19 of tnpA-110. Similar to Type II 3’UTR derived sRNAs , 
the tnpA sRNA is likely a stable processing intermediate of tnpA, whereby the biogenesis 
of the tnpA sRNA comes as a consequence of ribonucleolytic degradation of an mRNA 
(Miyakoshi et al, 2015b). Evidence for the instability of tnpA 3’ of processing sites comes 
from the relatively small amount of these downstream products detected by primer 
extension. At this point we have not identified the ribonuclease responsible for 
ribonucleolytic processing of tnpA but we predict that RNase III and/or RNase E would 
be involved based on sequence and structural elements at both processing sites. Future 
work will investigate the precise mechanism of endoribonucleolytic processing of tnpA 
including the potential involvement of art200 in generating tnpA-110 and -90. 
 We found that only the first 50nt of tnpA is required for repressing invF and 
sicAsipBC expression which fits fully with either tnpA-110 or -90 acting as a trans-acting 
sRNA. Mutations to nt 12-19 on tnpA (tnpAT1) prevent pairing with invF in vitro, and 
repression of invF in vivo. Since tnpA-90 lacks the first 19nt, our data points to tnpA-110 
as the active tnpA-derived sRNA, and tnpA-90 as an inactivated form of tnpA-110. The 
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second processing event at nt 19 on tnpA would therefore represent a point of regulation 
in tnpA mediated repression of invF, and ongoing work will address this.  
 While the current work presents the first example of a bacterial transposon 
producing a trans-acting sRNA, there are two recent examples of transposase derived 
sRNAs in archaea. The Sulfolobus solfataricus sRNA RNA-257 shares substantial 
homology with the 3’UTR of the ISC1904 transposase, ORF1182. RNA-257 is believed 
to be a remnant of transposition reactions, and this sRNA base-pairs with ORF1183, 
which encodes a putative phosphate transporter. Similar to tnpA-invF, base-pairing 
between RNA-257 and ORF1183 results in degradation of the mRNA (Martens et al, 
2013). In Halobacterium salinarum, the IS1341 transposase, tnpB, expresses more than 
10 different sRNAs, one of which regulates growth rate by an undetermined mechanism 
(Gomes-Filho et al, 2015).  
It is perhaps surprising that neither tnpA-110 or -90 have been detected in 
previous work identifying sRNAs in S. Typhimurium (Chao et al, 2012; Kroger et al, 
2012; Sittka et al, 2008). However, a standard practice in mapping RNA-Seq reads to the 
reference genome is to omit non-unique reads, and the presence of 7 identical copies of 
IS200 in SL1344 would result in reads derived from tnpA being overlooked. Ambiguity 
in mapping short reads to multi-copy genes (e.g. many ribosomal proteins) is one 
limitation to many pipelines for analyzing next-generation sequencing data. Additionally, 
we found that the most abundant molecule of tnpA in WT SL1344 is tnpA-90. Since this 
molecule is processed and possesses a 5’monophosphate, it would be eliminated in 
protocols designed for dRNA-Seq (e.g. (Kroger et al, 2012)). However, we note that tnpA 
is enriched up to 4.1-fold in Hfq-CoIP experiments (Chao et al, 2012), and the previously 
characterized Hfq-binding site on tnpA (nts 68-83; (Ellis et al, 2015a)) would be present 
in both tnpA-110 and -90. We have not yet investigated the role of Hfq in tnpA-invF 
pairing, in part due to the complications of dysregulated SPI-1 expression (destabilized 
hilD) (López-Garrido et al, 2014) in an hfq-null strain.  
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5.3.2 Regulatory cross-talk between horizontally acquired genes and 
the S. Typhimurium core genome 
Salmonella Typhimurium contains a mosaic genome consisting of a core genome 
complemented with a number of horizontally acquired genetic elements. The core 
genome is highly conserved amongst Enterobacteriaceae and contains all of the genes 
required for normal cellular processes. The accessory or ‘flexible’ genome is made up of 
a number of horizontally acquired genes including pathogenicity islands, prophage, 
plasmids, and transposons. This flexible genome has been acquired over evolutionary 
time and provides most of the genes required for virulence (Desai et al, 2013). 
Horizontally acquired genes become integrated into host regulatory networks whereby 
components of the core genome regulate horizontally acquired genes and the core 
genome itself can be regulated by members of the accessory genome (Lercher & Pál, 
2008). In S. Typhimurium, the core genome encoded sRNA SgrS represses expression of 
the SPI-1 effector sopD (Papenfort et al, 2012), while the SPI-1 encoded sRNA InvR 
represses expression of the core genome encoded ompD (Pfeiffer et al, 2007). In 
enterohaemorrhagic E. coli, a bacteriophage encoded sRNA, AgvB, represses the core 
genome encoded sRNA GcvB, thereby increasing expression of many genes involved in 
amino acid transport (Tree et al, 2014). In the current work we provide evidence of cross-
talk between members of the accessory genome, where a transposon derived sRNA 
controls expression of part of the SPI-1 T3SS by repressing expression of InvF. 
Activation of SPI-1 is controlled by a complex network of transcriptional, post-
transcriptional, and post-translational regulation (Altier, 2005; Ellermeier & Slauch, 
2007). Environmental signals including low oxygen and high osmolarity first converge to 
activate transcription of hilD. HilD, HilC, and RtsA then participate in a feed-forward 
loop that converges on activation of hilA, which in turn activates transcription of 
structural components of the needle complex (prg/org) as well as invF, which is a 
transcriptional activator of secreted effector proteins (sic/sip and others) (Figure 5.8). In 
the current work we have identified a new component of this complex regulation: a 
processed form of tnpA represses invF expression in a growth phase dependent manner. 
We propose that similar to recently identified sRNA ‘sponges’ (Figueroa-Bossi et al, 
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2009; Lalaouna et al, 2015; Miyakoshi et al, 2015a; Tree et al, 2014), tnpA sets a 
threshold for activation of invF.   
Expression of virulence genes has an extreme fitness cost for many bacteria 
including S. Typhimurium, Y. pestis, and Shigella flexneri (Ali et al, 2014; Schuch & 
Maurelli, 1997; Sturm et al, 2011).  For example, single cell analyses revealed that SPI-1 
induction dramatically retarded growth and this growth defect was abrogated by deleting 
the sic/sip locus (Sturm et al, 2011). As the sicA promoter has the longest relaxation time 
for SPI-1 encoded genes (Temme et al, 2008), induction of sic/sip by InvF represents a 
key commitment step to virulence and the associated burden of producing effector 
proteins. We propose a model where repression of invF by tnpA sets a threshold for invF 
induction that must be passed to induce expression of virulence factors (Figure 5.8). 
Evidence for this comes from two key experiments. First, when we profiled SPI-1 
expression over growth we noted that (i) tnpA was expressed higher than invF in lag and 
early-exponential phase, and (ii) overexpression of tnpA did not affect invF expression in 
these two growth phases (Figure 5.5). Second, reducing tnpA expression two-fold in 
early-exponential phase increased invF expression >2-fold, while the same reduction in 
tnpA expression in late-exponential phase resulted in only a 1.4-fold increase in invF 
(Figure 5.6). This threshold for activation would ensure that InvF is only made once there 
is a sufficiently high transcriptional activation of the invF promoter by HilA. A similar 
threshold for activation occurs for activation of both hilD and hilA (Saini et al, 2010; 
Temme et al, 2008). In the case of HilD, post-translational repression by HilE dampens 
hilD activation, and H-NS repression of hilA counteracts transcriptional activation by 
HilD, HilC, and RtsA (Olekhnovich & Kadner, 2006). An additional role of tnpA may be 
to prevent leaky expression of invF, particularly HilC-dependent activation of the 
alternative promoter for invF (pinvF-2, Figure 8) (Akbar et al, 2003; Lim et al, 2012). 
While hilD, rtsA, and hilA are strongly repressed prior to induction, hilC is expressed at a 
basal level and expression has minor fluctuations independent of hilD (Sturm et al, 2011). 
As the predicted tnpA-invF base-pairing interaction extends 30 nt upstream of the HilA-
dependent TSS for invF, the HilC-dependent invF transcript may be subject to even 
stronger repression by tnpA.  
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Figure 5.8. Model for role of tnpA in regulating SPI-1 gene expression. 
Environmental signals activate transcription of hilD, which activates a feed-forward loop 
that converges on activation of hilA. HilA is a transcriptional activator of components of 
the needle complex (prg/org) as well as invF, a transcriptional activator of SPI-1 effector 
proteins (sic/sip and other genes). A processed form of tnpA (tnpA-110) base-pairs with 
invF mRNA and inhibits InvF expression. Processing of tnpA-110 to tnpA-90 would 
inactivate tnpA and prevent repression of invF. Three activation checkpoints for SPI-1 
gene expression are indicated with dashed boxes. 
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5.3.3 Bacterial transposons as a source of regulatory RNA 
Our initial goal for the current work was to determine if any IS200 encoded RNAs affect 
gene expression in S. Typhimurium. Our transcriptomics experiment identified at least 73 
genes that are dysregulated by tnpA overexpression. We have investigated how tnpA 
impacts on expression of three of these genes (sicA, sipB, and sipC) and our data is 
consistent with an indirect mechanism where tnpA acts through invF to control sicAsipBC 
expression. We believe that the effect of tnpA on many of the other genes identified here 
will likewise be indirect, and mediated through a smaller number of direct targets. 
Regardless of the mechanism by which tnpA regulates gene expression in S. 
Typhimurium, we have identified a new way that bacterial transposons can ensure 
survival: contributing a regulatory RNA. The dual use of a promoter for mRNA and 
sRNA would ensure that transcription of the transposase is maintained, and post-
transcriptional regulation of TnpA expression protects against detrimental effects of 
transposition. 
It is now clear that bacterial sRNAs can be derived from unexpected places. 
Transposons likely represent an unexplored reservoir of regulatory RNAs that could 
ultimately provide a benefit to the host organism.  
 
5.4 Materials and Methods 
5.4.1 Growth conditions, strains, and plasmids 
Unless otherwise stated, Salmonella was grown at 37°C with shaking in Lennox Broth 
(LB; 5 g/L NaCl, 10 g/L tryptone, 5 g/L yeast extract). For experiments where RNA was 
extracted at multiple time-points, overnight cultures were diluted once (1:100 into 7 or 25 
mL) and aliquoted (2 mL) into separate culture tubes for each time point. For SPI-1 
inducing conditions, cells were grown as previously described (Sittka et al, 2008). For 
SPI-2 inducing conditions, cells were grown overnight in LB and diluted 1:100 into 
acidic low-phosphate, low-magnesium (LPM) media (80 mM MES pH 5.8, 5 mM KCl, 
7.5 mM (NH4)2SO4, 0.5 mM K2SO4, 38 mM glycerol, 0.1% casamino acids [w/v], 8 µM 
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MgCl2, 337 µM KH2PO4) (Coombes et al, 2004). Where appropriate, antibiotics were 
used at the following concentrations: tetracycline, 15 µg/mL; chloramphenicol, 20 
µg/mL; kanamycin, 25 µg/mL; streptomycin, 150 µg/mL. For experiments with marked 
alleles, selection was only used in the overnight culture.  
All strains and plasmids used in this study are listed in Table S5.1 and oligonucleotides 
are listed in Table S5.2. S. Typhimurium str. LT2 or SL1344 were considered wild-type 
strains, and derivative strains were made in the SL1344 background. E. coli DH5a was 
used for routine cloning and plasmid propagation.  
 Mutant strains of SL1344 were constructed by Lambda Red recombineering 
(Datsenko & Wanner, 2000) and all mutations were checked by colony PCR. DBH401 
(DtnpA_2/4/6/7) was constructed by transducing individual IS200 knockout alleles into a 
single strain. DBH393 and related strains were created by inserting a kan-pTet cassette in 
front of tnpA_7 such that the Tet promoter is driving transcription of tnpA (tnpA_7::kan-
pTet). Further details of strain and plasmid construction are provided in Supplementary 
Material.  
5.4.2 RNA isolation, Northern blot, and primer extension 
Total RNA was prepared by the hot acid phenol method (Aiba et al, 1981). Northern 
blots were performed as previously described (Ellis et al, 2015b) using 5 or 10 µg of total 
RNA and 5’32P-labeled oligonucleotide probes (oDH428 tnpA; oDH427, art200) or a 
uniformly 32P-labeled riboprobe (5S rRNA, generated with oDH234 and oDH235; art200, 
generated with oDH450 and oDH394). Primer extension was performed as previously 
described (Ellis et al, 2015a) using 9 µg of total RNA and primers oDH428 or oDH394. 
Processed RNA was eliminated by TEX (Epicentre) treatment according to the 
manufacturer’s instructions.  
5.4.3 RNA-Seq and data analysis 
S. Typhimurium LT2 was transformed with pDH900 (empty vector), pDH899 (pTet-
tnpAtruncWT-255), or pDH914 (pTet-tnpAtruncM1-255). Two colonies from each 
transformation were each used to inoculate 1 mL of LB-Luria (0.5 g/L NaCl, 10 g/L 
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tryptone, 5 g/L yeast extract) with tetracycline and were grown for 8 hr. Precultures were 
subcultured 1:100 into LB-Luria and grown for 16 hr. Total RNA was isolated and 
treated with TURBO DNase (Ambion) to remove residual genomic DNA and submitted 
to the London Regional Genomic Centre for library preparation and sequencing. Libraries 
were prepared with the Ribo-Zero (Gram-Negative Bacteria) (Epicentre) and ScriptSeq 
v2  (Epicentre) kits. The six libraries (2 biological replicates from each plasmid) were 
pooled and sequenced with 50 cycles on an Illumina MiSeq. Reads were aligned to the S. 
Typhimurium LT2 genome (NC_003197) with Rockhopper (McClure et al, 2013) and 
differential expression was analyzed using ALDEx2 (Fernandes et al, 2014). More detail 
on data analysis is provided in Supplemental Materials and Methods. Excel files 
containing RNA-Sequencing reads and ALDEx2 analysis are available as a supplement 
to this thesis through the Western University Electronic Thesis and Dissertation Thesis 
Depository. 
5.4.4 Reverse transcription quantitative polymerase chain reaction 
(RT-qPCR) 
DNase treated RNA (2 µg) was converted to cDNA with the High-Capacity cDNA 
Reverse Transcription Kid (Applied Biosystems); cDNA was diluted to 30 ng/µL in TE 
(50 mM Tris-HCl, pH 8.0, 1 mM EDTA) and stored at -20°C.  A minimum of 3 
biological replicates were analyzed in technical triplicate in each experiment and the 16S 
rRNA (rrsA) was used as a reference gene for relative quantitation. Reactions (20 µL) 
contained 10 ng of cDNA, 500 nM of each primer (Table S5.5), and PowerUP SYBR 
Green Master Mix (Applied Biosystems). Standard settings on the ViiA 7 Real-Time 
PCR System were used except for the anneal/extension step, which was performed at 
60.5°C. Relative expression of each target was calculated by the efficiency corrected 
method (Pfaffl, 2001). The amplification efficiency was determined for tnpA (2.20), thrS 
(2.04), rrsA (2.00), invF (2.12), sipB (2.03), sipC (2.01), and sicA (2.00); an efficiency of 
2.0 was used for all other primer pairs. 
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5.4.5 Western Blot 
DBH388 (invF::3X-FLAG-kan) transformed with pDH900 (empty vector), pDH960 
(pTet-tnpAtrunc-50), or pDH962 (pTet-tnpAtrunc-200) was grown to OD600 = 0.5 and cells 
from 1 mL of culture was collected by centrifugation. For the experiment comparing 
DBH388 to DBH398 (invF::3X-FLAG-kan tnpA_7::kan-pTet), the volume of culture was 
adjusted so that an equivalent of 0.5 OD were harvested. The cell pellet was resuspended 
in 200 µL of SDS sample buffer (60 mM Tris-HCl, pH 6.8, 2% SDS [w/v], 0.01% 
bromophenol blue [w/v], 1% b-mercaptoethanol [v/v]) and boiled for 5 mins. Samples 
(10 µL) were resolved on 10% polyacrylamide gels and electroblotted to a PVDF 
membrane. Membranes were incubated in 5% milk overnight with primary antibody 
(1:5000 dilution: mouse a-FLAG M2, Sigma; rabbit a-GroES, Sigma; mouse a-DnaK, 
Enzo), followed by incubation with a 1:5000 dilution of secondary antibody (a-mouse-
HRP or a-rabbit-HRP, Promega). Blots were developed with a Pierce ECL 2 Western 
blotting substrate and a STORM scanner. Membranes were stripped and re-probed for 
loading controls (GroES/DnaK). Bands were quantitated in ImageQuant and the amount 
of InvF-3xFLAG was normalized to the internal standard (GroES/DnaK) and then the 
control strain (empty vector or DBH388). 
5.4.6 Electrophoretic Mobility Shift Assay (EMSA) and Lead 
Footprinting 
In vitro pairing experiments were performed as previously described (Ellis et al, 2015a; 
Ross et al, 2013) except that the RNAs were mixed prior to denaturation.  
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5.5 Supplemental Material 
5.5.1 Supplemental Materials and Methods 
5.5.1.1 Strain and plasmid construction 
DBH370 (SL1344 DhilA::FRT) was created using pKD4 as a template with primers 
oDH725 and oDH726, and the kanamycin resistance gene was removed by transforming 
the recombineered strain with pCP20 (a temperature sensitive plasmid expressing FLP 
recombinase). DBH393 and DBH401 (tnpA_7::kan-pTet and tnpA_7::kan-pTet-T1) were 
made using pKD4 as a template with one primer containing the pTet promoter and 
homology to the left end of IS200 (oDH755 or oDH760) and a primer with homology to 
sequence upstream of tnpA_7 (SL1344_RS179555) (oDH754). The resulting strains have 
the pTet promoter driving constitutive transcription of the full-length tnpA mRNA 
initiating at nucleotide 46 of IS200 and an upstream kanamycin resistance gene expressed 
in the opposing direction (see Figure S5.3B). DBH398 was made by first constructing a 
strain identical to DBH393 except using pKD3 as a template. The invF::3X-FLAG-kan 
allele from DBH388 was then introduced to this strain by P22 transduction. 
The IS200 knock-out strain was constructed by sequential P22 transduction of one 
strain with individual IS200 deletions. First, a pool of IS200 deletions was made by 
constructing a universal IS200 knock-out cassette (able to target any of the 7 identical 
copies of IS200 in SL1344) using either pKD4 (kanR cassette) or pKD3 (cmR cassette) 
with primers oDH613 and oDH614. Individual colonies from both the kanR and cmR pool 
were screened by PCR to determine which copy of IS200 was disrupted. Next, P22 (HT-
105/int-201) transduction was used to move two marked alleles (DtnpA_2::cm, 
SL1344_RS06060; DtnpA_7::kan, SL1344_RS17955) sequentially to DBH347 (WT 
SL1344). After purification of transductants on EBU plates (10 g/L tryptone, 5 g/L yeast 
extract, 5 g/L NaCL, 0.25% glucose [w/v], 5 mM K2HPO4, 0.00125% Evans Blue [w/v], 
0.0025% uranine [w/v], 15 g/L agar), colonies were cross-streaked against P22 H5 to 
select phage-sensitive colonies. Both selectable markers were removed by transforming 
the strain with pCP20 and both alleles were checked by colony PCR. P22 transduction 
was then repeated to move DtnpA_6::cm (SL1344_RS17020) and DtnpA_4::kan 
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(SL1344_RS09790) to create DBH400 (SL1344 DtnpA_2::FRT DtnpA_7::FRT 
DtnpA_6::cm DtnpA_4::kan).  
Plasmids overexpressing truncated forms of tnpA were modified from the 
pACYC184-derived pDH899 (pTet-tnpAtruncWT-255) (Ellis et al, 2015a). A PCR product 
amplified from DBH199 (WT LT2) genomic DNA with oDH531 and oDH746 (pTet-
tnpAtrunc-50), oDH743 (pTet-tnpAtrunc-200), or oDH742 (pTet-tnpAtrunk-250) was digested 
with EcoRI and cloned into the same site of pACYC184. 
5.5.1.2 RNA-Seq Data Analysis 
Transcripts predicted by Rockhopper were manually annotated with the genomic interval 
and whether it was intergenic (predicted RNA, e.g. 4824999-4825049_predicted RNA) or 
intragenic (antisense, e.g. 1906043-1906092_antisense: fadR) prior to expression 
analysis. 
 Differential expression was analyzed using ALDEx2 version 1.0.0 (Fernandes et 
al, 2014) which is a tool for analyzing the compositional nature of high-throughput 
sequencing data. Since ALDEx2 compares two conditions this analysis was performed on 
each pairwise comparison (i.e. Vector vs pTet-tnpAtruncWT-255, Vector vs pTet-
tnpAtruncM1-255, pTet-tnpAtruncWT-255 vs pTet-tnpAtruncM1-255). Briefly, the relative 
expression (abundance) of each gene within a sample was calculated as the median 
centered log-ratio (clr) from 1000 Monte-Carlo Dirichlet instances. The ALDEx2 effect 
size is then calculated for each feature as the median log2 difference between conditions 
(i.e. strains) divided by the maximum difference within a condition (i.e. difference in 
relative abundance between biological replicates). Accordingly, the effect size is a 
measure of the confidence one has in the difference in expression for a gene between two 
conditions, but does not necessarily inform on the magnitude of the difference. An effect 
size of 2 means that the difference between conditions (i.e. log2 fold-change between two 
strains) is twice as large as the greater difference within a condition (variance between 
biological replicates). We took a more conservative approach for considering genes 
differentially expressed and used an effect size of 2 as the cutoff for differential 
expression. 
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5.5.2 Supplemental Tables and Figures 
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Table S 5.1. Strains and plasmids for Chapter 5. 
 Relevant Genotype/ Description Reference/source 
S. 
Typhimurium 
  
DBH199 Wild-type LT2, StrR Miguel Valvano 
DBH347 Wild-type SL1344, StrR Salmonella Genetic 
Stock Centre 
(SGSC438) 
DBH370 DBH347 DhilA::FRT, StrR This Study 
DBH388 JVS-2325 (SL1344 invF::3X-FLAG-kan), 
StrRKanR 
Jörg Vogel 
DBH393 DBH347 tnpA_7::pTet-kan, StrRKanR This Study 
DBH398 DBH347 tnpA_7::pTet-cm invF::3X-FLAG-
kan, StrRKanRCmR 
This Study 
DBH400 DBH347 DtnpA_2::FRT DtnpA_7::FRT 
DtnpA_6::cm DtnpA_4::kan 
This Study 
DBH401 DBH347 tnpA_7::pTet-kan-T1 StrRKanR This Study 
   
Plasmids   
pDH739 pCP20, temperature sensitive FLP expression 
plasmid, ApRCmR 
(Datsenko & Wanner, 
2000) 
pDH740 pKD46, temperature sensitive Lamda Red 
expression plasmid, ApR 
(Datsenko & Wanner, 
2000) 
pDH742 pKD4, kanamycin cassette for Lambda Red 
recombineering, ApRKnR 
(Datsenko & Wanner, 
2000) 
pDH743 pKD3, chloramphenicol cassette for Lambda 
Red recombineering, ApRCmR 
(Datsenko & Wanner, 
2000) 
pDH899 pACYC184-derived plasmid expressing 
tnpAtruncWT-255 from the pTet promoter, 
CmSTetR 
(Ellis et al, 2015a) 
pDH900 pACYC184-derived empty vector control, 
CmSTetR 
(Ellis et al, 2015a) 
pDH914 pACYC184-derived plasmid expressing 
tnpAtruncM1-255 from the pTet promoter, 
CmSTetR 
(Ellis et al, 2015a) 
pDH960 pACYC184-derived plasmid expressing 
tnpAtrunc-50 from the pTet promoter, CmSTetR 
This Study 
pDH962 pACYC184-derived plasmid expressing 
tnpAtrunc-200 from the pTet promoter, 
CmSTetR 
This Study 
pDH963 pACYC184-derived plasmid expressing 
tnpAtrunc-250 from the pTet promoter, 
CmSTetR 
This Study 
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Table S 5.2. List of oligonucleotides for Chapter 5. 
Name Sequence (5’ to 3’) Description/Use 
Strain and 
Plasmid 
Construction 
  
oDH725 TATAACTTTTCACCCTGTAAGAGAATACACTAT
TATCATGGTGTAGGCTGGAGCTGCTTC 
Amplifying kan-cassette 
from pKD4, hilA deletion 
(DBH370) oDH726 TCTCCTCTCTCAGATTTTACCGTAATTTAATCA
AGCGGGGCATATGAATATCCTCCTTAG 
oDH727 GCACCAGGATATACGGCAGCGTCC Checking hilA locus 
oDH728 GGCGCCAGGTTTCATCGCCG 
oDH754 TACCAGGGGATATGATTTAAAAAGGCCGCTTAA
TAATAAGCCATATGAATATCCTCCTTA 
Amplifying kan-cassette 
from pKD4, 
tnpA_7::kan-pTet strain 
(DBH393, DBH398) 
oDH755 TAACAAATCAAAAGGGGTTTTAATAACTGGCTT
AAAGCTGACTACCGCATTAAAGCTTATCGATGA
TAAGCTGTCAACATGAGAATTCTTGTGTAGGCT
GGAGCTGCTTC 
oDH613 TGTCTATGGAAAACCCCCAGCTAGGCTGGGGGT
TCCGGAAGTGTAGGCTGGAGCTGCTTC 
Amplifying kan-cassette 
from pKD3/4, 
DIS200::cm/kan 
(DBH400) 
oDH614 CATGTGAATATGATCTGCACAACATTCTGCTTC
CAGCATATGAATACCTCCTTA 
oDH760 CAGACCGCAAGATGTTTTAACAAATCAAAAGGG
GTTTTAAATTGACCATTAAAGCTGACTACCGCA
TTAAAGC 
Amplifying kan-cassette 
from pKD4, 
tnpA_7::kan-pTet-T1 
(DBH401) 
oDH615 GACGTATGACTTCCAGAGTGC Checking tnpA_1 locus 
(SL1344_RS04595) oDH616 GCCTTATCCGCCTACCGC 
oDH617 GGAGCTGACGGCTAAGCGG Checking tnpA_2 locus 
(SL1344_RS06060) oDH618 CCGCATCATCAATAAACGTC 
oDH619 CGACGAGAACTGCGTGACG Checking tnpA_3 locus 
(SL1344_RS09075) oDH620 CTAAAGCAATAGCCGGACATG 
oDH543 TATAGTTTTCACTCCCGCAGCC Checking tnpA_4 locus 
(SL1344_RS09790) oDH544 CCTGCGTTAAATGAGTTATCGG 
oDH623 CGTATCGTGAATATGGTGGC Checking tnpA_5 locus 
(SL1344_RS12685) oDH624 TTGTGCATAGTACAGATT 
oDH625 GCAACACGATGTCAGAGC Checking tnpA_6 locus 
(SL1344_RS17020) oDH626 CGTTCAGGATCCCCATAACATG 
oDH627 GTACGATAGCAATTAATGAATC Checking tnpA_7 locus 
(SL1344_RS17955) oDH628 GCTACATCTGGATGCCTACC 
oDH531 AAGAATTCTCATGTTTGACAGCTTATCATCGAT
AAGCTTTAATGCGGTAGTCAGCTTTAAGCCAGT
TATTAAA 
Forward primer for pTet-
tnpAtrunc 
oDH746 TGGACGAATTCAAAAAAAACCAGCAGGTATAAT
CTGCTGGCAAGATGTTTTAACAAATCAAAAG 
Reverse primer for pTet-
tnpAtrunc-50 (pDH960) 
oDH743 TGGACGAATTCAAAAAAAACCAGCAGGTATAAT
CTGCTGGACGCTTCTCTCCATAGAACGC 
Reverse primer for pTet-
tnpAtrunc-200 (pDH962) 
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oDH742 TGGACGAATTCAAAAAAAACCAGCAGGTATAAT
CTGCTGGCGTACGTTTTTCCATTCACAC 
Reverse primer for pTet-
tnpAtrunc-250 (pDH963) 
   
Northern blot 
and in vitro 
transcription 
  
oDH428 GTTGCCAGACCGCAAGATG Probe for tnpA 
oDH427 CATCTTGCGGTCTGGCAAC Probe for art200 
oDH234 TAATACGACTCACTATAGGCCTGGCAGTTCCCT
ACTCTCG 
ITR template for 5S 
rRNA Northern probe 
oDH235 CGGCAGTAGCGCGGTG 
oDH450 TAATACGACTCACTATAGGCTTTCAGCTTTAAG
CCAG 
 
Forward primer for 
tnpAWT/LS ITR template, 
contains T7 promoter 
sequence 
oDH394 TATTTGGGCGCGAAAACTATG Reverse primer for tnpA 
ITR template 
oDH749 TAATACGACTCACTATAGGGTATTAAAATGATT
TTTAACTGGTGC 
Forward primer for 
invFWT ITR template, 
contains T7 promoter 
sequence 
oDH750 GCAAAAAAGCAGCGCGCCTTCCTG Reverse primer for invF 
ITR template 
RT-qPCR 
oDH704 TTCAGTTGGCATACTGCCGC sicA 
oDH705 GAAGGCGCCACGCTAAAAGA 
oDH706 TGAGACAGCGAAACATCGCC sipB 
oDH707 GGAACAAAGTCCGGCGAGAG 
oDH702 TGCCGTCGTTTTAGCTGCAT sipC 
oDH703 AAACCCAGTTACGCGAGCAG 
oDH661 TCTGGGAAACTGCCTGATGGAGG rrsA (16S rRNA) 
oDH662 CGTAGGAGTCTGGACCGTGTCTC 
oDH686 TCACTCTTGTGCGCATCTGT thrS 
oDH687 TGCGGTCAAGATCAACGTCA 
oDH710 GGTCTCCTGATACTGGTGCG invF 
oDH711 AGCCCGGAAGCATGGTTTAT 
oDH394 TATTTGGGCGCGAAAACTATG tnpA 
oDH428 GTTGCCAGACCGCAAGATG 
oDH764 GCCAGCTGCGGATAATAGGT prgH 
oDH765 TGTCGCTGCGCAAAATGAAA 
 
 
 
256 
 
 
Figure S 5.1. Growth phase dependent regulation of art200 and art200 knockdown 
by tnpAtrunc overexpression. 
(A) An overnight culture of wild-type SL1344 (DBH347) was subcultured 1:100 into 
Lennox broth and grown for 7.5hrs with shaking. The absorbance at 600 nm (OD600) of 2 
mL aliquots of culture was measured regularly over this period. RNA was extracted from 
cells grown to early-exponential (OD600=0.2), mid-exponential (OD600=0.5), late-
exponential (OD600=1.2), early-stationary (OD600=2.0) and 2 or 4h after cells reached 
stationary phase (2.0+2h and 2.0+4h). Cells were also subcultured into SPI-2 inducing 
media (LPM salts, pH 5.8) or grown overnight under SPI-1 inducing conditions 
(overnight growth in a tightly sealed falcon tube containing LB with a final NaCl 
concentration of 0.3M) to an OD600 of 0.35 or 0.9 respectively. (B) Art200 levels were 
measured by Northern blot from RNA collected from the different growth conditions in 
(A). The 5S rRNA was used as a loading control. (C) Northern blot showing the effect of 
tnpAtrunc expression on art200. S. Typhimurium LT2 was transformed with an empty 
vector (pDH900) or plasmid overexpressing tnpAtruncWT-255 (pDH899) or tnpAtruncM1-255 
(pDH914) and RNA was prepared from cultures grown to deep stationary phase.The blot 
was probed successively for art200, tnpA, and the 5S rRNA as a loading control. Note 
that these samples were ultimately used for RNA-Seq. 
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Figure S 5.2. Processing of tnpA. 
(A) Processing at site “B” generates a 5’monophosphate on tnpA105/118 molecules. RNA 
isolated from WT or tnpA_7::kan-pTet (pTet (WT)) cells was treated with 
5’monophosphate-dependent terminator exonuclease (TEX, +) or left untreated (-) and 
analyzed by primer extension using oDH394 (anneals to tnpA coding sequence). L, C, 
and A, refer to a DNA size ladder and ddNTP sequencing lanes respectively. (B) 
Secondary structure of tnpA highlighting processing sites on tnpA determined by primer 
extension (Figure 5.3). Processing at only the ‘purple’ site (nts 105, 107, 108) would 
yield the ~110nt species detected by Northern blot, while processing at the ‘red’ (nt 19) 
and ‘purple’ sites would produce the 90 nt species in the Northern blot. The sequence on 
tnpA recognized by the Northern probe is indicated in green. Numbering is relative to the 
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transcription start site of tnpA expressed from the pTet promoter. (C) Proposed 
processing pathway for tnpA. Full-length tnpA would be processed at site ‘B’ (purple) 
generating tnpA-110 and tnpA-111-? (3’end unknown). This 3’fragment is inferred to be 
unstable and presumably degraded by cellular RNases. Subsequent processing at site “A” 
on tnpA (red) generates tnpA-90, which is the most stable tnpA species. The binding sites 
for the primers used to detect tnpA in RT-qPCR experiments are shown in green. 
Accordingly, only unprocessed tnpA would be detected in these experiments. (D) 
Northern blot of RNA isolated from cells expressing various tnpAtrunc constructs from a 
plasmid. The processed forms of tnpA were detected with an oligonucleotide probe that 
anneals to the 5’UTR of tnpA (indicated in (B)). Note that the probe used for detecting 
tnpA anneals to sequence absent (tnpAtrunc-50) or mutated (tnpAtruncM1-255) in certain 
constructs, and accordingly only endogenous tnpA was detected. The membrane was 
stripped and reprobed first for art200 and then 5S rRNA as a loading control. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
259 
 
 
Figure S 5.3. Schematic of tnpA overexpression constructs used in this work. 
(A) Schematic of various tnpAtrunc constructs used in this work. The WT or M1 tnpAtrunc-
255 constructs (used in RNA-Seq) consist of the first 255 nts of tnpA fused to the 3’end 
of SgrS (nts 143-227, indicated in red). For subsequent constructs (tnpAtrunc -50, -200, -
250), only the SgrS Rho-independent transcriptional terminator was included. Numbering 
for all tnpA constructs indicates how many nucleotides of tnpA (beginning with the 
transcription start site) are included, and all constructs are expressed from the pTet 
promoter on a pACYC184-derived vector. The secondary structure of the tnpA 5’UTR 
was determined previously (Ellis et al. 2015a). (B) Schematic of the native tnpA_7 locus 
(in WT SL1344, DBH347) and kan-pTet cassette inserted to drive tnpA expression from 
the pTet promoter (DBH393 and DBH401). The 7th copy of IS200 (tnpA_7, 
SL1344_RS17955; numbering of IS200 elements is according to chromosomal co-
ordinates) is flanked by bigA and yhfL. The cassette to overexpress tnpA was amplified 
from pKD4 and includes a kanamycin resistance gene (blue) flanked by FLP recombinase 
target sites (FRT) and the pTet promoter driving expression of tnpA beginning at nt 45 of 
IS200. The end of this cassette is ~300bp away from yhfL. 
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Figure S 5.4. Growth phase dependent regulation of invF by tnpA. 
Lennox broth (2 mL) was inoculated with single colonies (4 biological replicates) of WT 
or tnpA_7::kan-pTet cells and RNA was harvested after 18 hrs (F, deep-stationary phase, 
OD600=1.80). The 18hr cultures were used to seed subcultures, and RNA was isolated 
after 1.25 hrs (B, lag-phase, OD600=0.10), 2 hrs (C, early-exponential phase, OD600=0.37), 
3hrs (D, late-exponential phase, OD600=1.28), or 4hrs (E, early-stationary phase, 
OD600=2.01). The OD600 for each time point and strain is plotted in (A), with error bars 
showing standard error on the mean. Expression of the indicated genes was measured by 
RT-qPCR; the ΔCt (relative to 16S rRNA, rrsA) is reported to compare expression 
between different genes and growth phases. Error bars show the standard error of the 
mean of 4 biological replicates, each measured in technical triplicate. 
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Figure S 5.5. The T1 mutations to tnpA disrupt base-pairing with invF in vitro. 
Lead(II) acetate footprinting was used to analyze base-pairing between 5’32P-labeled invF 
(70 nM) and unlabeled tnpAWT or tnpAT1 (700 nM; see also Figure 5.7). An RNase T1 
sequencing reaction (G) was used to assign positions of lead sensitivity (numbers relative 
to the 5’end of invF), and an untreated RNA control (UT) is shown. Red bars to the right 
of the gel image highlight tnpAWT dependent protections on invF. 
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Chapter 6 
6 General Discussion 
Mobile genetic elements such as transposons exist in a delicate relationship with the host 
organism. Transposons must mobilize at a frequency high enough to ensure survival of 
the element but below a level that would damage or kill the host cell. Bacteria tolerate 
low levels of transposition and benefit from rare transposon-induced genetic changes that 
can provide adaptive advantages and aid genome evolution, and can also directly benefit 
from transposon-encoded proteins. This balance is reached through multiple levels of 
regulation achieved by the cooperation of transposons and their bacterial hosts. Most 
transposons employ a molecular form of self-restraint where the transposon itself has 
evolved to transpose at a low frequency. This is achieved largely by poor expression of 
the transposase protein and includes low levels of transcription and inefficient translation 
initiation. Additionally, transposition reactions are inherently inefficient and transposons 
encode regulatory RNAs and/or proteins that act to inhibit transposition. The host 
organism further limits transposon activity by regulating transcription initiation as well as 
steps in transposition that occur after the transposase protein is synthesized. In general, 
the frequency of transposition is dependent on the amount of transposase protein 
synthesized and accordingly transposase expression is a major point of regulation 
(Gueguen et al, 2005; Nagy & Chandler, 2004; Siguier et al, 2014; Siguier et al, 2015). 
Given the importance of regulatory RNA in bacteria (Bouloc & Repoila, 2016; Papenfort 
& Vogel, 2014; Storz et al, 2011; Wagner & Romby, 2015), post-transcriptional 
regulation of bacterial transposase proteins could be an unappreciated wide-spread 
mechanism for host-control of transposons. In this thesis I’ve shown that the RNA-
binding protein Hfq—a core component of post-transcriptional regulation in bacteria—
regulates IS10 and IS200 transposase expression by two distinct mechanisms. The 
finding that a transposase mRNA (IS200) can regulate host gene expression provides an 
unexpected twist on our understanding of the host-transposon relationship in bacteria. My 
work has provided novel insight into the function of Hfq and suggests that RNA 
transactions are an important component of host-transposon interactions. 
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6.1 Host-transposon interactions at the RNA level 
6.1.1 Hfq represses IS10 transposase expression by two distinct 
mechanisms 
The serendipitous discovery that Hfq represses IS10/Tn10 transposition provided the first 
example of a host-protein controlling transposase expression at the post-transcriptional 
level (Ross et al, 2010). This work concluded that Hfq repressed RNA-IN translation by 
antisense-dependent and -independent mechanisms. For the former, Hfq accelerated 
pairing between RNA-OUT and RNA-IN 8-fold, suggesting that Hfq could catalyze 
antisense regulation as described for sRNAs.  
Work is presented in Chapter 2 that follows up on this initial finding and shows 
that the distal surface of Hfq binds RNA-IN while the proximal surface interacts with 
RNA-OUT. Overall, Hfq treats the asRNA and mRNA components of the IS10 antisense 
system like a canonical sRNA/mRNA pair. A U-rich internal bulge on RNA-OUT 
engages the proximal surface of Hfq, in contrast to most sRNAs where the proximal 
surface binds the poly-U tail and stem-loop structure of Rho-independent terminators. It 
therefore seems that Hfq employs a single RNA-binding surface to recognize different 
motifs on functionally related RNAs. Antisense RNAs were presumed to be Hfq-
independent because of the extensive complementarity with their target mRNA and it 
therefore was not clear why Hfq would be needed in the IS10 system (Brantl, 2007; 
Thomason & Storz, 2010). IS10 antisense pairing involves 35 bp of perfect 
complementarity, however previous genetic evidence and secondary structure predictions 
suggested that RNA-OUT formed a single stem-loop structure where 24 nts involved in 
antisense pairing were engaged in intramolecular base-pairing (Case et al, 1989; Simons 
& Kleckner, 1983). Initial models for RNA-IN/RNA-OUT pairing relied on the 
assumption that the 5’end of RNA-IN was unstructured. The unstructured 5’end of RNA-
IN interacts with the terminal loop of RNA-OUT and full pairing was believed proceed 
through a strand-displacement reaction where intramolecular base-pairs on RNA-OUT 
were exchanged for intermolecular base-pairs with RNA-IN (Brantl, 2002; Kittle et al, 
1989; Kleckner, 1990; Wagner et al, 2002). My structure probing experiments show that 
the 5’end of RNA-IN is moderately structured (18 nts involved in pairing are involved in 
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intramolecular base-pairs), and this would mean that full RNA-IN/RNA-OUT pairing 
would actually involve a double strand-displacement reaction (i.e. intramolecular base-
pairs on both RNA-IN and RNA-OUT are exchanged for intermolecular base-pairs 
between RNA-IN and RNA-OUT). I propose that RNA restructuring by Hfq would 
bypass the strand-displacement step and this accelerates the rate of full pairing (Figure 
6.1A). This model predicts that more extensive IN-OUT pairing occurs in the presence of 
Hfq and footprinting experiments with 32P-labeled RNA-OUT show that this is the case 
(data not shown). 
Exactly how Hfq alters secondary structure is not clear although new insight into 
the elusive role of the Hfq CTD may provide some clues. RNA-IN interacts with both the 
distal and proximal surfaces of Hfq which is in contrast to many mRNAs that interact 
solely with the distal surface (Sobrero & Valverde, 2012; Updegrove et al, 2016). 
However, an interaction between the proximal surface of Hfq and an mRNA appears to 
be required for sRNA-mRNA pairs where the 5’end of an mRNA is structured (e.g. rpoS, 
(Henderson et al, 2013; Soper et al, 2011); fhlA (Salim & Feig, 2010); glmS, (Salim et al, 
2012); sodB, (Geissmann & Touati, 2004)) (Beisel et al, 2012; Schu et al, 2015; Zhang et 
al, 2013). Recent work suggests that the Hfq CTD antagonizes sRNA binding to the Hfq 
by ‘sweeping’ the proximal surface and promoting dissociation of the RNA from this 
binding site (Santiago-Frangos et al, 2016). An mRNA like RNA-IN would be stably 
engaged with Hfq through the distal surface and interactions between the CTD, proximal 
surface, and the mRNA may promote unfolding. In this way the identification of 
proximal surface binding sites on a mRNA may be an indicator that restructuring is 
employed by Hfq to promote pairing with either an sRNA or asRNA.  
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Figure 6.1. Summary of new insights into post-transcriptional control of 
transposons IS10 and IS200 gained in this work. 
(A) Overview of IS10 antisense pairing in the (i) absence or (ii) presence  of Hfq. Hfq 
(green circles) would not affect the initial interaction between RNA-IN (red) and RNA-
OUT), but complete pairing without Hfq would require a presumably slow double-strand 
displacement reaction to occur for full pairing. Hfq remodels the secondary structure of 
both RNA-IN and RNA-OUT to expose pairing sequences which accelerates full pairing. 
(B) Control of translation initiation for (i) IS10 and (ii) IS200 transposase. (i) 30S 
ribosome binding to RNA-IN is inhibited by RNA-OUT and Hfq binding to the Shine-
Dalgarno sequence (SD). (ii) 30S ribosome binding is inhibited by secondary structure in 
the tnpA 5’UTR that includes the SD. A putative translational enhancer sequence just 
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upstream of the SD may be recognized by ribosomal protein S1 which could tether the 
30S ribosome to tnpA or promote RNA modelling to expose the SD and start codon 
(AUG). Both Hfq and art200 (purple) block this translational enhancer sequence and 
together with secondary structure ensure that translation initiation on tnpA does not 
occur. 
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 In Chapter 3 I investigated the antisense-independent role of Hfq in repressing 
IS10 transposase translation and show that Hfq binding to the TIR of RNA-IN is 
sufficient for inhibiting translation (Figure 6.1B, i). The dispensability of sRNA-binding 
surfaces, in vitro toeprinting experiments, and the correlation between in vitro and in vivo 
experiments measuring Hfq-binding to RNA-IN and the effect on translation all support 
an sRNA-independent regulatory role for Hfq. Notably, this is only the second example 
of Hfq inhibiting translation fully-independent of an sRNA. In the previous example, Hfq 
is proposed to autoregulate its expression by binding to the TIR of hfq mRNA although in 
this case the involvement of an sRNA was not conclusively ruled out in vivo (Vecerek et 
al, 2005).  An important caveat to this form of regulation is that a sustained interaction 
between Hfq and the target mRNA is required for translational control. We tested this by 
inducing other Hfq-binding sRNAs to ask if in vivo competition for Hfq binding would 
lead to derepression of RNA-IN translation. We identified a single sRNA (ChiX) that was 
able to activate IS10 transposase expression by preventing Hfq-binding to RNA-IN. I 
proposed that this was due to ChiX interacting with the distal surface of Hfq which is an 
atypical Hfq-sRNA interaction. Subsequent work has supported this proposal and it 
seems that ChiX is a member of a small class of sRNAs (termed Class II sRNA) that bind 
the distal surface of Hfq (Malecka et al, 2015; Santiago-Frangos et al, 2016; Schu et al, 
2015; Updegrove et al, 2016).  
We have suggested for several years that Hfq could link transposition to stress 
where induction of sRNA would titrate Hfq away from transposase mRNA and this 
would increase translation and subsequently transposition. The characterization of the 
‘direct’ pathway used by Hfq to inhibit translation provides a clear mechanism for how 
this could occur and my experiments with ChiX are proof of this principle. The fact that 
only Class II sRNAs could titrate Hfq away from RNA-IN might ensure that 
transposition is not readily activated in response to other stress-induced sRNAs, the 
majority of which belong to Class I (bind proximal surface only). Alternatively, many 
stresses induce multiple sRNA response pathways and the simultaneous accumulation of 
many Class I sRNAs might lead to transposon activation similar to what we observed for 
a single Class II sRNA. 
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6.1.2 Cooperation between host- and transposon-encoded factors 
controls transposase translation 
My work investigating how Hfq enhances antisense pairing in the IS10 system prompted 
me to ask if other transposons would be subject to similar regulation. An antisense RNA 
was previously identified in the IS30 system although in this case pairing occurs within 
the transposase coding sequence (Arini et al, 1997). One of the first attempts to identify 
novel sRNAs in Salmonella Typhimurium used an Hfq immunoprecipitation (Hfq-IP) 
followed by RNA-Seq of bound RNAs (Sittka et al, 2008). This study identified an Hfq-
binding sRNA (art200) antisense to the 5’UTR of the IS200 transposase mRNA (tnpA) 
and it therefore seemed likely that Hfq would regulate IS200 similarly to IS10. I found 
that art200 represses tnpA translation similar to RNA-IN/OUT in IS10, but in this case 
Hfq does not facilitate pairing. However, Hfq does directly inhibit translation initiation 
on tnpA, albeit to a lesser extent than with RNA-IN. Hfq, art200, and an intrinsic 
secondary structure formed in the tnpA 5’UTR function independently to repress 
translation initiation. Both Hfq and art200 appear to target a putative translation enhancer 
located just upstream of the SD sequence, and subsequent work has found that this 
sequence is important for 30S ribosome binding to tnpA in vitro and translation in vivo 
(M. Ellis and R. Trussler, unpublished data). In this regard, translation of tnpA is 
repressed by intrinsic- (mRNA secondary structure and art200) and host-factors (Hfq) 
that cooperate to inhibit translation initiation by masking the SD sequence (secondary 
structure) and a translational enhancer (Hfq and art200) (Figure 6.1B, ii). 
 It is important to note that in the case of IS10, Hfq enhances antisense control of 
transposase expression but is not absolutely required for the function of RNA-OUT 
((Ross et al, 2010); Chapter 2; data not shown). In this regard, Hfq acts to enhance an 
intrinsic regulator of transposase expression. In contrast, Hfq alone represses translation 
initiation on RNA-IN and tnpA and this form of regulation complements antisense control 
in both systems. For IS10, the dual role of Hfq in regulating transposase expression might 
be important for the normal biology of IS10/Tn10 elements (see section 6.2).  
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6.1.3 Biogenesis of a trans-acting sRNA from a transposase mRNA 
The work presented in Chapter 4 shows that IS200 transposase translation is repressed by 
three seemingly redundant mechanisms. Secondary structure in the 5’UTR of tnpA is the 
strongest repressor of translation followed by art200 and a smaller contribution by Hfq. 
The fact that art200 binds Hfq in vivo but Hfq is not required for antisense control was 
unexpected, and this prompted me to initially ask if art200 has a role independent of 
regulating transposition. Chapter 5 describes my work to address this question and the 
unexpected finding that the transposase mRNA and not art200 controls gene expression 
in Salmonella Typhimurium. I initially believed that art200 could act as an Hfq-
dependent sRNA in part because of an assumption that tnpA was transcribed at very low 
levels, like most transposase mRNAs (Nagy & Chandler, 2004). However, initial RT-
qPCR experiments measuring tnpA expression, combined with Northern blot 
experiments, showed that tnpA was expressed at a level higher than expected and formed 
several stable low molecular weight species. Upon re-examining my RNA-Seq data, it 
became clear that tnpA overexpression had a much greater impact on Salmonella 
Typhimurium gene expression than art200 depletion. The use of progressively shorter 
tnpAtrunc constructs was a key experiment for convincing us that tnpA was in fact the 
regulatory RNA, and this revealed that the sequence determinants for repressing SPI-1 
gene expression were in the first 50 nt of tnpA. Our characterization of RNA processing 
of the tnpA 5’UTR indicates that IS200 encodes a small noncoding RNA that is liberated 
from the tnpA mRNA by RNA processing. At this point I have not determined exactly 
what form of tnpA is active for riboregulation but for invF, it seems most likely that tnpA-
110 is the functional sRNA while tnpA-90 is an inactivated form. The finding that tnpA is 
processed to produce tnpA-110 and then tnpA-90 revealed an additional layer of 
regulation for suppressing TnpA synthesis. Unlike translational control, RNA processing 
would irreversibly silence TnpA expression. The location of the two main processing 
sites implicates art200 as a key factor in directing RNA cleavage, and in this way 
translation repression leads to synthesis of a regulatory RNA and permanent silencing of 
an mRNA. 
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I believe that the contribution of transposon-derived sRNAs to post-
transcriptional regulation of host genes is an under-explored aspect of transposon 
biology. In particular, regulatory RNAs could be an important way that transposons 
interact with the host organism. Transposon-derived sRNAs could be derived from the 
sense or antisense strand of transposase genes in IS elements or be encoded as a stand-
alone gene in a composite transposon. For the former, there are two examples where the 
3’end of an archaeal transposase mRNA produces an sRNA (Gomes-Filho et al, 2015; 
Martens et al, 2013). Although my work represents the only example of a bacterial 
transposase gene producing an sRNA, the two examples in archaea suggest that 
prokaryotic transposase transcripts are a general reservoir for sRNAs. This would add 
transposase mRNAs to the growing list of protein-coding genes that give rise too trans-
acting sRNAs (Chao & Vogel, 2016; Guo et al, 2014; Miyakoshi et al, 2015) Transposon 
asRNAs may also act in trans to regulate other host-encoded genes. Expression of several 
newly identified transposon-encoded asRNAs appears to be regulated in response to 
stress (Dsr30, (Tsai et al, 2015)), growth phase (art200, (Sittka et al, 2008); vc0870, 
(Papenfort et al, 2015)) and nitrogen availability (asRNA036, (Jager et al, 2009)). It is not 
obvious why an asRNA repressing transposase expression would be regulated in such a 
way. One simple explanation is that these asRNAs are also functioning in trans to 
regulate host genes. Although tnpA had a much greater impact on gene expression than 
art200, there were at least 6 genes affected by art200 depletion in Salmonella 
Typhimurium. The above asRNAs would therefore be strong candidates for transposon-
encoded asRNAs that act in trans to affect host gene expression. Lastly, there is to my 
knowledge only a single example of an sRNA that is encoded in the non-IS sequence of a 
composite transposon. sRNA-Xcc1 was first identified in Xanthomonas campestris and 
homologs are found in the chromosomes or associated with integrons in a diverse range 
of bacteria (Chen et al, 2011) (Jiang et al, 2010). In one case, three copies of sRNA-Xcc1 
are located in the plasmid-encoded Tn5542 in Pseudomonas putida ML2.  
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6.2 An integrated model for repression of IS10/Tn10 
transposition by Hfq  
The work presented in this thesis employed a reductionist approach to study the two 
distinct mechanisms by which Hfq represses Tnp synthesis in the IS10/Tn10 system. Hfq 
can repress translation initiation on RNA-IN directly by preventing 30S ribosome binding 
(Chapter 3) and indirectly by catalyzing pairing between RNA-IN and RNA-OUT 
(Chapter 2). However, the role of Hfq must be considered in the context of three 
additional features of IS10/Tn10 biology: (i) Tnp expression is repressed at the 
transcriptional level by Dam methylation at the RNA-IN promoter (pIN) (Case et al, 
1988; Roberts et al, 1985); (ii) the strength of antisense control increases with IS10/Tn10 
copy-number, in large part because RNA-OUT expression from a single element is not 
high enough to repress Tnp expression (Kleckner, 1990; Simons & Kleckner, 1983); (iii) 
only two molecules of Tnp need to be synthesized for transposition to occur (Bolland & 
Kleckner, 1996). The latter point is important because it means that Hfq must inhibit 
essentially all translation on RNA-IN to suppress transposition.  
Direct repression of translation initiation on RNA-IN requires a sustained Hfq 
interaction to prevent 30S ribosome binding. Although Hfq is an abundant protein 
(~10,000 hexamers per cell) there is constant competition amongst cellular RNAs (and 
possibly DNA) for Hfq binding which results in continual cycling of Hfq on different 
RNAs (Fender et al, 2010; Hussein & Lim, 2011; Mandin & Gottesman, 2010; Moon & 
Gottesman, 2011; Papenfort et al, 2009; Updegrove et al, 2016). In the absence of Dam 
methylation, RNA-IN could be transcribed at a level high enough that the available pool 
of Hfq is not sufficient to completely repress Tnp synthesis (Figure 6.2A). In support of 
this the extent of direct repression by Hfq was inversely correlated with the amount of 
RNA-IN produced (cf. Figures 3.2 and 3.5). In fact, a Dam-insensitive transposase-lacZ 
reporter expressed from a high-copy plasmid was almost completely insensitive to Hfq 
regulation (data not shown).  Dam regulation of RNA-IN transcription would therefore 
ensure robust post-transcriptional regulation of IS10/Tn10 by Hfq (Figure 6.2B). When 
IS10/Tn10 is present in multi-copy the total amount of RNA-IN per cell will be higher 
than for a single-copy, and this would likely result in less efficient direct repression of 
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Tnp synthesis by Hfq. However, as IS10 copy-number increases so does the strength of 
antisense control by RNA-OUT. As Hfq acts catalytically to promote pairing between 
RNA-IN and RNA-OUT, the amount of Hfq required for total repression would be 
reduced (Figure 6.2C). 
I envision that Hfq, Dam, and RNA-OUT cooperate throughout the IS10/Tn10 
life cycle to silence transposition. If IS10 DNA is introduced to a new host as single-
stranded DNA (e.g. conjugation or certain bacteriophage) there will be a short amount of 
time where RNA-IN transcription will be high as a consequence of unmethylated DNA. 
Unmethylated DNA could also be introduced from a donor cell without functioning Dam 
methylation. Direct repression of translation by Hfq may be impaired through 
competition between RNA-IN and other RNAs for Hfq-binding, and there could be a 
short time where IS10/Tn10 is active. For the transposon, this could be an important way 
to become unlinked from other mobile genetic elements (i.e. the bacteriophage or 
plasmid) and lead to the transposon becoming stably integrated into the genome of the 
new host. Once DNA methylation on pIN is established by Dam, RNA-IN transcription 
will be reduced and Hfq could inhibit translation completely. A similar situation could 
occur if IS10 DNA is introduced by natural transformation of a high-copy plasmid. The 
RNA-OUT promoter is only ~2.5-fold stronger than pIN, however RNA-OUT is ~50 
times more stable than RNA-IN (Case et al, 1989; Simons et al, 1983). It therefore takes 
time for RNA-OUT to accumulate to a level high for efficient antisense control mediated 
by Hfq. Similar to a short amount of time without DNA methylation, this delay in 
establishing antisense control could provide IS10/Tn10 the time to stably integrate into 
the new host genome. Once RNA-OUT levels increase Hfq acts catalytically through 
RNA-OUT to silence Tnp synthesis. 
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Figure 6.2. Influence of Dam methylation and transposon copy-number on Hfq-
mediated repression of IS10 transposition 
(A,B) A single-copy IS10 element does not produce enough RNA-OUT (blue) for 
antisense control to be a significant regulator of transposase expression. Here, Hfq (green 
circles) represses translation on RNA-IN (red) by direct binding to the SD and blocking 
ribosome access. Dam-mediated methylation on pIN (B) maintains RNA-IN transcription 
at a level low enough that the limited pool of Hfq in the cell is able to fully repress 
translation. In the absence of methylation (A), RNA-IN transcription is increased to a 
point that competition with other mRNAs (orange) or sRNAs (light blue) for Hfq binding 
280 
 
results in some RNA-IN transcripts being translated. (C) The cellular concentration of 
RNA-OUT increases with IS10 copy-number and antisense control becomes an important 
regulator of transposase expression. Hfq acts catalytically to promote RNA-IN/RNA-
OUT pairing and therefore less Hfq is required to fully repress transposase expression. 
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6.3 Is post-transcriptional regulation a general mechanism 
employed by host bacteria to silence transposons? 
In this thesis I have shown that Hfq is a negative regulator of two different transposition 
systems and two distinct mechanisms of regulation have been defined. Hfq also represses 
IS50 and IS1413 transposase expression although for IS50 Hfq is proposed to act 
indirectly to repress transposase transcription, and the exact mechanism for post-
transcriptional repression of IS1413 transposase has not been determined (Munshaw, 
2012; Ross et al, 2014). However, it remains unclear as to the scope of Hfq regulation in 
bacterial transposition systems. Given the work presented in this thesis, one way to 
identify transposons potentially regulated by Hfq would be to mine Hfq-IP RNA-Seq data 
sets to identify transposase transcripts and/or putative asRNAs that bind Hfq in vivo. As 
an example, RNA-Seq data from an Hfq-IP performed in E. coli found that the 
transposase transcripts for IS5 and IS186 showed strong enrichment (7- and 10-fold) in 
the Hfq-IP over total RNA (Bilusic et al, 2014). A similar Hfq-IP experiment in 
Mycobacterium smegmatis found 5 novel asRNAs to transposase transcripts that interact 
with Hfq in vivo (Li et al, 2013).  
 Other RNA-binding proteins may play a role in regulating transposons at the post-
transcriptional level. In particular, recent work identified ProQ as a major RNA-binding 
protein in Salmonella Typhimurium with a preference for structured asRNAs (Smirnov et 
al, 2016). Of note, art200 was one of the most abundant RNAs recovered in a ProQ-IP, 
implicating this poorly characterized host protein as a regulator of IS200. We have 
preliminary data showing that tnpA-lacZ expression increases in a DproQ strain of E. coli 
(R. Trussler, unpublished data) and I expect that future work will demonstrate that ProQ 
promotes antisense pairing with tnpA. If ProQ is required for art200-tnpA pairing this 
would explain my difficulty in measuring pairing despite the extensive complementarity 
between the two RNAs.  Over 17 putative asRNAs to transposase transcripts have been 
identified in Gram-negative and Gram-positive bacteria (Ellis & Haniford, 2016), and 
ProQ and/or Hfq may be required for their function as described here for IS10.  
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6.4 Concluding remarks 
Almost 70 years have passed since McClintock’s first proposal of a dynamic genome. 
The entire field of modern genetics was founded on the principle that chromosomes are 
unchanging and therefore predictable. Of course geneticists understood that 
chromosomes could accumulate small mutations and underwent recombination and 
segregation during meiosis but in general chromosomes were thought to be static with 
fixed positions for genes. McClintock’s discovery of transposable elements that could 
move throughout a genome and alter a phenotype was so widely dismissed that she 
withdrew from the scientific community within ten years of publishing her landmark 
papers. Transposons are now appreciated as major drivers of evolution and genome 
plasticity. In bacteria, transposons have a profound impact on their host and this thesis 
provides a small glimpse into the remarkable complexity of transposable elements. As we 
enter the post-genomics era it is becoming clear that there is no such thing as a standard 
genome and transposons play a large role in generating this diversity. I also think it likely 
that we will continue to discover new and unexpected ways that transposons affect their 
host in all domains of life. 
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